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  Radiomics, an advanced form of imaging analysis, is a growing field of interest in 
medicine.  Radiomics seeks to extract quantitative information from images through use 
of computer vision techniques to assist in improving treatment.  Early prediction of 
treatment response is one way of improving overall patient care.  This work seeks to 
explore the feasibility of building predictive models from radiomic texture features 
extracted from magnetic resonance (MR) and computed tomography (CT) images of 
lung cancer patients.  First, repeatable primary tumor texture features from each 
imaging modality were identified to ensure a sufficient number of repeatable features 
existed for model development.  Then a workflow was developed to build models to 
 
 
 
 
xviii 
predict overall survival and local control using single modality and multi-modality 
radiomics features.  The workflow was also applied to normal tissue contours as a 
control study.  Multiple significant models were identified for the single modality MR- 
and CT-based models, while the multi-modality models were promising indicating 
exploration with a larger cohort is warranted.    
Another way advances in imaging analysis can be leveraged is in improving accuracy of 
contours.   Unfortunately, the tumor can be close in appearance to normal tissue on 
medical images creating high uncertainty in the tumor boundary.  As the entire defined 
target is treated, providing physicians with additional information when delineating the 
target volume can improve the accuracy of the contour and potentially reduce the 
amount of normal tissue incorporated into the contour.  Convolution neural networks 
were developed and trained to identify the tumor interface with normal tissue and for 
one network to identify the tumor location.  A mock tool was presented using the output 
of the network to provide the physician with the uncertainty in prediction of the interface 
type and the probability of the contour delineation uncertainty exceeding 5mm for the 
top three predictions.   
  1 
 
1 Introduction 
 
 
 
Advances in computer science and technology in medicine have opened new 
avenues of research to assist in the personalization of medicine.  Particularly in the area 
of cancer treatment, there has been an increased interest in individualized therapy to 
improve patient outcome.  The need for further individualization of treatment stems from 
the fact that cancer is a multi-faceted disease that is unique to almost every patient.  
Cancer is caused by one or more mutations that cause a cell to divide continuously by 
suppressing its ability to “switch off” when in close contact with other cells.  Normally, 
these aberrant cells are detected by the body and the immune system removes them 
before they can cause harm.  However, cancer cells have adapted ways of tricking the 
immune system into ignoring them and in some cases even helping them to grow.  As 
solid tumors get larger, they coerce the body into providing them with a network of blood 
vessels through angiogenesis to fuel their growth while simultaneously reducing the 
available nutrients for the rest of the body. As cancer is a result of mutations to an 
individual’s deoxyribonucleic acid (DNA), the resulting cancer cells are as unique as the 
DNA from which it mutated. 
In the early days of cancer treatment, there was a one size fits all approach. Every 
patient was treated the same way, however, some patients responded while others did 
not.  As we learned more about cancer physiology and the interactions between radiation 
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and the body, new techniques were developed to reduce exposure of the normal tissue 
and organs, and to better target the cancer lesions.  Research began to uncover which 
genetic mutations were present in patients who responded to treatment and those who 
did not, and which mutations lead to higher risk of developing cancer.  Existing treatments 
began to be individualized, different amounts of radiation were prescribed to individuals 
with the same cancer location, and alternative treatments such as chemotherapy were 
developed.  Combinations of different treatment techniques were employed for some 
cancers.  More recently, immunotherapy has grown to further target individual mutations 
to improve results.  Researchers have also begun to incorporate research from the field 
of computer vision to advance our understanding of cancer and to improve the ability to 
locate and treat cancer lesions. 
Medical images are acquired in nearly every cancer treatment diagnosis and during 
cancer treatment and response verification.  These images provide a snap shot of the 
current tumor environment at a macroscopic level.  The ability for the human eye to 
discern phenotypic features of a lesion is limited by the spatial resolution of the image 
being viewed and the observer’s ability to discern complex patterns, such as the range of 
characteristics present in a solid tumor, which can take years of training. During tumor 
growth, angiogenesis typically results in a network of chaotic blood vessels that leads to 
areas of proliferating cells, hypoxia, and necrosis as the nutrients source grows further 
away. Biopsies can only sample a small area of the tumor, leaving physicians without a 
detailed picture of the whole tumor volume and taking enough biopsies to characterize 
the full tumor volume would be extremely uncomfortable for the patient.  The use of 
medical images has an advantage over biopsies due to their non-invasive nature and 
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ability to capture the full tumor volume. The underlying biology of a tumor, such as the 
cell sizes, density, amount of vascularization and areas of necrotic, or dead, tumor and 
actively proliferating tumor, cannot easily be detected in medical images with high 
precision at present.  One area of active research in radiation oncology is to use computer 
vision techniques, such as texture analysis, to identify phenotypic signatures of the 
tumors to inform treatment options.  The biological differences in tumors are hypothesized 
to lead to changes in the visible tumors which may appear through more advanced 
analysis of the medical images.  By identifying these patterns, researchers may be able 
to link these differences to the underlying pathophysiology and more successful treatment 
regiments, thereby improving patient outcome and quality of life. 
In cancer treatment, there are two competing objectives: to eradicate the tumor cells 
and to prevent damage to the normal tissue. One of the best ways to reduce damage in 
healthy tissue is to reduce the amount of radiation delivered to it.  During the course of 
radiation treatment, the physician outlines the boundaries of the tumor or structure to be 
treated during contour delineation.  This contour of the tumor is referred to as the gross 
tumor volume (GTV).  The GTV is expanded upon during the treatment planning process 
by a margin to account for microscopic disease that is not evident to the human eye on 
the images.  The expanded volume is referred to as the clinical target volume (CTV).  
Depending on the treatment method, the CTV is expanded again to account for 
uncertainty in the ability to localize the tumor during treatment, such as set-up 
inconsistencies, mechanical tolerance of the equipment, etc., into the planning target 
volume (PTV).  For lung cancer and other mobile tumors, the CTV is first expanded into 
an internal target volume (ITV) due to the large amount of motion that can occur during 
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breathing combined with cardiac motion.  An ITV is constructed from a free breathing 
computed tomography (CT) scan where the entire path of the tumor from end inhalation 
to end exhalation is considered part of the ITV. This ITV is again expanded into a PTV to 
account for the uncertainty in set-up and mechanical tolerances.  During treatment, the 
prescribed radiation dose is delivered to the entire PTV with a desired coverage 
percentage, usually 95%. The larger the margins used to expand the tumor, the more 
normal tissue may be included in the treated volume and thereby irradiated to higher 
doses, increasing the chance of damage to the normal tissue.  On the other hand, margins 
that are not large enough risk missing a portion of the tumor, allowing it to recur and the 
patient to potentially undergo treatment again.  Recent advances in machine learning 
have shown the ability for a computer to learn how to differentiate between classes of 
images and locate different objects of interest by learning different features present in the 
images.  These networks are being actively explored to segment an image and could, in 
the future, assist with defining the target volumes with greater accuracy. 
This work will explore two different avenues of improving individualized treatment: 
using texture analysis to explore correlations between medical images and treatment 
response, and using machine learning via deep neural networks to improve contour 
delineation uncertainty.  The following section provides further details on the treatment 
process for non-small cell lung cancer (NSCLC), image types, predictive modeling 
through radiomics, contour delineation uncertainty, and techniques for image 
segmentation/classification using machine learning.  The section concludes with an 
overview of the dissertation, specific aims, and innovation. 
  5 
1.1 Non-Small Cell Lung Cancer  
Lung cancer is the second most commonly diagnosed cancer in the United States 
behind skin cancer, and has the highest mortality rate of any cancer for both men and 
women in the world.1, 2  The World Health Organization estimates 19.4% of cancer related 
deaths are from lung cancer.2  The overall incidence rates for lung cancer have been 
declining; however, the overall 5-year survival rate for  all stages of lung cancer remains 
poor at 17.7%.3  Lung cancer has two main classifications, small cell lung cancer and 
NSCLC.  NSCLC, which is the focus of this work, accounts for approximately 86% of 
diagnosed lung cancer cases.4  As with most cancers, the earlier the cancer is diagnosed, 
the better the chance of survival.  Unfortunately, only 16% of cancers are diagnosed at a 
local stage which has a survival rate of 59.2%.3 For the majority of NSCLC patients, the 
cancer is more advanced at the time of diagnosis with 55% of patients being diagnosed 
with distant tumor spread and 24% being diagnosed with local-regional spread where 
there is a 31.4% 5-year survival rate.3   
NSCLC is typically diagnosed by a chest CT image, and the identified nodules are 
biopsied to determine histology.  In addition to the CT scan, a positron emission 
tomography (PET) image is typically acquired to help identify involvement of lymph nodes, 
metastases, and active tumor, especially in presence of collapsed lungs, called 
atelectasis, or other pathologies that make the tumor boundaries difficult to ascertain from 
CT images alone.  Atelectasis typically occurs near the tumor where the lesion growth 
has obstructed one or more air ways.  Depending on the location, this could collapse a 
small portion of the lobe, the entire lobe, or the entire lung.  Lung cancer can metastasize 
to different areas of the body, but most frequently metastasizes to the lymph nodes, 
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adrenal glands, and brain. For advanced stage lung cancer, a brain magnetic resonance 
image (MRI) is also typically obtained to check for metastasis as the PET scan would not 
be sufficient.  The high level of activity in the brain causes a proportionally high uptake of 
the PET tracer obscuring the location of any metastasis making MR, which has excellent 
soft tissue contrast, the ideal image for diagnosing metastases to the brain. 
As mentioned earlier, a biopsy is often taken in order to determine the histology of 
the tumor and also to look for the presence of genetic markers.  There are three common 
types of histology for NSCLC: adenocarcinoma, squamous cell carcinoma, and large cell 
carcinoma.  The adenocarcinoma typically begins development in the alveolae of the lung 
and is slower to grow. Squamous cell carcinoma typically begins in the cells that line the 
airways of the respiratory track and is faster growing than adenocarcinoma.  The large 
cell carcinoma has large and abnormal cells and is assumed to have neuroendocrine 
origin.  
Several different treatment options for NSCLC exist, and the treatment selected 
depends on several factors including location, size, and stage of tumor as well as the 
overall health of the patient.  For early stage and smaller tumors where the patient is 
healthy enough to withstand removal of part or all of a lung, the tumor can be removed 
by surgery.  Surgical options include pneumonectomy, lobectomy, segmental resection 
or video assisted thoracic surgery (VATS). Pneumonectomy removes the entire affected 
lung while a lobectomy removes the entire affected lobe.  If the tumor is small enough, 
only a portion of the lobe can be removed through a segmental resection or VATS. 
Surgery can be combined with radiation and/or chemotherapy to treat any possible 
microscopic disease remaining following surgery. When surgical resection is not possible, 
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radiation therapy with or without chemotherapy is the common course of action. 
Depending on which genetic markers are present, there are several emerging and 
established immunotherapy treatments that can be used to increase the overall survival 
of patients, protect normal tissue, or increase effectiveness of the radiation or 
chemotherapy.  During radiation therapy, high energy photos or protons are aimed at the 
lesion from several different angles.  As these photons and protons travel through 
different mediums, they deposit energy to the surrounding tissue or air.  The amount of 
energy imparted to the medium by charged and uncharged particles interacting within the 
volume per unit mass is referred to as the absorbed dose an is measured in Gray (Gy). 
During radiation treatment, typically the tumor is treated to a prescribed dose of between 
50-70 Gy.  Small tumors are candidates for Stereotactic Body Radiation Therapy (SBRT) 
where a small number (typically 1-5) of high dose treatment sessions, or fractions, are 
delivered to the tumor with ablation as the goal.  Larger tumors receive smaller dose 
fractions, approximately 1.8-2 Gy at a time, over a longer period of time, typically 6 weeks.  
The goal of the radiation treatment is to induce tumor cell death by destroying the 
DNA or preventing further cell division.  The radiation dose that is delivered to tissue can 
directly or indirectly damage the cells.  Direct damage is when the photon, or charged 
particles that the photon has excited such as electrons, interact with the DNA strands and 
break them.  More commonly these photons and charged particles cause indirect damage 
by interacting with the water in the body to create free radicals that damage the DNA.  
The higher the dose, the more damaging interactions occur.  As previously mentioned, 
the beams are spread out at different angles in order to reduce the dose delivered to the 
healthy tissue while overlapping the beams within the tumor and delivering the full 
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prescription dose.  In addition, breaking the total dose to be delivered into smaller 
fractions allows the healthy tissue to repair damage to the DNA between treatment 
sessions and can reduce the risk of normal tissue complications.  Tumor cells are also 
able to repair during the time between fractions, but they are less efficient and are 
preferentially damaged during radiation therapy. 
Response to radiation treatment is often determined by the response evaluation 
criteria in solid tumors (RECIST).  The RECIST criteria are based on a change in the sum 
of the longest diameter(s) of the lesion(s) and involved lymph nodes.  Treatment response 
is classified as complete response, partial response, progressive disease, or stable 
disease depending on the percentage decrease or increase in this longest length.5, 6 Lung 
tumors are known to shrink during the course of radiation treatment with various studies 
finding approximately 1.2% reduction of the tumor volume per day,7 or 44-51% reduction 
in volume by the end of treatment.8, 9 However, the decrease is not consistent from 
fraction to fraction.8  Therefore, final tumor response often cannot be determined using 
RECIST criteria until weeks following the completion of treatment. There is a desire to 
predict the treatment response earlier in order to provide the best patient care. By 
predicting response and tumor control earlier, physicians can potentially change the 
treatment regimen by modifying overall tumor dose, fractionation schedule, 
chemotherapy regimen, treatment goal, and other options. The additional information 
before or early into treatment also allows for the patient and physician to make better 
informed decisions about continuing and follow-up care. Researchers have been 
exploring various methods of predicating the tumor response with particular emphasis on 
pretreatment and early treatment features based predictive models. 
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1.2 Medical Imaging 
The models mentioned before are in part based on imaging features, including 
texture features, extracted from images that are routinely used in the treatment of various 
tumors and are acquired at various stages of the treatment process according to the 
individual studies.  Diagnostic images are used to determine the type and location of a 
lesion and to suggest areas for biopsies.  Once the cancer is diagnosed, planning or 
simulation images are taken.  The gold standard for radiation therapy is the CT image.  
The treatment process begins by acquiring CT simulation images of the patient in the 
treatment body position with any immobilization devices that will be used throughout the 
treatment process. These images are transferred to the treatment planning system and 
used to define the treatment target(s), organs at risk (OARs), and accurately construct 
the dose deposition within the body.  The tumor and OARs delineated on the planning CT 
images are typically used throughout the treatment process.  If the patient undergoes 
significant changes during treatment, such as drastic weight loss, resolution of 
atelectasis, or significant tumor volume reduction, additional CT images would be 
acquired to determine the need for re-planning. Follow-up CT images are used to 
determine the RECIST classification of a patient after completion of treatment.  Cone 
Bean Computed Tomography (CBCT) images are acquired prior to treatment to insure 
correct patient alignment and to monitor changes in patient anatomy for significant 
changes.   
For lung cancer and other advanced cancers, a PET scan is often taken in addition 
to the planning CT.  Unlike a CT image, PET images show little to no anatomy and are 
functional images instead. Radioisotope-labeled glucose, typically Fluorine 18 labeled 
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fluorodeoxyglucose (18F-FDG), is injected prior to the image acquisition. The intensity, or 
brightness, of a PET image is directly related to the uptake of the labeled glucose in the 
active tissue.  Since actively proliferating tumor cells have a higher metabolic need than 
the surrounding health tissue, the active tumor appears bright on the PET images. The 
PET image is useful in determining the lymph node involvement, identifying any distant 
metastases, and distinguishing tumor from similar appearing tissue surroundings such as 
near atelectasis. These PET images are frequently registered to the planning CT and 
used to assist in the delineation of the tumor in the previously mentioned cases.   
MRI has superior soft tissue contrast to CT images and is the imaging modality used 
extensively for brain tumors.  The contours are delineated for the brain on the MR image 
before being registered with the planning CT and transferred.  For lung tumors, it is hoped 
that the improved soft tissue contrast will aid in contour delineation near the mediastinum 
and in distinguishing between atelectaisis and tumor.  Depending on the imaging signal 
sequence applied to the tissue, MR scanners can generate anatomical images or 
functional images.  One example of functional MR imaging is the diffusion weighted (DW) 
sequence.  DW imaging seeks to capture the motion of water in and around cells.  A 
sequence of diffusion gradients are applied to the tissue to produce different signal 
strengths related to the amount and direction of water movement. More restricted water, 
such as in areas of inflammation due to injury, appear brighter and freely moving water 
appears darker.10 The DW images are acquired at different b-values, or strength of 
diffusion weighting as described by equation ( 1 ), typically at least a low b-value and a 
high b-value.   
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𝑏 = 𝛾$𝐺$𝛿$ Δ − )* 																																																																		( 1 ) 
Where 𝛾 is the gyromagnetic ratio of the element of interest, most commonly hydrogen, 𝐺 is the amplitude of the diffusion gradient pulse, 𝛿 is the duration of the diffusion gradient 
pulse, and Δ is the time between diffusion gradient pulse pairs.  At least two different b-
value DW images are then used to generate the apparent diffusion coefficient (ADC) map 
which captures the magnitude of diffusion of water within the tissues.  The ADC map is 
being researched as an alternative functional imaging modality to PET imaging. The ADC 
map’s intensity has the inverted meaning of the DW images where a dark signal indicates 
areas of restricted water movement. In tumor cells, the movement of water is more limited 
given the irregular shape and spacing of the cells in the tumor mass and necrotic regions 
which, similar to the standard uptake value (SUV) in PET images, can better discriminate 
between tumor and healthy tissue than anatomical appearance alone.  Several MRI 
sequences are designed to show anatomical features, unlike PET, potentially allowing for 
better specificity in location given the clearer definition of the anatomy without the 
additional CT scan. These anatomical MR images can be acquired in the same session 
as functional MR image sequences. Furthermore, the spatial resolution of a PET image 
is relatively poor when compared with CT and MR images, so a functional MR image 
could potentially increase the target definition.  For these reasons, there has been an 
increased interest in exploring the potential of MR in lung cancer predictive modeling as 
will be explored in this work. 
1.3 Predictive Modeling 
Predictive modeling is using patient data to discern trends that have the ability to 
give insight into the likely response to therapeutic treatment. These predictive models will 
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hopefully provide insight into probable treatment response allowing physicians to adapt 
treatment plans as necessary, determine appropriate follow-up care, and provide more 
detailed information to patients.  Statistical analysis of retrospective patient data is 
preformed to identify which factors correlate with desired or adverse outcomes. The 
patient data used in predictive modeling ranges from clinical factors, such as tumor stage, 
volume, location, and lung function test performance, to more advanced imaging features 
derived from computer vision techniques and radiomics and, more recently, genomic 
data.  The hypothesis underlying most of these studies is that the tumor microenvironment 
exhibits observable characteristics that can be used to predict response to different 
treatment regiments.  For lung cancer patients, overall survival, local control, freedom 
from distant metastasis, and radiation induced lung injury are the major clinical outcomes, 
or endpoints, that have been explored. Different modeling techniques have been explored 
including single modality image analysis for pretreatment images and, more recently, time 
series analysis on images acquired at multiple time points during the course of treatment. 
CT and PET are the most commonly studied imaging modalities for lung cancer, but with 
superior soft tissue contrast, MRI is experiencing increased interest. 
Pre-treatment images are of particular interest to researchers as they have the 
potential to provide insight into a treatment before it begins.  One model, by 
Balagurunathan et al.,11 found texture features related to homogeneity of the tumor were 
significant predictors in overall survival.  In particular, tumor with indicators of high  
homogeneity were predictive of longer survival.11   Another later model by Fried et al.,12 
used texture features extracted from pretreatment 4D contrast enhanced CT images and 
the 50% phase of the 4D CT image to stratify patients into risk groups based on Kaplan-
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Meyer curves.  They found a significant improvement in the stratification over models that 
only used clinical prognostic features.  The model’s classification repeatability was 
approximately 80% for overall survival, local regional control, and freedom from distant 
metastasis.12  Coroller et al.13 used pretreatment CT scans to predict distant metastases 
in lung cancer for adenocarcinoma histology.  They investigated features from the CT 
images, such as texture and shape descriptors, and clinical factors, such as the 
pretreatment tumor volume, for their ability to predict distant metastases.  Univariate 
analysis identified 35 prognostic features and multi-variate analysis was used to create a 
final model.  The final model with the combined clinical factors demonstrated a significant 
improvement in identifying patients with distant metastasis, p-value= 1.56 x 10-11.13   
In developing predictive models, the emphasis has primarily been on pretreatment 
imaging features and longitudinal studies have not been conducted in many instances.  
One early longitudinal predictive model for tumor response by Bral et al.,14 looked at the 
amount of volume regression as a predictor for metabolic complete remission of NSCLC.  
They found, by calculating the regression coefficient from fitting the volume change to a 
negative exponential curve and using a cut off of 0.03, they could predict the non-
responders with 80% accuracy while misclassifying only 16.4% of patients who achieve 
complete remission.14 George et al.,15 evaluated PET images acquired at two different 
time points: pretreatment and follow-up.  Texture features were extracted from the regions 
of interest (ROIs), in the case of this study the tumor volume, and used to create a 
subspace signature, which defines the collection of features identified by principal 
component analysis (PCA) to explain the most variation, for each subject at each time 
point.  Using the distance between the subspaces of two time points, the study was able 
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to predict the RECIST classification with an area under the time dependent receiver 
operating characteristic (ROC) curve of 0.6676 to 0.6817.15  This study only included 
imaging features extracted from PET images. In another study, Jabbour et al.,16 used the 
lung tumor volume reduction seen from weekly CBCT images acquired prior to treatment 
fractions from day 1 to end treatment on day 43.  The Cox proportional hazard models 
showed a 44.3% decrease in death for every 10% decrease in tumor volume between 
day 1 and day 43.16  More recently, Fave et al.17 explored the change in texture features 
extracted from weekly 4D CT scans’ ability to increase the predictive power for local 
recurrence, survival, and freedom from distant metastasis.  They found adding the change 
in texture features did improve the model for overall survival when compared to clinical 
factors and pretreatment features alone, but the same was not true of models predicting 
distant metastasis. They also found local recurrence was significantly predicted by the 
change in texture features alone.17  
1.3.1 Radiomics 
Recently, the fields of radiomics and radiogenomics have gained popularity.  The 
field of radiogenomics combines the information from clinical data and extracted imaging 
features with genetic markers to identify correlations between imaging features, genetic 
markers, and clinical information to predict a variety of clinical endpoints or genetic 
expression.18–20  Radiomics, on the other hand, seeks to combine features extracted from 
imaging and clinically available information to identify potential imaging biomarkers and 
utilize features in ways to predict response,11–13, 21–24 segment tissue,25, 26  classify lesions 
as benign or malignant,27–30 and evaluate other characteristics of a tumor.31–34  One 
advantage to investigating texture and other imaging features is the non-invasive nature 
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of the imaging.  Images are routinely acquired as part of the radiation therapy workflow, 
and therefore, by using those images, the patient is afforded no additional dose or time 
requirements.  The main advantage to extracting the imaging features is it quantifies 
characteristics of the intensity level patterns in the images that may not be readily 
apparent to a human observer.   Imaging, unlike a biopsy, is able to assess the entire 
tumor volume and quantify the patterns of heterogeneity within the tumor.  These patterns 
are hypothesized to arise from physiological and genomic characteristics of the tumor 
giving the physician insight into radio resistance and/or sensitivity, and genetic expression 
which, in turn, can influence treatment decisions.35, 36  
The general workflow for radiomics is comprised of three basic steps: imaging, 
feature extraction, and analysis.  The process begins with image acquisition in which 
single or multiple imaging modalities acquire images of the target. After image acquisition, 
the ROIs are defined specific to the problem being addressed and features are extracted. 
The extracted features are then analyzed for the end goal of the study, Figure 1.36  Each 
step has its unique challenges.  Multiple aspects of image acquisition can affect the 
features extracted from the images including different manufactures, reconstruction, slice 
thicknesses, imaging protocol, and contour delineation methods.29, 34, 37–41  Target 
delineation and generation of predictive modeling are two common uses for the extracted 
features.  Delineation seeks to identify regions that exhibit distinct characteristics from the 
surrounding medium that helps define the location of a tissue or ROI, where predictive 
modeling seeks to identify the features within an ROI that are correlated with treatment 
outcome or other clinical endpoints. There are thousands of possible features that can be 
extracted from the ROIs. This, coupled with various image preprocessing steps, makes 
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radiomics a very high dimensional problem.  High dimensional problems with limited data 
introduce another challenge: insufficient data to evaluate all the potential parameters.  As 
a result, different methods for reducing the number of features have been employed and 
analysis should control for false discovery rates.  Feature reduction seeks to employ 
statistical techniques to reduce the number of correlated features, thereby reducing 
redundancy, and to evaluate the features that are most clinically relevant.  By decreasing 
the number of features, the dimensionality of the problem is reduced.  False discovery 
rates arise when multiple hypotheses are being tested using same data.  If a large number 
of features are tested for significance, then some of them are bound to be significant due 
to chance.  If 100 features are tested at the 5% error rate, 5 features can be expected to 
be significant by chance alone.  A more detailed description of false error rate control can 
be found in 2.4 False Error Rate Control. While early research shows there is potential 
promise in radiomics, experts stress an overall need, as this field of study matures, to 
create best practices and standardize methods.36, 42–44 
  17 
 
In the following section, the texture features and image processing steps employed 
for this work will be described in further detail.  The texture features and imaging 
processing steps used are not intended to be an exhaustive sampling of all available 
texture features and image processing techniques but, rather, an application of the 
frequently reported and promising techniques from lung and other sites applied to NSCLC 
for MR and CT images. 
1.3.1.1 Texture	Features	
At the core of radiomics are the image features.  There are several types of image 
features that can be extracted from an image, many of them stemming from the field of 
Figure 1: Visual representation of the radiomics workflow.  The target is defined (top 
left), features are extracted (top right) and analyzed for the study end goal (bottom). 
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computer vision.  Information about the tumor volume, surface area, and shape can be 
determined from the physician delineated contours.  Texture features can be calculated 
to describe the different patterns of intensity within the contour or a neighborhood 
surrounding a location of interest. Texture analysis, or the use of texture features to 
describe an image, is used in the field of computer vision to classify images, perform 
segmentation, enrich details of objects in video games, and determine the shape of an 
object.45–47  First order texture features include basic histogram features derived from the 
intensity values.  Higher order texture features include the gray level co-occurrence matrix 
(GLCM), gray run length matrix (GLRLM), neighborhood gray tone difference matrix 
(NGTDM), gray level size zone matrix (GLSZM), and others which seek to capture 
spatially varying texture features.  These texture features are frequently investigated in 
the literature and are regarded as the easiest to compute.22   
The histogram texture features are the more traditional texture features relating to 
the intensity distribution within the ROI and do not include spatial information.  The ROI 
is first defined using autosegmentation, semi-automatic segmentation, or manual 
delineation.  Afterwards, a histogram of the intensity levels is created and used to 
compute statistical descriptions of the intensity distribution such as the mean, minimum, 
maximum, standard deviation, skewness, etc. Figure 2 shows an example of an intensity 
histogram derived from an example image slice. 
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The GLCM extracts features based on the probability of pixels (2D) or voxels (3D) 
at a given distance apart being from two different gray levels.48–51  The GLCM is an N by 
N matrix where N is the number of gray levels in the image matrix post any desired 
processing.  There are two hyper parameters that govern the GLCM calculation: the 
direction and the distance.   Each element in the GLCM matrix, p(i,j), represents the 
number times pixels/voxels of gray level i and j appear in a designated direction such as 
0, 90, or 45 degrees and distance, such as 1, 2 or 5 pixels/voxels, away from each other, 
seen in Figure 3. This matrix is normalized prior to calculation of the texture features 
making each element represent a probability as opposed to the number of elements.  The 
GLCM as described by Haralick et al.48 is symmetric and therefore p(1,2) is the same as 
p(2,1). By exploiting this symmetry, the number of connections needed to fully describe 
the image is reduced by a factor of two.48  A different GLCM can be calculated for each 
combination of the connection directions and distances.  In order to make the features 
more robust, the average of the 4 connected directions for 2D or the 13 directions for 3D, 
when exploiting symmetry, can also be averaged together thereby removing the 
directional dependence of the texture features.   
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Figure 2: Sample image with corresponding histogram.  The 
highlighted portion of the image corresponds to the highlighted count in 
the histogram. 
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The GLRLM describes features extracted from the probability of pixel or voxel with 
the same gray levels having an unbroken linear connection along a give direction of 
varying lengths.52–56  The GLRLM is an N by M matrix where N is the number of gray 
levels and M is the length of the longest continuously connected run of a single gray level 
in the specified direction, see Figure 4. Originally, the directions used were the principal 
directions such as 0 and 90 degrees as opposed to 45 degrees, but the diagonal 
directions can be calculated as well.  This type of analysis is useful in evaluating the linear 
structure of an image.  Each element in the GLRLM, p(i,j), represents the number of runs 
of gray level i with length j. The GLRLM is normalized before calculating the texture 
features and each element in the matrix now represents the probability of having a gray 
level i with length j.  The different directions can be averaged together like the GLCM to 
increase robustness by calculating a directionally independent feature.  The original  
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Figure 3: Sample image with corresponding gray level co-occurrence matrix(GLCM).  
Here the 0 degree and, with symmetry, 180 degree angles along the x-axis at a 
distance of 1 pixel hyper parameters are being used to calculate the GLCM. The 
highlighted boxes show corresponding calculations.  Notice the blue highlighted boxes 
in the image correspond to a value of 2 in the GLCM due to symmetry. 
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features proposed by Galloway52, were inspired by the Haralick features and  later papers 
expanded these features.53–56  
 
The GLZSM is an extension of the GLRLM in which connections in all directions are 
considered not just linearly in one direction.57, 58  The GLSZM is a N by M matrix where N 
is the number of gray levels desired in the image, and M is the number of pixels/voxels, 
making up the largest connected patch of a single gray level.  Each element of the 
GLSZM, p(i,j), represents the number of clusters of gray level, i, being comprised of a 
total j pixels/voxels, see Figure 5.  Unlike the two previous texture feature classes, the 
GLSZM does not have a directional dependence. Cluster sizes are determined by looking 
for pixels/voxels of the specified gray level that are adjacent to another pixel or voxel of 
the same desired gray level in any of the 8 (2D) or 26 (3D) connected directions and 
continuing until all connected pixels or voxels are identified.  Where the GLRLM captures 
linear structural information, the GLSZM, which was originally developed by Thibault et 
al.58 to classify cell nuclei, seeks to provide insight into large homogenous areas and 
intensity changes.  Prior to calculating the texture features, the matrix is normalized again 
transforming the raw counts into probabilities. The texture features calculated from the 
GLSZM are the same as for the GLRLM. 
Figure 4: Sample image with corresponding gray level run length matrix(GLRLM). 
The run length along the x+ direction is calculated with highlighted boxes showing 
corresponding calculations. 
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The NGTDM extracts features from the variation of gray levels in a local 
neighborhood around a selected pixel or voxel.59 The NGTDM is a 1 by N matrix where 
N is the desired number of gray levels. Unlike the other texture feature matrices, the 
elements of the NGTDM are not based on the number of different gray levels in a defined 
relationship with the gray levels spatial connected to it, but rather the average of the gray 
levels surrounding pixels/voxels of the specified gray level.  The NGTDM element values, 
p(1,i) represent the sum of average difference between pixels/voxels of intensity i and 
their surrounding neighbors throughout the entire ROI.  First, the average gray level in a 
neighborhood of defined size, such as the elements directly connected to the central pixel 
or voxel, of a desired gray level, i, excluding the central pixel or voxel of interest is 
calculated.  Then this average is subtracted from the central gray level, i, of interest 
thereby calculating the neighborhood gray tone difference.  This calculation is repeated 
for every pixel/voxel of intensity, i, throughout the valid portion of the image.  Finally, all 
the calculated differences per value of i are summed together to create the final element 
p(1,i) value in the NGTDM.  The valid portion of the image includes all pixels/voxels whose 
surrounding neighborhood is completely within the image boundaries.59  As with the other 
Figure 5: Sample image with corresponding gray level size zone matrix (GLSZM).  
Connections in any direction are considered in determining the zone size.  Highlighted 
boxes show corresponding calculations.  
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matrices, the values are normalized prior to calculating the texture features.  An example 
of the NGTDM can be seen in Figure 6. 
  
Texture features are dependent on the distribution of gray levels within the image. 
As such, even subtle changes to the gray level intensities can alter the value of the texture 
features calculated.  Ways to reduce or change this dependence can include quantizing 
the data into fewer bins than the number of gray levels in the ROI, and applying filters to 
strengthen texture features either directionally, as with wavelet filters and Gabor filters, or 
by scale, as with Laplace of Gaussian filters.  Wavelet filters act as simultaneous low and 
high pass filters and decompose an original image into pure edge (high pass), pure 
contrast (low pass), and combination of directional edges and contrast images.60  For a 
3D-image, the image is decomposed into 8 different images by applying different 
permutations of either the high pass or low pass portion of the filter on the row, column, 
and slice directions.  The decomposed image can be reconstructed with different weights 
to emphasize edges or contrast in different directions or throughout the image.  The 
Laplace of Gaussian filter identifies intensity changes within an image via the Laplace 
gradient operator after Gaussian blurring has been applied to the image.  The Gaussian 
Figure 6: Sample image with corresponding neighborhood gray tone difference 
matrix (NGTDM).  The average of the non-highlighted cells within the red box is 
subtracted from the highlighted central box in the image to calculate the highlighted 
value in the NGTDM. 
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filter blurs the features finer than the chosen width, allowing emphasis of different 
coarseness levels of detail.28  Gabor filter banks are similar to wavelets in that they are 
spatially and directionally defined; however, they have the form of a Gaussian modulated 
complex sinusoidal that highlights edges along the given direction and spacing.  These 
filters can be made rotationally invariant by either using a circularly symmetrical filter61 or 
by aligning the feature vectors for each image along the highest total energy, or dominant 
orientation, filtered image.62 
1.3.1.2 	Biomarker	Characteristics		
In order for the texture features extracted from the image to be clinically useful, they 
must meet certain requirements.  The potential for using radiomics features as biomarkers 
is still under investigation with varying degree of success having been reported thus far.  
Some features, such as the SUV in PET, have been studied in greater detail and can be 
linked to tumor characteristics such as metabolic activity.63  Other texture features, such 
as the ones presented earlier, are not directly linked to tumor phenotypes or other 
biological characteristics definitively and are being actively researched.11, 12, 18, 20, 22, 26, 40, 
64–68   Repeatability, reproducibility, dynamic range, non-redundancy, ease of calculation, 
and a reasonable link to a biological characteristic, radiographic appearance, or endpoint 
are all traits that are highly desirable for imaging features to be used in the predictive 
models for this work.36, 69, 70  Repeatability refers to the ability of a potential imaging 
biomarker to obtain the same value given a short time interval and under the same 
imaging acquisition conditions; while reproducibility is the ability to obtain a similar value 
for the imaging protocol under changes in equipment or centers.69  The dynamic range 
refers to the range of potential values of a feature.  If the dynamic range is too small, it 
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may not have the ability to distinguish between different classifications.36  With the large 
range of texture features being investigated, there is a high probability that one or more 
features are correlated.  The set of features used in predictive models should avoid highly 
correlated or redundant features as this leads to multicollinearity issues with the final 
model. To this end, researchers have been reducing the number of features by identifying 
the redundancies and utilizing only those features that are the most repeatable and have 
a larger dynamic range.36, 40, 71  In this work, the number of texture features will also need 
to be reduced due the limited number of patients available for the study.  In regression, 
at least twice as many observations as variables are recommended in order to have a 
decent fit.  Investigating the direct link between the texture features and tumor phenotype 
or genetic expression is in its infancy and is currently an area of research for different 
imaging modalities.20, 72 Despite the lack of a concrete link between the texture features 
and the underlying biological cause, texture features and their changes over the course 
of treatment can be useful if they are linked to the appearance of the tumor to an observer.  
The texture features are being investigated in this work, as said by Hunter et al., “under 
the hypothesis that they are related to gene expression and phenotype.”73  In other words, 
this work is assuming that texture features and changes in texture features beyond the 
threshold of repeatability are related to a biological or gene expression change.  This is 
not completely unfounded as areas of necrotic tissue appear different on images and 
chaotic vasculature may lead to inhomogeneity of the solid tumor appearance. 
Texture features are being actively investigated for CT, MR, and PET imaging 
modalities.  Several studies have successfully been conducted on the repeatability and 
reproducibility of texture features utilizing CT11, 12, 24, 26, 40, 41, 66, 71 and PET.31, 32, 34  
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However, researchers have had less success in determining the reproducibility of MR 
texture features in T1-weighted and T2-weighted images due to changes in imaging 
parameters,37 machine parameters,23, 29, 39, 74 imaging protocols,39, 74 and image 
characteristics.38, 75, 76  One recent study published by Gourtsoyianni et al.,77 on MR 
texture features for T2-weighted turbo spin echo sequences in liver images showed very 
low repeatability of higher order texture features (GLRLM, NGTDM, GLSZM) and more 
repeatable features in the global (histogram) and GLCM features.  Other than the 
Gourtsoyianni et al. study, the repeatability of the T1- and T2-weighted texture features 
has not been prominently studied in the literature. On the other hand, the repeatability of 
apparent diffusion coefficients (ADC) as calculated from different b-value diffusion 
weighted MR (DW-MR) images and dynamic contrast enhanced MR (DCE-MR) images 
have found success.64, 78, 79  
This work will seek to identify if there are any T1- and T2-weighted MR texture 
features that are repeatable under the same imaging conditions as a starting point for 
finding potential predictive models utilizing MR texture features. DW-MR and ADC texture 
features will also be evaluated for repeatability and compared to the literature. In addition, 
this work will also seek to identify CT features from the imaging protocols used at Virginia 
Commonwealth University (VCU) and compare them to the features found in the literature 
for agreement.  
1.4 Contour Delineation Uncertainty 
Accurate target localization is essential to radiation therapy. In the radiation 
treatment process, as previously mentioned, the physician delineates the GTV on the 
planning CT.  Afterwards the GTV is expanded by adding a margin to account for 
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microscopic disease that may not be seen with the unaided eye on the clinical images to 
the CTV often about 5-8mm for lung cancer.  The CTV is further expanded to account for 
different uncertainties which have been reported by Sonke and Belderbos80 as having 
standard deviations for interfraction setup errors of 4mm systematic error and 4mm 
random error, motion of 0-7mm systematic and 0-7mm random error, delineation 
uncertainty of 2-7mm systematic error, baseline shifts of 4mm systematic error and 3mm 
random error, and intrafraction target motion of 4mm systematic error and 4mm random 
error from their literature search. The traditional margin recipe used was proposed by van 
Herk81 and consisted of estimating systematic and random errors, such as those reported 
above, adding the all systematic errors in quadrature to get an overall estimate of the 
systematic errors and then doing the same for the random errors before using the overall 
estimates in a population based margin formula to achieve 90% of the population 
receiving a cumulative dose of 95% of the prescription to the CTV. In some cases, this 
population based margin could be quite large, such as the 12mm illustrated by van Herk 
for a prostate case.81  One particular danger for lung cancer patients, is the risk of 
toxicities, such as radiation induced pneumonitis, which are shown to correlate with the 
mean lung dose and the volume of the lung receive more than 20Gy, meaning smaller 
margins are desirable.  The use of 4D gating, breath hold, and image guided radiation 
therapy (IGRT) can be used to reduce the uncertainty from motion and set up.  With 4D 
gating, the respiratory motion is monitored and the beam is only turned on during a certain 
phase of motion.  Alternatively, with breath hold techniques, motion is limited by arresting 
breathing for periods of approximately 20s while the beam is on and allowing the patient 
to breath freely between breath holds.  With IGRT, images are taken prior to delivering 
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radiation to align the planning CT image with the anatomy of the day, reducing the 
uncertainty in the set up error. These techniques move away from the population based 
margin to a patient specific margin model aimed at reducing margins where possible.80  
However, these methods do not address uncertainties from contour delineation. 
The physician-drawn contour is taken as ground truth throughout the radiation 
treatment process. However, the contour delineation process can be complicated in areas 
where there is a lack of a clear boundary, such as low intensity difference between the 
tumor and the surrounding tissue.  In such instances, for example near areas of 
atelectasis in the lung, the boundary between the tumor and surrounding tissue is difficult 
to distinguish with the eye and can lead to multiple interpretations by single or multiple 
observers.  Studies have been conducted to quantify the amount of inter- and intra-
observer delineation uncertainty.  In a study comparing the contour delineation of NSCLC 
with 14 radiation oncologists and hematologic oncologists, Vorwerk et al.82 found good 
agreement (defined as more than 70% overlap) in 23.7% of radiation oncologists 
(different departments) and 35.9% (same department) on the PTV.  Karki et al.83 in a 
study with seven physicians found an average delineation uncertainty in the GTV of 
2.96mm, 2.06mm, and 2.77mm for CT only, PET/CT, and MRI respectively. Giraud et 
al.84 found uncertainty of 3.1 cm laterally, 2.8 cm anterioposteriorly, and 2.1 cm 
craniocaudally in a study on lung GTV delineation among radiation oncologists and 
radiologists. 
Different approaches have been studied to reduce the delineation uncertainty such 
as using a prescribed protocol,85 matched CT-PET instead of just CT images,86 and auto-
contouring;87 however, the delineation uncertainties remain larger than the mechanical 
  29 
uncertainties.  Steenbakkers et al.86 noted a reduction in lung cancer delineation 
uncertainty, as measured by the standard deviation of the difference between the 
individual contours and the median contour, from 1cm with CT only to 0.4 cm with CT-
PET.  The greatest gains were made in regions bordering atelectasis from 1.9 cm to 0.5 
cm.   The auto-contouring and, in addition, autosegmentation based techniques seek to 
create an automatic or semiautomatic process by which an algorithm defines the 
boundaries of the tumor and/or thoracic organs with little to no input from the operator.  
These contours can then be checked and adjusted manually if needed.  Several of these 
algorithms are based off intensity changes.   Baardwijk et al.,87 suggested an auto-
contouring technique based on the source-to-background ratio for PET/CT images.  The 
manual contours were compared to the auto-contours, which had been edited by the 
physicians. Auto-contours showed a significant reduction in the variation of the contoured 
GTV.  Others use a grow region technique where the physician chooses a start seed, or 
seeds, within the target or at the boundary and the algorithm grows the contour from the 
identified seeds.  Gu et al.88 developed a single click grow region algorithm that would 
create an ensemble based final contour from the single internal start seed. This method 
was able to achieve a similarity index of almost 80% with two different observers with 
97% repeatability of the contours with 20 different starting seeds.88  Other methods 
include graph-cutting and snakes which seek to minimize energy and mutual information 
to determine a contour, but these methods are time consuming and computationally 
expensive in some cases.88, 89  Lu and Higgins89 suggested a live wire algorithm that 
created a suggested contour by connecting successively chosen points along the 
boundary of the contour.  The operator selects a starting point then moves the cursor to 
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another point along the boundary.  The algorithm suggests a contour path from the start 
point to the cursor location which can be accepted by clicking (thereby creating a new 
starting location for the next piece of the contour) or modified by moving the mouse until 
the desired boundary is created.  Both the inter- and intra-observer reproducibility were 
found to have a mean of about 98% with a maximum standard deviation of 0.98% for 2D 
and 3D contours, with a speed increase of up of 14 times for 2D and 28 times for 3D over 
manual contouring.89 
Autosegmentation algorithms, like those described above, are often based on 
intensity driven mechanisms, such as region growing and mutual information, that may 
fail in areas that are similar in intensity, such as atelectasis, for centrally located tumor 
near the mediastinum.  Other methods, like the live wire method, involve a lot of user 
intervention.  Machine learning and in particular deep learning based convolutional neural 
networks (CNNs) approaches have an advantage over purely intensity driven methods 
as they are able to incorporate information about texture and subtle changes in intensity 
patterns in addition to intensity level.  The incorporation of learned features may be able 
to differentiate areas of similar intensity and appearance.  After a neural network has been 
trained, results can be produced in seconds with very little user input giving them an 
advantage over live wire and other semi-automatic contouring processes.  Neural 
networks are also learning algorithms which means by adding corrected predictions into 
the training set, the network can continually be refined to get better with time allowing the 
algorithm to potentially perform better on difficult cases in the long run. 
The reduction of uncertainty in contour delineation would lead to a better and more 
consistent definition of the GTV and, by extension, normal tissue as well.  An increase in 
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accuracy of the target contour could also have an effect on the amount of dose escalation 
possible in the target.  Some studies have shown that an escalation in the dose is related 
to an increase in local control of the tumor and increased overall survival for NSCLS.90–92 
However, this effect is not fully understood as other studies have suggested that dose 
escalation could be harmful, most notably in the randomized stage III clinical trial by 
Bradley et al.93  Reducing the uncertainty in the contour delineation could potentially allow 
the proposed dose escalations without an increase in normal tissue complications.  
1.4.1 Machine Learning  
Machine learning is the use of programming algorithms to extract information from 
a dataset to perform a designated task and improve upon the results without each step 
being explicitly programmed.  In machine learning, the user provides a dataset, 
framework for the algorithm, and rules for updating results, but does not explicitly program 
each update step instead letting the algorithm learn the appropriate variables for each 
step through iteration.  For example, machine learning techniques have been used to find 
the separation between different classes such as species of iris flowers.  In this dataset, 
the algorithm uses the input data: sepal length, sepal width, petal length, and petal width, 
to predict the species of iris without being explicitly told that iris species “A” has a sepal 
length “x” and petal width “y.”  Instead the network learns the appropriate levels of “x and 
“y” necessary to distinguish the iris species. 
  32 
Machine learning and neural networks have been around since the early 20th 
century.94  The very first neural networks, often referred to as McCulloch-Pitts neurons, 
were designed to mimic the function neurons in the brain and can be thought of as a logic 
gate, or series of logic gates, where each neuron accepts an input, calculates an 
activation, and if the activation is high enough, produces an output signal, Figure 7.  
 
As seen in Figure 7, each triangle represents a neuron where the input signals are 
summed and compared to a defined threshold, in this case a hard threshold, where the 
output is either 1 if larger or equal to the threshold, or 0 if less than the threshold.  Each 
of the inputs is multiplied by a weight indicated by the number above the input and output 
lines.  The input “A” and “B” are binary either 0 or 1 indicating either “on” or “off,” or 
activated (1) and not activated (0).  The neurons are arranged into layers as defined by 
inputs.  The first layer in the figure above has two neurons; they both accept the initial 
inputs.  The next layer contains only one neuron and is considered a new layer because 
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Figure 7: Example of a simple exclusive or (XOR) two-layer neural 
network.  Here the neuron is activated if the sum of the inputs “A” and 
“B” exceeds the threshold. The numbers along the line indicate the 
weight to multiply the signal by. All inputs and outputs in this example 
are 0 or 1.  
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it accepts inputs from the layer before it, regardless of whether it accepts the original input 
or not, as seen in Figure 8.  The final output of the network provides the result of the 
network analysis on the inputs.  Not pictured in either figure is the bias input to each 
neuron.  This bias input can be thought of as similar to the intercept term in the equations 
of a line.  The entire network can alternatively be visualized as a series of linear equations 
of form 𝑦 = 𝑎𝑥	 + 	𝑏 that are being solved with the “𝑥” representing the input, “𝑎” the 
weight, ”𝑏” the bias, and “𝑦” the output of each neuron. 
 
The learning part of machine learning developed when the networks were able to 
update their weights according to learning rules.  There are two types of learning: 
supervised and unsupervised.  In unsupervised learning, the network is not presented 
with a “correct” answer to compare the network output to, but rather is given a set of rules 
and tends to learn patterns that the network thinks are important within the confines of 
the rules.  On the other hand, in supervised learning, the network compares the output 
with the provided, or human defined, “correct” answer.  With either learning method, the 
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Figure 8: Another example of a two-layer XOR neural network.  
This time the original inputs “A” and “B” are transferred to the first 
and second layers of the network. 
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network calculates the error of the network output and uses this error throughout the 
network to update the weights iteratively until told to stop or it has met some criteria 
defined by the loss function.  The loss function and the optimization method govern how 
each network updates the weights.   
The loss function is chosen for the problem being solved.  In the case of a linear 
regression problem, the mean square error might be chosen; for a binary classification 
problem, binary cross entropy might be a better choice.  In semantic image segmentation, 
a Dice similarity loss is often employed.  The value of the loss function represents the 
error of the network, and the goal of the optimizer is to update the weights in a manner to 
minimize the loss.   
Early optimizers, or learning rules, were simple such as the Hebb rule95 for 
unsupervised learning where the output was multiplied by the learning rate, which dictates 
how large a step to take at each iteration, and the perceptron rule,96 where the difference 
between the output and “correct” answer is multiplied by the learning rate.  Today, there 
are several different optimizers available with one of the most common being stochastic 
gradient decent (SGD).  With the SGD optimizer, the derivative of the activation functions 
at each layer with respect to the bias and weights are multiplied by the learning rate and 
error from the loss function before being added to the existing weight.  The resulting 
values then travel backwards to the previous layer where they are again multiplied by the 
learning rate and derivative of the loss with respect to the weights and biases for the 
previous layer which are used to update the weights in the current layer and so forth until 
all weights in the network are updated in a process known as backpropagation.97  The 
learning rate dictates how large a change, or step, is taken along the gradient towards 
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the minimum.  Later variations of the SGD algorithm have modifications for regularizing 
the process to prevent overfitting, such as momentum, which retains a weighted 
“memory” of the previous weights to help prevent getting caught in local minima.   
The activation functions are essential to the learning process and should be chosen 
for the needs of the problem.  The hard activation function mentioned earlier is not the 
most useful and was replaced early on by soft activation functions.  These soft activation 
functions could output a range of values as opposed to just 0 and 1 for the hard activation 
functions.  Examples of soft activation functions include the sigmoid and hyperbolic 
tangent functions, which are characterized by low and high plateaus at large positive and 
negative values respectively, and a gradual slope between them allowing for maximum 
learning.  These soft activation functions allowed the network to reach convergence 
faster, or at all in some cases.  Today, there are a variety of different activation functions 
such as the very popular rectified linear units (ReLU), which keeps the positive portions 
of a linear function while setting the negative portion to 0, and the softmax normalized 
exponential function, which is used frequently in multi-class classification networks. 
As technology has advanced, neural networks have become more and more 
complicated but remained limited in application until the wide spread use of graphic 
processing units (GPUs).  Before GPUs, larger networks remained limited because of the 
time and computational power required to train a network and the large datasets needed 
for success.  GPUs allowed the time to train a network to be cut down from months to 
days and today the time has reduced further to minutes, fueling further exploration. With 
new neural network techniques the input expanded from binary signals to images.  In 
addition, as networks got larger, more and more training images were needed to 
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adequately train the networks.  Labeling of training examples began to be crowd-sourced 
in order to build larger training datasets.  In addition, techniques such as data 
augmentation, transfer learning, and utilizing image patches were employed to create 
adequate training sets for networks, especially in the medical field.  For medical, and 
image analysis in general, CNNs have become a particularly powerful tool.  
1.4.2 Convolutional Neural Networks   
CNNs are networks that use a series of filters of size n in the dimension space of 
the image, for example n by n for 2D images or n by n by n for 3D images, that are then 
convolved with the images in a kernel like fashion in order to build a map of hierarchical 
features.  One of the earliest networks, that later became known as a convolutional neural 
network, was developed by LeCun98 and was a series of shared weight convolutions. 
These networks were designed to “read” handwritten numbers and were later expanded 
to read hand written zip-codes.99  From this zip-code network, the basic structure of the 
CNNs used today began to appear: 1) a convolution layer, 2) a down sampling layer, 3) 
a convolution layer,4) a down sampling layer, and 5) a fully connected output layer.  These 
layers will be described in greater detail in the following sections herein.  Today, the CNN 
is the power house behind almost all image classification, object recognition and 
localization, and segmentation tasks, such as Alex NET100, GoogLeNet101, VGG Nets102, 
residual networks (ResNets)103, 104, efficient neural networks (E-Nets)105, CIFAR-net106, 
and others.  The structures of these newer networks have become more complicated than 
the basic structure outlined above. 
As research and network architectures evolved a new concept called deep learning 
gained popularity.  Deep learning refers to using several weight bearing layers in a 
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network.  Though there is no consensus as to how many layers are needed for a network 
to be considered “deep,”  the term is generally used in the literature for networks having 
greater than 5 weight bearing layers.  These deeper layered systems, such as ResNets, 
VGG, GoogLeNet, and others are able to learn more features from images.  However, 
they include a much larger parameter set and need larger datasets to train on.  
CNNs have become the go to for any type of neural network trained on raw image 
inputs.  Two areas of research that utilize CNNs, that are relevant to this work, are image 
classification and image segmentation.  The task of image classification is to identify 
which category an image belongs to.  The output is the best guess as to which category, 
such as cat, dog, bird, etc., the image represents.  Image segmentation strives to partition 
an image into regions having similar characteristics without assigning classes or labels.   
Semantic image segmentation, on the other hand, returns a map of what class each pixel 
or voxel is predicted to be, thereby determining the location of the class(es) throughout 
the image.  Semantic image segmentation is similar to another CNN heavy task called 
object detection.  However, the end goal of most object detection algorithms is a bounding 
box around the object rather than a pixel by pixel map. 
1.4.2.1 	Convolution	layers	
The convolution layer can be thought of as the feature detection layer.  The user 
defines the number and shape of the filters employed by this layer, as well as what stride 
and padding to use.  The stride defines how many pixels/voxels the kernel skips before 
the next calculations, while the padding adds additional pixels/voxels around the image 
to allow the kernel to get closer to the edges of the image.  Padding can be any amount, 
however, “same” and “valid” are the two most commonly used.  The “same’ padding 
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provides only enough padding around the image to allow for the same size after 
convolution with the filters, while ‘valid’ adds no padding allowing the output shape to be 
reduced.  
The output size of any layer can be calculated using the following equation: 
                                                        𝑂 = 1234$56 + 1	     ( 2 ) 
where, 𝐼 is the size of one dimension of the input image, 𝐹 is the size of the filter, 𝑃 is the 
amount of padding, and 𝑆 is the stride.  This calculation is repeated for each image 
dimension.  Square or cube images and filters are often used, so this calculation is usually 
performed once per layer.  There are two other dimensions included in the size of the 
output layer: the channels and the number of filters.  Color images use 3 channels one 
for each of the red, blue, and green values, while gray scale images only have one 
channel.  Some techniques when working with medical images provide different slices of 
a 2D medial image to each of the 3 channels.107, 108  It is important to keep track of the 
output shape of each layer when designing a network as typical CNNs tend to reduce the 
size of the image and increase the number of filters as the network gets deeper. 
Each filter has its own set of weights and bias terms and seeks to capture 
information from a local portion of the input image.  At lower levels in the network, the 
convolutions act much like edge detectors and color pattern filters.  For example, when 
trying to classify an image as containing a face, the early filters may look for vertical edges 
such as the side of a nose or jaw and oval patches of white for the eyes, Figure 9.  The 
subsequent layers look at local patches of the lower level features from the previous layer 
and begin to construct higher level features of an image like, in continuing the example, 
eyes, lips, or nose.  This continues until the network learns which features need to be 
present in order to positively identity the image as a face.  Convolution layers are typically 
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followed by a non-linear activation function such as the ReLU activation function 
described earlier.  
 
CNNs can have a large number of weights and biases, also referred to as free 
parameters.  For one layer with 16 filters of size 5 by 5 convolved using a stride of 1 with 
an original image of size 50 by 50 and same padding, there are about 40,000 free 
parameters.  With CNNs, it is not uncommon to have tens to hundreds of thousands of 
free parameters.  In order to reduce the number of free parameters at a given layer, 
periodic down sampling or pooling is often employed. 
1.4.2.2 	Pooling	layers	
Pooling layers are often used to reduce the size of the layer input and number of 
parameters.  These layers employ a user defined filter size and stride but do not have 
2 2 4 2 0 1 0 9 9
3 3 2 4 0 1 0 9 7
2 4 3 4 0 1 0
3 2 2 1
0 0 0 8 9
1 1 1 9 11
0 0 0
Image:4x4x1 Filters:	3X3X2 Output:	2x2x2
* 
* 
Figure 9: Example of a convolution layer for a 4x4x1 image with two 3x3 filters, valid 
padding and a stride of 1.  The filter weights are seen in the second column with the 
resulting output in the third column.  The portion of the image in the red box is 
convolved with the weights to produce the values within the red box in the output 
layer.  The entire filters slides over by one horizontally or vertically to fill the rest of the 
output image. 
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weights or biases to tune.  These layers are often not included in the count of how many 
layers a network contains.  Frequently, the stride will be chosen to have the same length 
as the filter size so as to have non-overlapping connections. Others, however, have 
employed a non-overlapping pooling layer with success.100 There are different types of 
pooling that can be applied.  The most common are maximum pooling and average 
pooling, Figure 10.  In maximum pooling, the largest value within the filter at each kernel 
stride is kept while average pooling, as the name suggests, averages the value within the 
filter and assigns the average to the corresponding pixel/voxel in the output.  Pooling 
layers typically are not followed by an activation function. 
 
1.4.2.3 Fully	Connected	layers	
Fully connected layers, as the name suggests, connects each element, pixel/voxel 
or neuron depending on the network architecture, of the input layer with each element of 
the output layer.  These layers serve to bring all the information the network has learned 
together to provide a final output.  In more recent years, the traditional dense fully 
connected layer has been replaced by the use of convolution layers using a filter size of 
2 2 4 2 3 4 2.5 3
3 3 2 4 4 4 2.8 2.5
2 4 3 4
3 2 2 1
Max	Pool	 Average	PoolImage
Figure 10: Maximum and Average pooling layers with a 2x2 filter and a stride 
of 2.  Colored boxes in the image correspond to colored boxes in the output 
following pooling calculations. 
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1 for the given image dimensions, as it is computationally faster and accomplishes the 
same end goal.  The user defines how many output neurons are needed depending on 
the goals of the network.  For example, in the final layer of a classification network, the 
fully connected layer typically has the same number of neurons as classes being 
classified.  Each neuron in the final layer can be seen as measuring the probability of 
each class given the activation levels from each of the high level features learned by the 
network.  The fully connected layers are typically followed by an activation function with 
the very last layer utilizing the activation function necessary to provide the desired output 
from the network as described previously. 
1.4.2.4 Batch	Normalization	
Batch normalization layers seek to normalize the input values across the batch, or 
chunk of data with a user specified size, being analyzed by the network to maximize 
learning.  The activation functions that can be applied to a particular layer often have a 
region where learning is maximized and excessively large or small values saturate the 
activation function, making learning a very slow process.  During the process of training, 
the weights of the network are updated at the end of a batch.  The size of a batch is 
usually determined by how large the dataset is, where smaller datasets use batch sizes 
as small as 1, the desired speed of training, where larger batches trained faster, and the 
memory limits of the system, which provides the upper limit on the possible batch sizes.  
The batch normalization layer standardizes the batch of inputs to between a range of 
values such as -1 to 1 or 0 to 1 depending on the nature of the data in the batch to prevent 
saturation of the activation functions. While many networks employ normalization as a 
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pre-processing step, the batch normalization has been found to be particularly useful in 
ResNets.103 
1.4.3 Image Classification 
Image classification was one of the first areas to see significant improvement with 
machine learning.  The annual ImageNet Large Scale Visual Recognition Challenge 
(ILSVRC) began in 2010 and is a competition where programmers compete to have the 
algorithm with the highest accuracy on classifying images into one of 1000 classes.109  In 
2012, a machine learning algorithm employing CNNs came in first in the ILSVRC-2012 
competition with an error rate over 10% lower than the second place contestant.100  Since 
then, the winning algorithms have all been based on machine learning techniques.  
In medical imaging, image classification techniques have been employed for a 
variety of tasks such as classification of lesions as benign or malignant,110–113 
classification of interstitial lung disease,114–116 type and staging of brain tumors,117 and 
other computer aided diagnosis (CAD) tasks.  In 2016, the American Association of 
Physicists in Medicine (AAPM), National Cancer Institute (NCI), and SPIE hosted the 
LungX challenge, where participants classified lung nodules as benign or malignant.  
Three machine learning based techniques had an area under the ROC curve (AUC) better 
than obtained by guessing.  All participants had AUCs between 0.5 and 0.68 with the 
CNN based model having an AUC of 0.59.110 In 2017, Shen et al.113 developed a multi-
crop CNN that replaced one of the maximum pooling layers with a multi-scale maximum-
pooling layer. This network achieved an AUC of 0.93 for detecting the likelihood of 
metastasis in a lung nodule. 
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As mentioned previously, to train a network from scratch there needs to be a large 
amount of data available for training.  One method that has been applied in the medical 
field is transfer learning.  In the process of transfer learning, a pre-trained network such 
as AlexNet, which is trained in the classification of images such as banana, cat, dog, 
human, etc., is used with all but the last few layers frozen or very minimally modified.  
Frozen layers do not have their weights updated and subsequently calculate the features 
they were trained to detect for the application they were originally optimized for.  Minimally 
modified layers are trained on the new data but with a very small learning rate so as to 
preserve most of the pre-trained information.  The last layer, or last few layers, depending 
on the case, are retrained using the new input images for the desired task to essentially 
teach the output layers which of the pre-trained features relate to the new task.  Transfer 
learning can be accomplished with a much smaller training set than the original data, 
however, the new input data must be manipulated into the same format as the original 
task.  For instance, in order to use AlexNet for medical images as Gao et al.116 did in 
classifying interstitial lung disease, the input images first have to be sized to 244 by 244 
and artificially generate 3 “color” channels by using different Hounsfield unit (HU) windows 
for low attenuation, normal CT range, and high attenuation. They were able to achieve an 
overall accuracy of 87.9% on a patch size similar to the literature (31 by 31 pixels) with 6 
classes and 68.6% on their “holistic” patch method using large portions of the CT image.  
By contrast, Microbiana et al.114 built their own network from scratch to classify the 
interstitial lung disease into 7 classes.  Their network took as input a 32 by 32 patch of 
the image and had a similar architecture to AlexNet consisting of 5 convolution layers and 
an average pooling layer before 3 fully connected layers.  They were able to obtain an 
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overall accuracy with 7 classes of 85.6%, which is comparable to the pre-trained network 
by Gao et al. mentioned previously. 
In this work, image classification will be used to classify the type of tumor/normal 
tissue interface in an image patch using built from scratch CNNs.  The hope is that the 
CNN may recognize patterns within the CT image that would assist physicians in 
distinguishing the tumor from seemingly similar non-cancerous tissue, such as 
atelectasis, and reducing the contouring uncertainty in these regions. 
1.4.4 Image Segmentation 
Semantic image segmentation is the task of labeling each pixel/voxel in an image 
as belonging to a particular class or background.  The object of semantic images 
segmentation is to provide the location of the class(es) within the image frame.  For 
instance, the machine learning algorithms in new self-driving car software must identify 
and locate where objects such as traffic lights, signs, other vehicles, people, etc. are in 
order to navigate and stop appropriately. Image segmenting is also a natural next step 
from image classification. 
Image segmentation is of particular interest to the medical community.  Within the 
radiation oncology workflow, as described earlier, the physician takes the time to draw 
out the tumor contours as well as OARs.  This is a very time consuming process.  
Autosegmentation, such as the PET/CT method described earlier by Baardwijk et al.,87 
that are not based on machine learning techniques have been shown to reduce contour 
delineation uncertainty.  With the advent of deep learning, there has been an increased 
interest in using the technology for medical images segmentation. 
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The initial image segmentation algorithms arose from the patch wise image 
classification networks.  The classification was performed in a sliding window fashion over 
the entire image creating a map of classes predicted for each central pixel of each 
window, as described in the neuronal membrane segmentation paper by Ciresan et al.118 
Since then, a few variations of an extended concept have been developed for image 
segmentation as well, mainly the V-Net,119 U-Net,120 and E-Net.105  All three networks 
revolve around the same architecture consisting of two paths: the first path, or the encoder 
path, is the same basic structure as the image classification network usually modeled off 
the VGG102 network; the second path, or decoder path, is the reverse of the encoder path 
with up sampling instead of down sampling between the convolution layers.  The 
information from the encoder path with the same output size is passed to the decoder 
path following each up sampling to preserve the original spatial information.  The result 
is a pixel by pixel map of the classes.  The V-Net, U-Net, and E-Net vary in small details.  
For speed, the E-Net does not perform as many convolutions on the decoding path as 
the encoding path.  The U-Net appears to perform a set of convolutions on the smallest 
down sampled image before beginning the decoding path whereas the V-Net is a true 
mirror.  For image segmentation tasks, a Dice coefficient based cost function has been 
employed by some to improve accuracy.119, 121 This cost function measures the amount 
of overlap between the predicted segmentation and the true label segmentation.     
Image segmenting has been applied to a wide variety of anatomical locations 
including but not limited to: the brain122–124, prostate119, 121, knee125, heart126, and lung.127 
Novikov et al.127 modified the U-Net architecture to create three new variations by 1) 
adding drop out layers, which randomly modifies the weights to prevent overfitting, after 
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each of the convolution layers, 2) inverting the number of filters used so the largest 
number of filters was at the top layer, and 3) replacing the pooling layer with non-
overlapping convolution layers to segment the lungs, heart, and clavicles on chest 
radiographs.  The drop out layers and inverted number of filters had the best Dice 
similarity, 83.7% - 97.3% depending on the organ. In another paper by Moeskops et al.,128 
they used a classification network passed over the image to segment tissue on brain MRI, 
breast MRI and chest CT angiography with the same network.  The network showed very 
little confusion between image classes at less than 0.0005% and the Dice score for the 
brain tissue was between 80-90%, with the exception of the ventricular cerebrospinal 
fluid, which has a Dice dissimilarity of about 70%, the breast about 70%, and the cardiac 
ventricles about 60%.  
This work aims to utilize the image segmentation techniques to build an uncertainty 
model for the tumor boundary. This can be accomplished though expanding the 
classification network for the different interfaces, or training a new network to predict the 
presence of an interface and the probability associated with the label to provide a picture 
of uncertainty.  This tool could then be used by physicians to reduce contour delineation 
uncertainty. 
1.5 Overview of Dissertation 
1.5.1 Problem Statement and Purpose 
Despite the advances in cancer treatment, lung cancer, in particular, still has very 
low five-year survival rates.  This work seeks to investigate the feasibility of building early 
prediction of lung tumor response and survival, and using machine learning techniques 
to provide additional information to physicians during tumor delineation about expected 
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uncertainty.  Predicting response prior to or early in the treatment course could inform 
physician decision making, provide better patient care and improve identification of the 
best treatment plan for the patient.  Measuring change in tumor volume is one method of 
determining treatment response, but the classification of complete response, partial 
response, stable disease, or progressive disease is often determined  after the completion 
of treatment.  One area of growing interest is radiomics, which seeks to utilize imaging 
and texture features extracted from routine images combined with clinical information to 
assist in a variety of clinical applications.  Critically, image features that cannot be 
repeated precisely between acquisitions should not necessarily be relied upon in 
predictive models. Thus, before use in the clinic, repeatable and robust texture features 
that are capable of describing the changes due to treatment and differences in tissue 
must be identified. 
A factor potentially contributing to the low survival rate in lung cancer is the 
uncertainty in tumor delineation. Multi-modality imaging has been used to decrease 
physician target delineation uncertainty. However, inter- and intra-observer variation 
remains one of the largest uncertainty factors in radiation treatment, possibly leading to 
excess irradiation of normal tissue or under treatment of tumors.  Another field of growing 
interest is machine learning and in particular deep learning.  These techniques are being 
investigated for automatic segmentation to reduce contouring uncertainty for organs at 
risk and tumors, and to distinguish between malignant and benign lesions in computer 
vision because of their success segmenting and classifying parts of images as different 
materials that appear the same to a human observer.  Reducing the contour delineation 
uncertainty could lead to better patient outcomes through reliable targeting of the tumor 
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tissue and sparing of normal tissue structures.  In addition, knowing the level of 
uncertainty to expect in an image could help to more accurately define the tumor and 
spare additional normal tissue. 
This thesis will seek to explore multi-modality imaging texture features in predictive 
and machine learning techniques for uncertainty modeling.  The first aim is to investigate 
texture features from pretreatment and, where available, images acquired during 
treatment to determine the texture features’ repeatability within the tumor, and test their 
feasibility along with clinical features in a predictive model for tumor response and 
survival.  The second aim is to explore the feasibility of building a probabilistic model of 
inter-observer contour delineation uncertainty given patches from images to aid 
physicians in contour delineation. 
1.5.2 Specific Aims 
Specific Aim 1:  Develop and evaluate robust texture features extracted from 
multiple modality images for potential use in predictive modeling of non-small 
cell lung cancer tumor response. 
SA 1.1: Assess the robustness of texture features extracted from different imaging 
modalities.  Robustness will be evaluated based on repeatability between scans and, 
where possible, under different scanning conditions.  Image pre-processing techniques 
will be evaluated for their ability to improve robustness.   
SA1.2:  Investigate the feasibility of building a predictive model for tumor response 
utilizing the identified texture features extracted from multi-modality images, clinical 
factors, and observed changes throughout treatment for a limited number of patients.  
Models for CT and MR will be investigated, as well as a multi-modality model utilizing the 
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similarities and independent features among the modalities. The success of the models 
will be validated and the limitations of the models examined. 
Specific Aim 2:  Build an uncertainty model utilizing imaging features from 
single and multi-modality images and tumor characteristics to support physician 
contour delineation. 
SA 2.1 Determine the ability to predict the uncertainty in contour delineation from 
the tissue interface.  This sub-aim will first determine the degree of uncertainty in a tissue-
tumor interface, and then establish how well the interface type predicts the level of 
uncertainty. 
SA 2.2: Investigate deep machine learning techniques to distinguish between 
different tumor/normal tissue interfaces given a patch input of the image.  This sub aim 
will determine the extent to which machine learning techniques are able to learn features 
from input patches to distinguish different interfaces. 
SA 2.3: Investigate feasibility of building a tool using machine learned features to 
predict the level of uncertainty at a point of interest.  If the network to determine the 
interfaces is successful, this network could be extended to produce a probability map of 
interface location and uncertainty derived from the interface predictions.  If the network is 
not successful, a new network could be developed to predict the uncertainty directly. 
1.5.3 Innovation  
Predictive models for patient outcome after cancer treatment have utilized a variety 
of parameters acquired from different imaging modalities, but few have investigated 
different parameters across different modalities and different time points in treatment. The 
focus of many predictive models has often included only one imaging modality with 
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pretreatment imaging features.  This work seeks to explore the possibility of expanding 
the scope of the features utilized in the predictive models for tumor response to include 
features acquired during treatment for each imaging modality as image data allows and 
further explore the feasibility of combining multiple modalities into a single predictive 
model.  MR image features are not as well studied due to the effect different imaging 
protocol parameters have on the resulting texture features, therefore this work will seek 
to establish the reliability of the MR derived texture features by evaluating the repeatability 
of the MR derived texture features and identify a set of non-redundant features that can 
be used, similar to those identified for CT images and PET, in an effort to develop an MR 
predictive model. As mentioned earlier, there are several factors affecting the 
reproducibility of the MR texture features, therefore this work will only focus on 
establishing the repeatable texture features for the imaging protocols used at the VCU 
hospital and seek to establish the feasibility of producing an institution protocol specific 
predictive model for MR.  The exploration of the multimodality predictive models will seek 
to determine the features from CT and MR that when combined give the “best” tumor 
response predictive power. Furthermore, the incorporation of longitudinal features, data 
permitting, into models predicting response could identify texture features that change as 
a result of irradiation.  These changes in underlying physiological processes caused by 
irradiation in the tumor could arise from tumor cell death resulting in changes in cell 
density as necrotic regions develop and/or are cleared, cell vascularity as tumor size and 
areas of proliferation change, and reoxygenation as previously hypoxic regions gain 
access to oxygen.  
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Recent methods of improving contour delineation have generally focused on assisted 
or autosegmentation. However, this may be a very challenging approach for lung tumors 
due to subtle boundaries and the highly variable appearance of tumor tissue between 
patients.  Instead, a novel approach is proposed herein to stratify delineation uncertainty 
by tumor to normal tissue ‘interface’ type. Then, the focus of this work is to use this 
uncertainty estimate to assist the physician with manual contouring, rather than the 
challenging task of automatically delineating the tumor directly.  The developed tool seeks 
to predict the amount of uncertainty in the contour delineation given the tissue interface 
or around a point to help guide the physician and inform them of the level of uncertainty 
to expect.  Deep convolution neural networks seem particularly well suited to take an 
image output and classify the different tumor/normal tissue interfaces in the lung, and by 
expanding the classification task into an image segmentation for the interface, could be 
a tool used by physicians to reduce contour delineation uncertainty. 
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2 Specific Aim 1:  Repeatability of Magnetic Resonance 
Image Derived Texture Features and Use in Predictive 
Models for Non-Small Cell Lung Cancer Outcome 
 
 
 
2.1 Introduction 
As mentioned previously in the introduction chapter, there has been an increased 
interest in early prediction of treatment outcome to allow for changes to the treatment 
regimen with the goal of providing better patient care. In order to accomplish this, the 
previously mentioned sub aims were devised:  
• SA 1.1: Assess the repeatability of texture features extracted from different 
imaging modalities.   
• SA 1.2:  Investigate the feasibility of building a predictive model for tumor 
response. 
This aim seeks to first identify texture features appropriate for predictive models based 
on the repeatability of the texture features and image processing applied. Then the 
identified texture features are used to investigate predictive models for tumor response 
at end of treatment, and overall survival at 12, 18, and 24 months.  The feasibility of a 
multi-modality model is also investigated by combining texture features across CT and 
MR modalities. The predictive capability of the resulting models is evaluated and 
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compared.  In addition, the developed workflow is also applied to normal tissue ROIs as 
a control and to identify potential spurious results.   
The first part of the study investigated the repeatability of a variety of images 
including: T1-weighted Volumetric Interpolation Breath-Hold Examination (VIBE), T2-
weighted True fast MRI with steady state precession (TRUFISP), DW-MRI, ADC maps, 
and helical 4D CT scans for 15 patients with NSCLC before and during the course of 
radiotherapy. See Table 1 for summary of patient characteristics. 
While the repeatability portion of the study investigates several imaging protocols 
and incorporates multiple time points, the predictive modeling focuses on pretreatment 
CT, VIBE, and TRUFISP images only due to the limited availability of during treatment 
data.  The detailed results of the predictive models as well as descriptions of the methods, 
developed workflow, and analysis can be found in manuscript provided in Appendix I.  
The key finding in the repeatability study identified several features from the MRI and CT 
images that were candidates for use in predictive models due to repeatability and stability.  
Multiple significant models for overall survival were constructed from single modality MR 
and CT, as well as multi-modality models in the predictive modeling portion of the study.  
In addition, normal tissue was investigated as a control to help reduce spurious results, 
which led to identifying the medoid feature selection process as being more robust with 
the small number of subjects in our study.  It is recommended that the reader return to 
this chapter following reading the manuscript.  The following sections will provide 
additional details regarding methods and analysis not provided in the manuscript.  
Chapter 3 will discuss preliminary research used to develop the workflow presented in 
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the manuscript as well as exploratory research on the delta radiomics data from the 
different time points. 
  
2.2 Code Modifications 
As mentioned in Appendix I, this work used the open source radiomics toolkit 
develop by Vallieres et al.22 and was extended in-house.  For this work, only the texture 
feature calculation portion of the toolkit and associated functions were utilized including 
the volume preparation code.  The original GLCM texture feature calculation code 
included only 8 texture features: energy, contrast, entropy, homogeneity, correlation, 
variance, sum average, and dissimilarity.  This code was expanded to include the 
additional proposed features by Haralick48 and in subsequent papers49, 50 and, in the case 
of contrast, rewritten in a vectorized form to decreased calculation time.  Appendix II 
provides the mathematical formulation for all texture features used in this work.  In 
addition, the original code provided different methods for quantizing the gray levels before 
computing the texture features.  A new quantization method was written to use the gray 
Table 1: Summary of patient characteristics for texture feature repeatability 
Male	 10
Female	 5
Squamous	cell	carcinoma	 9
Adenocarcinoma	 6
IIB 3
IIIA 6
IIIB 4
IV 2
Yes 12
No 3
Mean	Dose	(Range)
61.6	(59.4-66)	Gy
59.1	(50.0-73.4)	years
Sex
Mean	Age	(Range)
Histology	
Stage
Chemotherapy
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levels as the bin levels in effect allowing for a “no quantization” option which was not 
present in the original code.   
For all images except the DW-MR and ADC maps, the texture feature extraction 
and image processing was performed in 3D.  The image protocol used at VCU to acquire 
the DW-MR and ADC maps only consisted of 7 slices, which was not sufficient to cover 
the entire tumor volume in one image set for some patients.  Therefore, repeated 7 slice 
image sets were obtained to cover the whole tumor volume. For all the DW images and 
ADC maps, a volume weighted average of the texture features extracted from 2D slices 
was taken and used as a surrogate for the 3D volume.  Additional details regarding this 
procedure will be discussed in the 3D Surrogate for Diffusion Weighted Images and 
Apparent Diffusion section.  The Vallieres code was again modified to perform a 2D 
wavelet decomposition. 
2.3 Extended workflow  
A simplified diagram of the workflow developed for this project is depicted in Figure 
1 of the manuscript in Appendix I.  Presented, in Figure 11 is a more detailed diagram of 
the workflow developed. The workflow can be thought of as three overarching steps: 
repeatability, clustering/feature reduction, and modeling.  The repeatability step identifies 
the repeatable and stable features which are then passed to the clustering step.  The 
clustering takes the repeatable and stable features and clusters them, determines the 
optimum number of clusters, and then selects a representative feature from each cluster.  
The representative features are then combined with the response data and model 
selection is performed in the final step.  Specific details on the methodologies employed 
are given in the Methods section of Appendix I. 
  56 
 
Figure 11: Diagram of workflow developed for radiomic texture feature selection and 
modeling. 
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2.4 False Error Rate Control 
In radiomics, a large number of texture features and models are often tested as part 
of the hypothesis,increasing the probability of finding a statistically significant result purely 
by chance.  Often the type 1 error detection rate is set at 0.05 indicating a 5% chance of 
saying a result is significant when in reality it is not, or more commonly described as 
rejecting the null hypothesis when it is true.  If more than one family of comparisons is 
being tested for significance, the chance of committing a type 1 error increases.  In order 
to account for the increase in type 1 errors due to multiple comparisons, different 
familywise error rate control (FWER) and false discovery rate (FDR) procedures have 
been proposed.  
One of the most popular, and most stringent, FWER correction procedures is the 
Bonferroni correction.  The Bonferroni correction seeks to adjust the critical p-value by 
dividing it by the number of comparisons and using the corrected critical p-value to 
determine significance.129 However, the traditional variation of the Bonferroni correction 
lowers the power to correctly reject one or more false components of the hypotheses.   To 
maintain the power, a sequential Bonferroni correction was proposed by Holm130 and later 
popularized by Rice.131  In the sequential implementation of the Bonferroni correction, the 
model or univariate p-values from the multiple comparisons are first ordered from smallest 
to largest and compared to the appropriate level of the corrected critical p-value beginning 
with the smallest p-value compared to the first level of corrected critical p-value: the 
desired significance level divided by the number of comparisons.  If the smallest p-value 
is significant when compared to the first level of the corrected critical p-value, the next 
smallest p-value is compared to the second level of the corrected critical p–value: the 
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desired significance level divided by the quantity the number of comparisons – 1.  If the 
second smallest p-value is significant, then the third smallest is compared to the third 
level of the corrected critical p-value: the desired significance level divided by the quantity 
the number of comparisons – 2 and so forth until the calculated p-value is no longer 
significant when compared to the appropriate level of the corrected critical p-value.130, 131 
The Bonferroni correction in the case of a small dataset can be too restrictive as it 
increases the chance of a type 2 error (accepting the null hypothesis when it is false or 
saying a variable is not significant when in reality it is significant). In this case, using a 
FDR controlling procedure may be more appropriate as was used in the manuscript in 
Appendix I.  The FDR procedure adjusts the correction of the p-value using a 
predetermined acceptable error rate.  The Benjamini-Hochberg-Yekutieli (BHY)132, 133 
procedure is similar in nature to the sequential Bonferroni correction procedure except 
that the significance level is replaced by the acceptable error rate and is multiplied by the 
factor in equation ( 3 ) as opposed to just divided by the number of comparisons.  
<=∗	 ?@A@B?      ( 3 ) 
where 𝑖 is the rank of the ordered p-value, and 𝑚	is the number of comparisons.  The 
corrected p-values resulting from the BHY procedure will always be less than or equal to 
the Bonferroni corrected p-values when the significance level and acceptable error rate 
are the same. 
2.5 Normal Tissue Determination 
The same workflow was applied to unirradiated normal tissue as a control 
experiment to identify spurious results under the assumption that texture features 
extracted from unirradiated normal tissue would not have a biological correlation with 
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treatment outcome.  Three different normal tissues were investigated including: air within 
the main airways, blood within the descending aorta, and contralateral out-of-field muscle 
in either the erector spinae or the infraspinatus muscles.  All three normal tissues where 
chosen because they would not experience changes due to radiation treatment, and were 
to a certain degree homogenous and allowed for reproducible ROI definition. 
The concordance correlation coefficient (CCC), and other correlation measures, are 
sensitive to the range of the values present in the population.134  If the range of values 
across the sampled population is very narrow, then small deviations from perfect 
correlation will result in a low CCC score, as seen in Figure 12.135, 136  For the air and 
blood samples, the repeatability of texture features was lower than expected for values 
such as the mean, which numerically only deviated by about 4 HU on a CT scan.  This 
was because the CT value across all patients was very similar as expected but was 
sensitive to any artifacts induced by the movement of blood in and out of the imaging 
slice.  Similarly, the air contour was sensitive to noise given the small range of values 
across patients.  The muscle contours produced a number of repeatable features in the 
same range as the tumor and was selected for further investigation as described in 
Appendix I. 
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Figure 12: Comparison of the Aorta ROI Mean HU values from the inspiration (0%) 
phase images from different times (top) and same scan inspiration (0%) and expiration 
(50%) phase (bottom) CT images demonstrating the difference observed in values for a 
homogeneous tissue. 
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2.6 Conclusion 
Texture features extracted from MR and CT images were utilized to develop 
predictive models for overall survival and local control for both single and multi-modality 
models for a small number of subjects.  The workflow developed ensured that repeatable 
and stable features were used as candidates for clustering and model selection.  The 
medoid representative cluster feature selection method appeared to select more robust 
texture features than the univariate selection method when compared to the model 
derived from unirradiated normal tissue.  The results are encouraging and further study 
into MR features for predictive models is warranted. 
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3 Specific Aim 1:  Preliminary and Supplementary 
Experiments for Radiomics Workflow Development and 
Predictive Modeling 
 
 
 
3.1 Introduction  
The work presented in the previous chapter and Appendix I was based on a final 
workflow developed through testing different methods of image processing and selecting 
features with desirable characteristics, such as repeatability and stability. The first step in 
developing the workflow was to determine which preliminary processing steps maximize 
repeatability of the texture features.  The focus of the preliminary workflow development 
research was on MR images and establishing if any of the texture features noted therein 
were repeatable under very similar scan conditions. The repeatability of CT and PET 
features have been studied to a greater extent by others,11, 20, 34, 40, 68, 71, 73, 137, 138 however, 
CT repeatability was still evaluated for completeness and comparison for applicable 
processing steps.   
The work presented in this chapter sought to evaluate some of the common image 
processing techniques and their effect on the repeatability of the texture features 
extracted from the different image types, such as bias correction for MR images, and 
wavelet decomposition and quantization of gray level values for both MR and CT.  Each 
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of these steps changes the distribution of the gray level values and the resulting texture 
feature calculations, thereby affecting the repeatability.  By evaluating the different 
processes’ effects on repeatability as measured by the CCC, the image pre-processing 
steps were determined for the workflow.  
Methods of limiting and correcting visual artifacts in the image, such as applying HU 
thresholds in CT images and bias correction in MR images, aim at improving the 
qualitative look of an image.  Previous work by Hunter et al.,71 showed that the number 
of repeatable features decreased with increasing HU thresholds, and for this reason, we 
did not apply any threshold limits to the CT images. However, research into the 
repeatability of MR texture features revealed a dependence on the imaging parameters 
and acquisition methods.23, 29, 37–39, 74–77 To alleviate some of these dependencies, a single 
imaging protocol and MR instrument was used to acquire the MR images allowing for an 
assessment of the repeatability of texture features when image processing techniques, 
such as bias correction were applied, and will be discussed in the following sections. 
Wavelet decomposition and gray level quantization are other processing techniques 
that have been applied to make texture features more robust or to emphasize different 
structural contributions within an image.  The effect of quantization on texture features 
has been studied by various groups.50, 139, 140 Quantization seeks to reduce the sparsity 
of the GLCM, GLRLM, and GLSZM that can arise when the number of gray level is not 
quantized.  It can be thought of as smoothing the gray levels and reducing the noise in 
the image. However, by quantizing the images, fine textures can also be lost.  Wavelet 
decomposition can be thought of as a simultaneous high pass and low pass filter 
decomposing the image into contrast and edge emphasized images.60  By recombining 
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the different decomposed images at different levels, edges and other structural 
information can be strengthened before computing texture features as explored by 
Vallieres et al.22   
The remaining sections of this chapter are dedicated to the development of the 
surrogate 3D texture features derived from 2D slices for the DW-MR and ADC images 
and exploration of time dependent changes of the texture features through treatment. The 
imaging protocol for acquiring the DW-MR and ADC maps was limited in range due to 
recommendation from the manufacturer.  For some patients, the entire primary tumor was 
not covered by the imaging sequence and multiple overlapping sequences were acquired.  
A method for computing a volume averaged 3D texture feature surrogate was developed 
from the 2D slices. To investigate the differences in the texture features over the course 
of treatment, both population and individual changes were explored.  A summary of the 
available images at different time points can be seen in Table 2. The ‘_Thickness’ label 
denotes a comparison between images with different slice thicknesses, and the ‘_Order’ 
label denotes a comparison between images with different slice acquisition orders. 
Table 2: Summary of available images at different time points. 
 
Time	1 Time	2 Time	3
CT	 15 9 9
TRUFISP 15 10 9
VIBE 16 9 7
DWI_Thickness 4 2 2
DWI_Order 4 6 6
ADC_Thickness 4 2 2
ADC_Order 4 6 6
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3.2 Bias Correction  
The bias artifact is the result of signal intensity non-uniformity causing a smooth 
non-uniform change in the signal intensity unrelated to anatomical variation. Bias 
correction seeks to correct the non-uniformity of the signal in post processing leading to 
more uniform looking image intensity.  An example of the bias artifact and a corrected 
image can be seen in Figure 13. The VIBE image gradually loses intensity toward the 
center of the images in the top row.  The restored uniform intensity from the bias 
correction procedure can be seen in the bottom row.  There are several potential causes 
for the signal non-uniformity including: non-uniform B0 magnetic field, RF coil 
homogeneity, sensitivity of the surface coils, gradient fields inducing eddy currents, and 
others.141 
Figure 13: Example of bias artifact (top) and the corresponding bias corrected image 
(bottom) for one pair of inspiration/expiration VIBE images used in this study. 
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This study utilized the 32 non-contrast enhanced VIBE inspiration/expiration image 
pairs and the 34 non-contrast enhanced T2-weighted TRUFISP inspiration/expiration 
image pairs from all 15 patients and all time points throughout the course of radiation 
treatment. One experienced radiation oncologist delineated the primary tumor on either 
the inspiration or expiration image at random per patient to prevent systematic bias.  A 
ridged registration was performed utilizing the MIM version 6.6 (MIM Software Inc., 
Cleveland, OH) program between the inspiration and expiration images prior to 
transferring the contour to the corresponding image and adjusting as necessary.  
Volumes of the final tumors corresponded within ±10% of each other.  
Since the MR images exhibited the bias artifact, applying a bias correction would be 
a reasonable pre-processing step.  To evaluate the effect a bias correction pre-processing 
step has on the repeatability of texture features, a bias correction was applied utilizing the 
N4 Bias Correction Algorithm in the Advanced Normalization Toolkits (ANTs) developed 
by Tustison et al.142, 143  This algorithm uses an iterative approach to estimate the 
unbiased image, calculate the bias field correction and preform a comparison to the initial 
image.  To ensure a smoothly varying bias field correction, b-splines were used to 
produce the bias field correction.142  A mask of the air outside the body and the normal 
lung tissue, since the lungs are primarily air, was supplied to the algorithm.  The procedure 
for determining the ideal threshold for air within the lung of the TRUFISP and VIBE mask 
images and bias correction parameters was determined by experimentation on a phantom 
and approved by a radiation oncologist.  
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Fifty-nine different texture features, detailed in Table 3, were extracted from the 
unprocessed and bias corrected images utilizing the modified version of the radiomics 
code by Vallieres et al.,22 via the MIM MatLab (MatLab 2016b, MathWorks, Natick, MA) 
extensions. Details regarding the modifications are described in the 2.2 Code 
Modifications section of the previous chapter.  The mathematical description of each 
texture feature can be found in Appendix II.  Prior to calculating the texture features, the 
images were isotopically resampled to the axial in-plane pixel width of the image and 
pixels greater than 3 standard deviations from the mean of the ROI were removed as 
suggested by Collewet et al.75 to improve feature stability.  Texture features were 
computed for 5 different wavelet decomposition ratios, 1/2, 2/3, 1, 3/2 and 2, where the 
ratio of 1 represents the unfiltered image.22    
The repeatability between the inspiration/expiration images for each image pair was 
again assessed by the CCC, where texture features with a CCC of greater than 0.9 are 
considered repeatable.134, 144  First proposed in 1989, the CCC seeks to characterize the 
departure of a test and re-test measurement from the 45 degree line through the origin 
which represents perfect one-to-one correlation.134  Other methods of agreement exist, 
such as the Pearson correlation coefficient, paired t-test, and the interclass coefficient, 
but each has potential draw backs.  The Pearson correlation coefficient measures the 
linear agreement of paired points, but does not characterize deviation from perfect 
agreement.  The paired t-test addresses the mean of all samples but not individual 
deviations, and the inter class coefficient treats the test and re-test measurements as 
replicates instead of distinct measurements, though the appropriate ICC has been shown 
to be equivalent to the CCC.134, 145, 146 
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Results from the preliminary research demonstrated that there were texture features 
for the bias corrected (BC) and non-bias corrected images, both VIBE and TRUFISP 
images, that had a CCC of greater than 0.9 as can be seen in Figure 14 and Figure 15 
respectively.  The high number of texture features with a CCC greater than 0.9 for the 
non-bias corrected images was encouraging as it indicated several texture features that 
could be candidates for further analysis for both MR a multi-modality and MR specific 
predictive models.  The same was not true for the bias corrected images as seen in the 
VIBE_BC and TRUFISP_BC results in Figure 14 and Figure 15.  The number of texture 
feature that had a CCC of greater than 0.9 was much less than the non-bias corrected 
images indicating that the bias correction, while improving the visual appearance of the 
images, did not improve the stability of the texture features.  This could be due to the 
iterative nature of the bias correction algorithms not finding exactly the same solution for 
both the inspiration and expiration images.  Bias correction was not implemented as part 
of the workflow to increase the number of repeatable features. 
Table 3: List of the texture features evaluated in this work. 
Histogram GLCM NGTDM GLRLM GLSZM
Variance Energy Coarseness Short	Run	Emphasis	(SRE) Small	Zone	Emphasis	(SZE)
Skewness Contrast Contrast Long	Rum	Emphasis	(LRE) Large	Zone	Emphasis	(LZE)
Kurtosis Entropy Busyness Gray	Level	Non-Uniformity	(GLN) Gray	Level	Non-Uniformity	(GLN)
Standard	Deviation	(SD) Homogeneity Complexity Run	Length	Non-Uniformity	(RLN) Zone	Size	Non-Uniformity	(ZSN)
Mean Correlation Strength Run	Percentage	(RP) Zone	Percentage	(ZP)
Minimum SumAverage Low	Gray	Level	Run	Emphasis	(LGRE) Low	Gray	Level	Zone	Emphasis	(LGZE)
Maximum Variance High	Gray	Level	Run	Emphasis	(HGRE) High	Gray	Level	Zone	Emphasis	(HGZE)
Median Dissimilarity Short	Run	Low	Gray	Level		Emphasis	(SRLGE) Small	Zone	Low	Gray	Level	Emphasis	(SZLGE)
Quartlie1 Mean	Pair	Sum	(MeanPS) Short	Run	High	Gray	Level		Emphasis	(SRHGE) Small	Zone	High	Gray	Level	Emphasis	(SZHGE)
Quartile3 Variance	Pair	Sum	(VariancePS) Long	Run	Low	Gray	Level		Emphasis	(LRLGE) Large	Zone	Low	Gray	Level	Emphasis	(LZLGE)
Entropy	Pair	Sum	(EntorpyPS) Long	Run	High	Gray	Level		Emphasis	(LRHGE) Large	Zone	High	Gray	Level	Emphasis	(LZHGE)
Variance	Pair	Difference	(VariancePD) Gray	Level	Variance	(GLV) Gray	Level	Variance	(GLV)
Entropy	Pair	Difference	(EntropyPD) Run	Length	variance	(RLV) Zone	Size	Variance	(ZSV)
Information	Correlation	Measure	1	(InfoCorr1)
Information	Correlation	Measure	2	(InforCorr2)
Auto-Correlation	(AutoCorr)
Cluster	Prominence	(ClusterProm)
ClusterShade
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Figure 14: Top 25 repeatable texture features for the VIBE images. Highly repeatable 
texture features (CCC ≥ 0.95) are green, repeatable features (0.90 ≤ CCC < 0.95) are 
yellow, potentially repeatable features (0.85 ≤ CCC < 0.90) are orange, and not 
repeatable feature (CCC < 0.85) are pink. 
 
GLCM GLRLM GLSZM Highly	Repeatable	 Potentially	Repeatable
HIST NGTDM Repeatable Not	Repeatable
Wavelet	Ratio 0.5 0.67 1 1.5 2 Wavelet	Ratio 0.5 0.67 1 1.5 2
RLN 0.97 0.97 0.97 0.97 0.97 RLN 0.97 0.97 0.97 0.97 0.97
GLNS 0.97 0.96 0.97 0.96 0.97 GLNS 0.96 0.96 0.96 0.96 0.96
GLN 0.96 0.96 0.96 0.96 0.97 Coarseness 0.96 0.96 0.95 0.91 0.94
ZSN 0.97 0.97 0.96 0.96 0.96 ZSN 0.95 0.94 0.94 0.93 0.93
LZE 0.96 0.96 0.94 0.95 0.95 GLN 0.94 0.94 0.94 0.94 0.94
Coarseness 0.96 0.96 0.94 0.93 0.93 Skewness 0.93 0.93 0.94 0.94 0.92
Entropy 0.93 0.93 0.93 0.93 0.92 Kurtosis 0.87 0.87 0.87 0.87 0.85
Skewness 0.93 0.93 0.93 0.93 0.92 Strength 0.87 0.88 0.85 0.83 0.87
EntropyPD 0.94 0.93 0.93 0.92 0.91 ContrastN 0.92 0.90 0.85 0.82 0.81
Busyness 0.88 0.91 0.95 0.94 0.94 Busyness 0.87 0.86 0.88 0.86 0.81
EntropyPS 0.93 0.92 0.92 0.92 0.92 InfoCorr 0.84 0.82 0.81 0.83 0.86
SumAverage 0.93 0.93 0.93 0.92 0.91 ZSV 0.81 0.90 0.84 0.81 0.76
SZE 0.93 0.93 0.92 0.92 0.91 SZLGE 0.89 0.64 0.89 0.86 0.71
Quartile 0.92 0.92 0.92 0.92 0.92 SRLGE 0.89 0.64 0.87 0.86 0.71
ContrastN 0.94 0.94 0.93 0.91 0.87 LGRE 0.89 0.64 0.87 0.86 0.71
ClusterShade 0.92 0.92 0.92 0.92 0.91 LRLGE 0.89 0.64 0.88 0.85 0.69
Dissimilarity 0.93 0.93 0.92 0.91 0.90 LGZE 0.89 0.63 0.87 0.84 0.70
Energy 0.92 0.92 0.92 0.92 0.91 LZHGE 0.78 0.80 0.84 0.81 0.68
Median 0.91 0.91 0.92 0.92 0.92 GLVS 0.68 0.86 0.83 0.70 0.75
ZP 0.92 0.92 0.92 0.91 0.90 SZE 0.79 0.76 0.77 0.74 0.72
Homogeneity 0.93 0.92 0.92 0.91 0.89 ZP 0.78 0.77 0.76 0.74 0.72
RP 0.92 0.92 0.92 0.91 0.90 SumAverage 0.81 0.81 0.78 0.71 0.63
LRE 0.92 0.92 0.92 0.91 0.90 SRE 0.77 0.76 0.75 0.74 0.73
SRE 0.92 0.92 0.92 0.91 0.90 RP 0.77 0.76 0.75 0.74 0.72
Mean 0.91 0.91 0.91 0.91 0.91 LRE 0.76 0.76 0.75 0.74 0.72
VIBE	(T1-weighted) VIBE_BC	(T1-weighted)
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3.3 3D Surrogate for Diffusion Weighted Images and Apparent Diffusion 
Coefficient Maps 
As mentioned earlier in 2.2 Code Modifications, the DW and ADC images were not 
calculated in 3D.  A surrogate 3D texture feature was calculated by taking a volume 
Figure 15: Top 25 repeatable texture features for the TRUFISP images. Highly 
repeatable texture features (CCC ≥ 0.95) are green, repeatable features (0.90 ≤ CCC < 
0.95) are yellow, potentially repeatable features (0.85 ≤ CCC < 0.90) are orange, and 
not repeatable feature (CCC < 0.85) are pink. 
Wavelet	Ratio 0.5 0.67 1 1.5 2 Wavelet	Ratio 0.5 0.67 1 1.5 2
Coarseness 0.97 0.97 0.97 0.97 0.97 RLN 0.97 0.97 0.97 0.97 0.97
GLNS 0.96 0.96 0.96 0.97 0.97 ZSN 0.96 0.96 0.96 0.96 0.96
RLN 0.96 0.96 0.96 0.96 0.96 GLNS 0.95 0.95 0.96 0.96 0.96
GLN 0.96 0.96 0.96 0.96 0.96 Energy 0.94 0.96 0.96 0.95 0.95
ZSN 0.96 0.96 0.96 0.96 0.96 GLN 0.95 0.95 0.95 0.95 0.95
Variance 0.96 0.96 0.96 0.96 0.95 Coarseness 0.93 0.95 0.95 0.95 0.95
Energy 0.96 0.96 0.96 0.95 0.95 InfoCorr 0.87 0.91 0.92 0.92 0.93
VariancePS 0.96 0.96 0.96 0.96 0.95 Entropy 0.92 0.92 0.90 0.89 0.87
SD 0.96 0.96 0.95 0.95 0.94 GLVS 0.89 0.93 0.87 0.87 0.87
Complexity 0.96 0.96 0.96 0.94 0.91 Correlation 0.87 0.88 0.89 0.87 0.86
ClusterProm 0.95 0.95 0.95 0.94 0.92 Busyness 0.84 0.85 0.87 0.88 0.89
Entropy 0.96 0.95 0.95 0.93 0.92 EntropyPS 0.89 0.88 0.86 0.85 0.84
InfoCorr 0.91 0.93 0.94 0.94 0.94 SD 0.87 0.87 0.86 0.85 0.83
SZHGE 0.94 0.95 0.95 0.94 0.89 Minimum 0.85 0.85 0.87 0.85 0.80
EntropyPS 0.95 0.95 0.93 0.92 0.91 SZE 0.83 0.85 0.84 0.84 0.82
SZLGE 0.91 0.92 0.93 0.95 0.95 VariancePS 0.83 0.83 0.83 0.83 0.81
LGZE 0.91 0.92 0.93 0.94 0.95 ZSV 0.71 0.76 0.88 0.88 0.89
Quartile 0.93 0.93 0.93 0.93 0.93 ZP 0.83 0.84 0.82 0.81 0.80
HGZE 0.94 0.94 0.95 0.93 0.89 Variance 0.83 0.83 0.83 0.82 0.80
SZE 0.94 0.94 0.93 0.93 0.91 Maximum 0.82 0.82 0.81 0.80 0.78
SRHGE 0.94 0.94 0.94 0.93 0.89 RLV 0.70 0.61 0.89 0.90 0.88
AutoCorr 0.94 0.94 0.94 0.93 0.89 ContrastN 0.82 0.76 0.79 0.79 0.80
HGRE 0.94 0.94 0.94 0.93 0.89 GLV 0.62 0.72 0.79 0.88 0.87
LZLGE 0.90 0.92 0.93 0.94 0.94 Quartile 0.78 0.77 0.75 0.76 0.79
SRLGE 0.90 0.91 0.93 0.94 0.94 Kurtosis 0.77 0.77 0.76 0.76 0.75
TRUFISP TRUFISP_BC
GLCM GLRLM GLSZM Highly	Repeatable	 Potentially	Repeatable
HIST NGTDM Repeatable Not	Repeatable
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weighted average of the texture features extracted from 2D slices and is described in 
further detail later in this section.  
In order to calculate a 3D-like texture feature, a surrogate 3D texture feature was 
calculated from the 2D slices. Contour delineation was performed in the same manner as 
the VIBE and TRUFISP contour delineation described in the previous section. Instead of 
the repeat inspiration/expiration images, the DW images and ADC maps had either:  
different slice thicknesses, 4 mm or 6 mm, or different slice order acquisition, ascending 
or interleaved.  In the case of the DW images and ADC maps, the portion of the primary 
tumor present in each image acquisition was delineated and the process was repeated 
for all image sets necessary to cover the tumor.  Overlap between images covering the 
entire tumor was removed using the MIM software to calculate the intersection of contours 
in adjacent images and to subtract the intersection from one of the two overlapping 
contours.  The direction of subtracting a superior and inferior portion of the tumor contour 
was varied randomly to prevent systematic bias. Texture features were then calculated 
for each 2D slice covering the entire primary tumor contour volume.  The final texture 
feature value for the tumor was calculated by taking the weighted average by volume of 
the texture features. The different slice thickness images were denoted with “_Thickness” 
after the image name and the image pairs with different slice acquisition orders were 
denoted with “_Order” after the image name.     
The surrogate 3D texture feature was tested for robustness to missing voxels, which 
could be introduced during the subtraction of overlapping slices, by evaluating the 
convergence of the coefficient of variation for the texture feature values extracted from 
randomly resampled ROIs.  Five different resampling levels were tested: 10%, 25%, 50%, 
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75% and 90%.  For each of the resampling levels, a random sampling of the indicated 
percentage of voxels was used to calculate the texture feature.  As the percentage of 
voxels utilized increased, the coefficient of variation for most of the texture feature value 
converged to less than 5 percent for both the DW images and ADC maps.  An example 
of the convergence for the mean ROI value can be seen in Figure 16. The low coefficient 
of variation combined with the convergence of most texture features seemed to indicate 
the surrogate 3D texture features were appropriate for use in the repeatability study as 
they are robust to changes in the voxels. 
Figure 16: Example of convergence of the coefficient of variation of the 3D surrogate 
mean texture feature for different b-value DW_Thickness images and the ADC_Thickness 
map (b0_1000_) as a function of percentage of pixels used for each of the wavelet ratios 
tested (top row shows wavelet ratios). 
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The DW image pulse sequence used an echo planar read out where the tissue was 
first excited and then multiple slices were read as the signal decays causing a slice to 
slice variation in the signal intensity with lower intensity present in slices acquired later in 
the sequence.  The slice to slice variation can be seen in the alternating bright and dark 
bands of the interleaved slice acquisition DW image in Figure 17.  In order to minimize 
the impact of the slice variation, the DW and ADC image were normalized prior to texture 
feature calculation by finding the average minimum and maximum intensity values of the 
slices and uniformly quantizing the intensity levels between this range.  
 
Figure 17: Example of slice intensity variation in sagittal DW 1000 b-value image.  This 
image was acquired with an interleaved slice acquisition pattern creating alternating slices 
with high (solid arrow) and low (dashed arrow) intensity. 
 
The same repeatability analysis was performed on the DW-MR and ADC 3D 
surrogate texture features as described in the previous section. Eight different b-value 
DW images were acquired: 0, 50, 100, 250, 500, 650, 800 and 1000 mm2/s and all 8 b-
value images were used to create the ADC map.  The b-value image that had the highest 
number of repeatable features was the 650 mm2/s for the DW_Thickness.  The DW_Order 
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image with the most repeatable texture features was a tie between the 50 mm2/s and 
100mm2/s, with the 100 mm2/s having more repeatable features across all wavelet ratios.  
However, the lower b-value represents perfusion rather than diffusion, so for analysis of 
the diffusion component was limited to the 650 mm2/s image which has the third largest 
number of repeatable features.  The results of the repeatability analysis were presented 
and discussed in the manuscript in Appendix I. 
3.4 Quantization and Wavelet Transforms 
The Vallieres22 code used for this work includes support for applying the wavelet 
transform at different ratios and quantizing the gray levels to a desired number of bins.  
The wavelet transform ratio selects the weighting of the band-pass sub bands, mixed high 
and low pass filter on different axes, to the pure high pass and low pass sub-bands, high 
pass or low pass along all axes.  By adjusting the ratio, different structural features or 
contrast features can be emphasized.  The quantization option allows for different binning 
schema for the gray levels which reduced the sparsity of the texture feature matrices 
when compared to the gray levels present.  While reducing the number of bins may 
reduce the effect of noise present in the image, it can also smooth over fine texture 
patterns. 
The VIBE, TRUFISP, and CT images were further analyzed for the effect 
quantization would have on the repeatability of the texture features.  The DW and ADC 
images were not included in this analysis due to the limited amount of data.  The texture 
features were analyzed by quantizing the number of gray level into 8, 16, 32, 64, and 256 
bins and comparing them to using the gray levels as the bins, or no quantization. The 
wavelet ratios for all image types were compared.  Aside from the different wavelet ratios 
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and quantization methods, all aspects of the image processing and texture feature 
extraction were the same.  In September of 2016, Vallieres released an update to the 
radiomics code that effected the calculation of some of the texture features, 
predominately the GLRLM and NGTDM. This lead to a reduction in the number of 
repeatable features when compared to the results in the bias correction section seen in 
Figure 14 and Figure 15. 
Initial experiments with clustering revealed that the different wavelet ratios of a 
texture feature appeared in the same cluster suggesting they contained redundant 
information. The wavelet ratios with the most repeatable features for the VIBE, TRUFISP, 
CT, DW, and ADC images were 0.67 and 1, the unfiltered image.  In light of this, the 
unfiltered image was kept and an average wavelet ratio texture feature was calculated by 
averaging the five wavelet texture feature values together.  The unfiltered and average 
texture feature values only were considered for clustering. 
Six different quantization levels were investigated and compared: 8, 16, 64, 128, 
256, and the number of gray levels.  For the VIBE, TRUFISP, and CT unfiltered images 
setting the number of bins equal to the number of gray levels resulted in at least 13 more 
repeatable texture features than any of the other quantization levels.  A similar pattern 
could be seen in the other wavelet ratios.  Since quantifying the gray levels did not 
improve the repeatability of the texture features, the final workflow used the number of 
gray levels as the bins.    
3.5 Delta Radiomics 
Investigation into the changes in texture features over the course of radiation 
treatment has been a new area of interest in the field of radiomics.  The hope with delta 
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radiomics is to detect features that are changing as a result of radiation treatment and 
therefore could more reliably predict a response to treatment.  Fave et al.17 recently 
published results that included delta radiomics features in predictive models for overall 
survival.  While the present work does not have enough data from different time points to 
create models, the texture features were evaluated for a significant change in the features 
throughout treatment. 
To assess if there was a difference in the population median of texture features 
between different time points, the Wilcoxon Rank sum test was used. To investigate if a 
significant change had occurred in an individual patient between the different time points, 
the confidence interval for the repeatability coefficient as described by Barnhart and 
Barboriak69 was calculated and evaluated under the hypothesis that a change occurred. 
All combinations of time point comparisons, time 1 to time 2, time 2 to time 3, and time 1 
to time 3, were analyzed for both the population and individuals. 
The repeatability coefficient to detect individual change at the 95% confidence level 
with 2 repeat images per subject is defined as: 𝑅𝐶 = 1.96 2 ∗ 𝑤𝑆𝐷$ = 2.77 ∗ 𝑤𝑆𝐷	   ( 4 ) 
Where 𝑤𝑆𝐷, the within subject standard deviation, is the standard deviation of the 
difference between the test and retest values of the texture feature per subject divided by  2 and summed over all subjects.   The confidence interval for the different time points 
becomes: 
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𝐿, 𝑈 = 𝑌T − 𝑌U − 𝑅𝐶, 𝑌T − 𝑌U + 𝑅𝐶    ( 5 ) 
where 𝑎 and 𝑏 are two different time points, 𝐿 is the lower bound, 𝑈 is the upper bound, 
and 𝑌 is the feature value of interest at the identified time point.  If the confidence interval 
includes 0, then no significant change for an individual has occurred. 
The Wilcoxon Rank test showed there were only a few texture features that had 
population differences that were significant at the 0.05 level.  The significant features were 
for the CT images: median from the intensity histogram between time points 1 and 2 for 
0.5 wavelet ratio (p=0.04) and homogeneity from the GLCM between time points 1 and 2 
for the 1, 1.5, and 2 wavelet ratios (p=0.04, p=0.03, and p=0.04 respectively); and for the 
VIBE images: correlation from the GLCM between time points 1 and 3 for 1.5 and 2 
wavelet ratios (p=0.045 and p=0.03 respectively).  There were no significant differences 
found for the TRUFISP, ADC_Order, ADC_Thickness, DWI_Order, or DWI_Thickness 
images.  
Delta radiomics for the ADC and DWI images sets were not calculated due to the 
small number of individuals with repeat imaging at different time points.  Most of the 
repeatable texture features showed a statistically significant change in at least 2 subjects 
at one or more time-point comparisons for the VIBE, TRUFISP, and CT images. For the 
unfiltered image and wavelet ratio 0.67, there were 7 texture features for the VIBE, 8 
texture features for the TRUFISP, and 0 for the CT images that did not exhibit a significant 
change in at least 2 individuals. Due to the same sample size of subjects containing all 
three time points, delta radiomics were not included in the creation of predictive models. 
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3.6 Conclusion 
The preliminary work helped to determine the image preprocessing steps that 
maximized the number of repeatable texture features for the CT and MR images.  The 
preprocessing steps maximized the number of repeatable texture features available for 
clustering and model selection.  For the MR images, bias correction did not increase the 
repeatability of texture features.  In light of this, unprocessed images were used for all the 
MR and CT images.  Additional research provided insight into the effects of quantization 
and the ratios of the wavelets.  The number of gray levels was selected to again maximize 
the number of repeatable features.  The unfiltered wavelet ratio was tied for the most 
number of repeatable features and, since the features of all wavelets clustered together, 
the unfiltered wavelets and the average of all the wavelet ratio texture features were used 
for clustering.  The preprocessing steps developed the initial steps of the workflow used 
in the manuscript in Appendix I. 
With the limited amount of repeat time data available for repeatability analysis on 
the DW, ADC, and the longitudinal data, a preliminary analysis was completed.  A 
surrogate 3D texture feature was developed to test the repeatability of the DW and ADC 
features.  The surrogate texture features were robust to changes in the contour due to 
the subtraction of overlapping images.  The longitudinal data, while not showing a 
significant change in the population data, revealed that many features appeared to 
demonstrate change on an individual level.  With increased data, a population change 
may be evident.  Further investigation of MR texture feature and delta radiomics is 
warranted. 
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4 Specific Aim 2:  Build an Uncertainty Model Utilizing 
Machine Learning Techniques 
 
 
 
4.1 Introduction 
This second aim seeks to build an uncertainty model utilizing imaging features and 
tumor characteristics to support physician contour delineation. As part of this second aim 
three sub aims were proposed:  
• SA 2.1 Determine the ability to predict the uncertainty in contour delineation 
from the tissue interface.   
• SA 2.2: Investigate deep machine learning techniques to distinguish between 
different tumor/normal tissue interfaces given a patch input of the image.   
• SA 2.3: Investigate feasibility of building a tool using machine learned 
features to predict the level of uncertainty at a point of interest.   
Machine learning techniques have recently been employed successfully in medical 
imaging for various tasks ranging from detecting lung nodules in images,113, 147 classifying 
radiation induced lung injury,114–116, 148 to image segmentation,105, 119, 121, 122, 125, 128, 149–151 
making machine learning an ideal tool to attempt classification of different tumor/normal 
tissue interfaces in lung tumors.  The expectation is that the CNN would be able to learn 
parameters that enable it to identify the boundary of the tumor with pathology and 
anatomy that are difficult for humans to distinguish from tumor, such as atelectasis.  Using 
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the output of the neural networks, more information could be provided to physicians to 
aid in contour delineation with increased accuracy. 
Our research group has previously investigated the amount of contour delineation 
uncertainty at the tumor and lymph node interfaces with normal tissues.  In the study by 
Karki et al.,83 seven observers contoured the primary tumor and affected lymph nodes for 
ten subjects on three image sets: MR, CT only, and PET/CT.  A median contour was 
calculated from the individual contours, and the bilinear distance was computed from 
each point on the median contour to each individual contour for each modality. The 
contour delineation uncertainty was estimated for each contour on each imaging modality 
by taking the root mean square (RMS) of the standard deviation of the bilinear distances.  
An experienced physician identified the regions on the median contour corresponding to 
the interface of the tumor, or affected lymph nodes, with the chest wall, lung parenchyma, 
hilum, mediastinum, vessels, and atelectasis.  The uncertainty for each interface type was 
determined utilizing bilinear distance as before, but only using the points identified as 
belonging to each interface.  The largest amount of uncertainty among the interfaces for 
all three modalities was between the primary tumor and atelectasis (p = 0.0006), while 
the interfaces with the least uncertainty were the tumor/lung for CT only and the 
tumor/mediastinum for PET and MRI.  A study by Steenbakkers et al.86 compared the 
difference in multi-physician contour agreement and delineation uncertainty, as measured 
by minimum distance between individual and median contour, using CT only and PET/CT 
images. They found a reduction in the uncertainty and increase in agreement when using 
the PET images in addition to the CT images. The anatomical area with the largest 
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improvement was near atelectasis, though improvement was seen in all interfaces 
examined: lung, mediastinum, chest wall, and lymph nodes. 
The amount of uncertainty in contour delineation appeared to be explained in part 
by the interface type with the tumor.  The first part of this aim endeavors to explore the 
correlation between interface type and contour delineation uncertainty and investigate the 
feasibility of using machine learning techniques to identify the interface type without 
physician input in order to provide additional information about the expected contour 
delineation uncertainty as an aid in improving contour delineation accuracy.   
4.1.1 Interface Uncertainty 
Using the bilinear distance gathered by Karki et al. for the primary tumor, further 
analysis of the uncertainty of each interface was investigated focusing on the CT only and 
PET/CT images.  The characteristics of the patients can be seen in Table 4.  The median 
uncertainty was analyzed using R (3.3.1) in R Studio (1.0.143, RStudios Inc., Boston, 
MA).  Analysis was preformed across all subjects and found the uncertainty was largest 
for the tumor/atelectasis interface for both the CT only and PET/CT images, and lowest 
for the tumor/vessel interface as seen in Figure 18 and Figure 19 respectively.  However, 
the trend for each patient varied with atelectasis, when present, generally exhibiting the 
highest median uncertainty while the other interfaces were more evenly spread as can be 
seen in Appendix III and Appendix IV. 
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Male	 7
Female	 3
Squamous	cell	carcinoma	 6
Adenocarcinoma	 3
Carcinoma	 1
IIB 1
IIIA 3
IIIB 6
Yes 7
No 3
Chemotherapy
Mean	Dose	(Range)
63	(45-66)	Gy
Sex
Mean	Age	(Range)
57.5	(50.0-64.6)	years
Histology
Stage
Table 4: Summary of Characteristics used in the study by 
Karki et al. and for the first portion of this aim. 
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Figure 18: Violin plots of the CT only uncertainty by interface type of all subjects where 
the width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum interface. 
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Figure 19: Violin plots of the PET/CT uncertainty by interface type of all subjects where 
the width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum. 
 
 Statistical analysis of the relationship between uncertainty and interface type 
revealed, for the PET/CT images, no significance for any of the interfaces. The 
atelectasis/tumor interface was trending towards significance with a p-value of 0.0752, 
but all other interfaces had p-values between 0.1073 and 0.7256.  K-means clustering of 
the uncertainty and spatial information of each point on the median contour for a given 
subject was attempted in Python (2.7) using the Sklearn package from scikit152 to try and 
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recover the interface boundaries.  The results of the k-means clustering were dominated 
by spatial information and failed to recover the interface boundaries.  When the spatial 
information was removed, the uncertainty also did not cluster by interface. A comparison 
of k-means clustering can be seen in Figure 20.  Qualitative inspection of the uncertainty 
showed it was largest in protruding regions of the tumor but within an interface the 
uncertainty did not have observable trends of homogeneity or increased uncertainty near 
boundaries with other interfaces. 
 
 While the interface type alone does not explain the amount of contour delineation 
uncertainty observed, knowing the amount of expected uncertainty in a given region of 
the image can provide additional information to the physician while contouring, allowing 
them to take the uncertainty into account while defining the region to be treated.  A 
comparison of the RMS uncertainty for the PET/CT delineated tumor overall and by 
interface can be seen in Figure 21.  The relationship between the interface type and the 
Figure 20:  K-means clustering for an example subject with the PET/CT 3D contour 
surface unrolled to be displayed in 2D.  The figure on the left shows the ground truth 
interface while the panel on the right shows the k-means clustering with only the 
uncertainty.  Color was used to differentiate different clusters 
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uncertainty level was explored and a convolutional neural network (CNN) was 
investigated for its ability to determine the interface type without aid from a physician as 
part of this work.  A tool to provide physicians with additional information about the 
uncertainty was proposed as the final product.  
 
4.2 Interface Type Identification Convolutional Neural Network 
The next phase of this specific aim endeavored to build a neural network to predict 
the interface type without user input.  Following the results of the initial network, additional 
network designs, techniques, and subjects were evaluated.  The following sections begin 
by describing the initial network design and dataset curation, and are followed by a 
description and results of the additional network designs implemented. 
Figure 21: Overall uncertainty RMS of the standard deviation of the bilinear 
distance for the primary tumor (PT) interfaces PET/CT imaging modality. 
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4.2.1 Methods 
The initial dataset for the first CNN used the same patients characterized in Table 
4.  The training dataset was created using the interface contours derived from the median 
contours used in the study by Karki et al.83  All contours were drawn with MIM (MIM 
Maestro v6.X, Cleveland, OH) and extracted using the MatLab extensions (2016b, 
MathWorks, Natick, MA) before being processed in Python (2.7)  for use in the developed 
CNNs.  An example of the interface contours can be seen in Figure 22.  First, each image 
and corresponding contours were resampled to have an isotropic voxel size of 0.5mm3.  
Then the bounding box containing all the interface contours for a subject was identified 
and a 4mm margin in each direction was added.  From the bounding box, patches of 12.5 
mm3, or 25 voxels3, were extracted along with the interface type label or a label indicating 
not an interface for the central voxel. This resulted in several thousand labeled patches 
across all subjects. 
Figure 22:  Examples of the aorta/tumor interface in green, the chest wall/tumor 
interface in yellow and atelectasis/tumor interface in pink. 
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As the number of patches extracted from each patient and interface type depended 
on the size and presence of an interface, the dataset was highly unbalanced.  To account 
for this unbalance in the data, a two stage training inspired by Havaei et al.123 was 
employed whereby the network was first trained on a balanced number of examples from 
each class randomly sampled across all subjects.  The second phase of training initialized 
the network weights using the weights learned in the first phase of training and continued 
to train the network on an expanded training set representing a “natural probability” where 
the number of examples from each training class is proportional to the frequency 
observed in the subjects.  The images are normalized across all training examples before 
training to have a mean of 0 and standard deviation of 1. Examples of the center slice of 
the normalized patches can be seen in Figure 23.  In addition, 20% of the training 
examples were withheld for an unseen testing validation set resulting in approximately 
13,000 examples for phase one training, 72,000 for phase two training, and 38,000 for 
testing. 
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Figure 23: Example of normalized center slice of the input patch.  The label is for the 
central pixel in each input example are as follows:  Row 1: aorta, lung, not interface; 
Row 2: atelectasis, hilum, not interface; Row 3: not interface, mediastinum, lung;  
Row 4: chest wall, hilum, atelectasis.  
 
The network employed for both phases of training was a 3D CNN with a structure 
similar to the VGG net.102 This small network consisted of two blocks of two convolutional 
layers followed by a maximum pooling layer, followed by two “fully connected” layers 
implemented as convolutional layers with a drop out layer in between.  A detailed 
explanation of each layer type can be found in section 1.4.2 Convolutional Neural 
Networks.  Unlike the VGG net, the filter size employed in this work decreased in size as 
the layers got deeper similar to the InvertedNet used by Novikov et al.127 without skip 
connections.  A diagram of the network architecture can be seen in Figure 24.  Valid 
padding was used in all layers.  Training was conducted using the Keras package153 
(version 2.1.6) with a Tensorflow (version 1.6) backend an M2050 Maxwell Nvidia GPU 
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(Nvidia, Santa Clara, CA) with an SGD optimizer with momentum for regularization using 
a categorical cross-entropy loss function.  The final class prediction was performed by the 
Softmax activation.  
Figure 24: Network architecture for the initial CNN network consisting of two blocks of 
two convolution layers followed by maximum pooling followed by two fully connected 
layers implemented as convolutional layers and dropout. 
 
 The network was evaluated for accuracy by computing the raw accuracy, number 
of correctly labeled test examples divided by the total number of test examples, and by 
analyzing the confusion matrix across all classes.  The accuracy for each class was 
assessed by calculating: 
                                                      	𝐴W = X5X5435Y43ZY																																																																		( 6 ) 
where 𝑐 is the class being evaluated, 𝑇𝑃 is the true positive, sum of all correctly identified 
class, 𝐹𝑃W is the false positives, sum of all examples incorrectly labeled as class 𝑐, and 𝐹𝑁W is the false negatives, the sum of all examples of class 𝑐 labeled as the incorrect 
class. The error rates, 𝜀 = 	1 −	𝐴W,  are reported in the results section below. 
4.2.2 Results 
Phase one training achieved accuracy on the unseen test set of 65% while the 
second phase of training improved the network accuracy to 70%.  The top two accuracy 
of the network following second phase training was 85%.   The confusion matrix results 
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following the second phase of training can be seen in Table 5.  The class with the highest 
error was the atelectasis (AT)/tumor with 18.7% accuracy followed closely by the not 
interface label with 16.8%.  The remaining interfaces had error rates of 13.4% 
hilum/tumor, 10.9% lung/tumor, 8.7% mediastinum (Med)/tumor, 3.8% chest wall 
(CW)/tumor, and 0.6% vessel(Aorta)/tumor.  
 
 
4.2.3 Discussion 
The result of this initial CNN showed it may be feasible to train a neural network to 
identify the interface type without physician input for a local patch.  The lower overall 
accuracy of the network suggested that improvements could be made by creating a 
deeper network and adding additional patients to the training dataset.  The need for 
additional training examples can be seen in the overfitting of the vessel(aorta)/tumor 
class.  In the dataset, only one subject had the vessel/tumor interface, meaning the 
unseen test examples were all from the same subject seen in the training, but different 
views, leading to the low error rate.  The testing set was comprised of a randomized 
selection of patches from each class from all subjects exposing the testing set to same 
type of bias seen by the vessel/tumor interface but to a lesser degree given the variety of 
Table 5: Confusion matrix following second phase of training for the initial CNN. 
[[2721	1561		808	1971		518		210			55] Not	Interface Lung Hilum AT Med CW Aorta Total	Labels
	[	180	7231		329		135			72				0				3] Not	Interface 2721 1561 808 1971 518 210 55 7844
	[		28		357	4847	1334		379				0			11] Lung 180 7231 329 135 72 0 3 7950
	[		62		486		515	4613		658		272				7] Hilum 28 357 4847 1334 379 0 11 6956
	[		50		165		382		287	2998			18				0] AT 62 486 515 4613 658 272 7 6613
	[			7				1			22		505			26	3687				0] Med 50 165 382 287 2998 18 0 3900
	[			9			21			41			10			10				0		973]] CW 7 1 22 505 26 3687 0 4248
Aorta 9 21 41 10 10 0 973 1064
Total	Prediction	 3057 9822 6944 8855 4661 4187 1049
Predicted	Label	
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subjects and views to be randomly selected from.  To reduce this bias and give a better 
real world accuracy, the test set should be comprised of completely unseen subject(s). 
In addition, the low class accuracy for the atelectasis and not interface suggested 
the network was struggling to identify these patches.  Part of the confusion for the 
atelectasis could come from the similarity of the atelectasis to the normal tissue on CT 
scans, which makes visually distinguishing the tumor difficult.  The mediastinum and 
hilum are both similar hybrid structures in the center of the thoracic cavity that contain 
multiple types of tissue, such as airways and/or blood vessels.  To reduce the confusion 
between these two structures, they could be combined into one class, as attempting to 
differentiate between mediastinum and hilum structures during contouring resulted in an 
anatomically often ambiguous separation.  The errors from the not interface class could 
be induced by the wide variety of possible patches included in the not interface class 
including normal tissue and tumor only tissue alike.  
Different pathways were investigated to implement the larger dataset and network 
design improvements to see if a deeper network is able to improve the accuracy by 
designing a network that could be used to predict the presence of an interface in general, 
and/or by designing a network to predict the presence of the tumor.   
4.3 Further Exploration of Network Predictions  
Following the success of the initial network, the number of patients was expanded 
to include a total of 39 patients.  Since the expanded patient set did not have median 
contours like the previous study, the tumor contour from the planning CT was used to 
create the interface contours for all patients.  Like the dataset before, the planning 
contours were created using the PET information as well as the CT scan.  The specificity 
  93 
of the interface labels was also changed by expanding to include a label for airways/tumor 
and bone/tumor in addition to lung/tumor, atelectasis/tumor, mediastinum/tumor, chest 
wall/tumor, and vessel/tumor.  Also, the previous hilum/tumor was combined with the 
mediastinum, and bone was removed from the chest wall contours.  The updated patient 
characteristics can be seen in Table 6.  These patients were utilized for the reminder of 
the experiments in this aim.  In addition, training was conducted on either the K80 Kepler 
or P100 Pascal Nvidia GPUs. 
 
4.3.1 Interface Prediction Networks 
4.3.1.1 Expanded	Traditional	CNN	
Building upon the architecture used previously, the network was made deeper by 
adjusting the padding and adding an additional block of two convolutional layers followed 
by a maximum pooling layer.  This expanded network architecture can be seen in Figure 
Table 6: Summary for patient characteristic for machine learning 
study. 
Male	 24
Female 15
I 1
IIA 1
IIB 4
IIIA 16
IIIB 10
IV 7
Yes 32
No 7
62.2	(40.0-70.2)	Gy
Sex
Mean	Age	(Range)
Stage
Chemotherapy
Mean	Dose	(Range)
60.6	(50.0-74.6)	years
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25.  The two phase training was again employed, at first to balance the dataset, but early 
testing showed no improvement in the accuracy of the network with the second phase of 
training, so only phase one with balanced interface types across all subjects was used to 
train the revised CNN architectures.  The same method was employed to create the 
labeled dataset by extracting patches from each subject.  During training, one subject 
was withheld to be the unseen test set while a class balanced dataset for training was 
randomly selected from the remaining subjects.  This network was again trained using 
SGD with a momentum term and categorical cross-entropy as the loss function.   
The expanded network was first tested using an unseen test set following training 
that consisted of a reserved subset of the training set derived from all subjects to assess 
the improvement in network accuracy due to the additional subjects.  The overall accuracy 
of the network rose to 78% for best guess.  The network was then retrained and optimized 
this time by withholding one subject entirely for the test set and training the network on 
the remaining subjects.  The overall accuracy of the unseen subject for the optimized 
Figure 25:  Diagram of the revised CNN architecture to include an addition block of 
two convolutional layers followed by a maximum pooling layer.  
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parameters was 40%.  The largest source of error was the atelectasis interface where a 
large number of image patches were classified as atelectasis/tumor despite the subject 
not exhibiting atelectasis.  Following these results, the network was adapted again to 
employ the skip connection techniques of the ResNet architecture to see if more accuracy 
was possible with an even deeper network. 
4.3.1.2 ResNet	CNNs	
The ResNet like network, referred to as the ResNet CNN, was also developed 
incorporating the batch normalization scheme suggested by He et al. in their follow-up 
paper103 to the original paper104 introducing the ResNet architecture.  The ResNet 
architecture differs from the extended tradition CNN described in the previous section by 
employing skip connections to pass information learned in previous layers to later layers 
and the use of identity blocks to prevent overfitting.  These skip connections improve the 
ability of the SGD optimization to learn by removing the exploding and vanishing gradient 
problem often seen as networks get deeper allowing the potential for additional benefits 
from deeper architectures.104  
The ResNet architecture begins like the traditional CNN where the input undergoes 
a series of convolution layers and a maximum pooling layer. However, following the initial 
maximum pooling layer, a series of residual and identity blocks are added in place of the 
additional traditional convolutional layers before the final, fully connected layers.  The 
identity blocks and single residual blocks implemented in this work are descried in the 
2016 paper by He et al.103 using the “full pre-activation”  set up. The double residual block 
added an additional convolution layer with desired filters followed by batch normalization 
with ReLU activation before the final weight layer seen in the single residual block. To 
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create the double ResNet CNN, convolution 2a and convolution 2b as a group and 
convolution 3a and convolution 3b as a group in Figure 25 were replaced with the double 
convolution block, one for each group, with varying numbers of identity blocks following 
before the max pool layers. This network was still trained using SGD, with a momentum 
term and categorical cross-entropy as the loss function. 
The overall accuracy of the unseen test subject for the double ResNet CNN varied 
with the number of identity layers used from 49% without any identity layers to 52%, 43% 
and 30% for 1, 2, and 3 identity layers respectively.  For comparison, the test subject was 
kept the same as used to test the extended CNN in the previous section.  For the best 
preforming network and hyper parameters, the individual class confusion matrix can be 
seen in Table 7.  The error for each individual class in order from highest to lowest was 
as follows: 31.9% mediastinum (Med)/tumor, 26.8% vessel/tumor, 24.0% not interface, 
21.0% atelectasis (AT)/tumor, 17.2% air way (AW)/tumor, 14.5% lung/tumor, 1% 
bone/tumor, and 0% chest wall (CW)/tumor.  There were three interfaces not present in 
the test subject: the chest wall, atelectasis, and bone, as the subject has a centrally 
located tumor that did not obstruct an airway.  The mediastinum/tumor was most often 
confused with the vessel/tumor and air way/tumor.  The not interface patches also had a 
low number of correctly predicted labels most often being mistaken for atelectasis and 
mediastinum.   
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4.3.1.3 Encoder	Network	
Following analysis of  the results of the ResNet CNN, one more modification to the 
network architecture was attempted.  In order to improve the accuracy of the not interface 
labels, the labels were modified to change the not interface label from a class identification 
to an encoder, indicating the presence of any interface by the value of 1 and no interface 
with 0.  The labels of the remaining interface were unchanged. This change to the labels 
resulted in changes to the network architecture, the loss function utilized, and the 
balancing method for the data given to the network. 
 To better train the network using the encoder label and interface labels, the 
dataset provided to the network had to not only have a balanced number of patches 
between the different interface types excluding the not interface patches but also between 
the total number of patches containing interfaces and number of patches without any 
interfaces.  This resulted in more examples of the not interface patches being added to 
the training set.  The extended CNN was again modified by replacing convolution 2a, 
convolution 2b, convolution 3a, and convolution 3b in Figure 25 this time individually with 
the single residual blocks described in the previous section.  The encoder portion of the 
label was evaluated by the binary cross-entropy loss, while the remaining interface labels 
1	layer	lr	0.0005	accuracy	52%		using	normalization	to	0	mean	and	1	sd
Not	Interface Lung AT	 Med CW Vessel AW Bone Total	Labels
Not	Interface 169 98 133 194 0 72 85 2 753
Lung 24 598 12 35 0 0 84 0 753
AT 0 0 0 0 0 0 0 0 0
Med 12 18 118 414 0 141 50 0 753
CW 0 0 0 0 0 0 0 0 0
Vessel 4 9 261 233 0 240 6 0 753
AW 2 55 3 127 0 0 560 0 747
Bone 0 0 0 0 0 0 0 0 0
Total	Prediction	 211 778 527 1003 0 453 785 2
Tr
ue
	La
be
l
Predicted	Label	
Table 7: Confusion matrix for the double ResNet CNN with one identity layer. 
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were evaluated with the categorical cross-entropy.  The total loss for the network was the 
summation of the binary cross-entropy and the categorical cross-entropy. Ideally, this 
allows the network to learn features that indicate an interface, and then for those that are 
an interface, distinguish which interface is present. 
The accuracy of the Encoder Net showed a compromise in the accuracy of 
identifying the interface type with the accuracy of identifying the presence of an interface.  
The highest accuracy achieved for identifying if an interface was present was 77% while 
the accuracy of identifying the interface type for the same network was only 37%.  With 
different hyper parameters, the interface type accuracy was able to reach 54% while the 
accuracy of identifying if any interface was present was only 66%.  This trade off 
suggested that creating two separate networks, one for each task, may be beneficial.  It 
further highlighted that the network may not be able to distinguish the tumor tissue from 
the surrounding healthy tissue, thereby identifying where interfaces between the tumor 
and normal tissue exist.  This was illustrated by creating a prediction map by preforming 
a sliding window prediction over the entire area of the image surrounding the tumor 
contour and plotting the prediction for the interface identification portion of the network 
only.  An example slice can be seen in Figure 26.   
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4.3.2 Single Task Networks  
Following analysis of the results of the previous networks, it appeared the task of 
determining where the tumor was located in order to identify the interfaces, and then 
identifying which interface was present was too ambitious for a single pass of the 
networks designed so far.  Considering this, it seemed appropriate to take a step back 
and evaluate simpler criteria for the network to identify.  Three different networks were 
Figure 26:  Illustrative slice from the prediction map for the unseen test 
subject from the encoder net.  The top and bottom images on the left side 
detail the ground truth interface type labels while the top and bottom images 
on the right demonstrate the predicted output of the encoder network for the 
presence of an interface of any type. 
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developed: the first and second were to break the Encoder Net into two separately trained 
networks, one to identify the location of any interfaces and the other to identify the type 
of interface given an input that was known to be an interface; the third network was 
developed to identify the location of the tumor.  The network architecture used for all three 
networks was the same: the Encoder Net architecture described above without the 
modifications to the loss function.  The data fed into each of the networks was different 
depending on the desired outcome and the filter size of the final layer was adjusted 
accordingly.  Instead of using only one test subject, the network was retrained three to 
five times with a different subject left out each time.  
4.3.2.1 BinaryRes_IF	Network	
The existing dataset was used to create the datasets for the interface location 
prediction network, referred to as BinaryRes_IF network, by modifying the labels.  The 
labels first disregarded the interface type information and instead collapsed them into one 
label indicating if any interface was present and leaving the not interface label unmodified.  
This created a binary set of labels indicating if the patch belonged the interface or not 
interface class.  The binary cross-entropy was used to train the BinaryRes_IF network.  
For this network, training was completed by alternating one of four test subjects.   
The accuracy of the new work for the first subject was 78%, the second subject 
was 63%, the third test subject was 80%, and fourth subject was 66%.  However, when 
the prediction maps were created, the results, while more specific, seemed to identify the 
region of the tumor and some interfaces instead of just the interface, Figure 27.  This 
observation was the motivation for the BinaryRes_Tumor network.   
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Figure 27:  Illustrative slice of the comparison of the ground truth interface location with 
the output of the BinaryRes_IF network.  The top row represents the ground truth and 
output maps while the bottom rows shows the maps overlaid on the corresponding 
images slice. 
4.3.2.2 	BinaryRes_Tumor	Network	
In an attempt to determine a network’s ability to detect the location of the tumor, 
the existing network structure was repurposed.  A new dataset was created for the 
BinaryRes_Tumor network in the same manner as described in section 4.2.1 with the 
planning tumor contour being supplied instead of the interface contours.  This resulted in 
a series of patches with binary labels identifying the center pixel of the patch as being 
within the tumor contour or not.  Like the contour used in the initial and subsequent 
  102 
networks, the tumor contours were created by physicians using information from the PET 
scan as well as the CT scan. The network was again trained with SGD optimization with 
a binary cross-entropy loss function five times with a different subject withheld for the 
testing each time. 
The network was able to achieve a relatively high accuracy for all 5 test subjects 
on the reserved set of patches with the accuracies ranging from 84% to 87%.  Prediction 
maps were again created for all subjects to visualize how well the network would perform 
on the entire image.  Analyzing these images indicated the network seemed to predict 
false positives in the muscle and atelectasis, Figure 28 , but overall seemed to capture 
most of the tumor.  Illustrative slices from all test subjects can be seen in Appendix V.  
The Dice score was calculated as a measure of how well the predicted tumor and original 
tumor contour were in agreement.  Conditional random fields (CRF) post processing was 
also applied using the pydensecrf package154 implementing the fast CRF by Krahenbuhl 
and Koltun155 to remove small areas of predicted classes that were not near similar labels.  
The Dice for the network output and CRF post processing can be seen in Table 8.  
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Figure 28:  Illustrative slice of the comparison of the ground truth tumor location 
with the output of the BinaryRes_Tumor network.  The top row represents the 
ground truth and output maps while the bottom rows show the maps overlaid on 
the corresponding images slice. 
Subject Pre-CRF Post-CRF
S 1 0.68 0.77
F 2 0.68 0.75
H103 3 0.60 0.69
M 4 0.60 0.68
W 5 0.68 0.78
Tumor
Table 8:Dice similarity coefficient for the BinaryRes_Tumor network 
predictions before and after CRF post-processing.  
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While the BinaryRes_Tumor network is able to identify the tumor with some 
precision, the number of false positives from regions such as atelectasis, at this time, is 
not conducive to building an uncertainty model.  Since the test subject seen above also 
had median contours drawn using the CT only, as well as the PET/CT from the study by 
Karki et al.,83 a Dice similarity coefficient between the network output and the median 
contours was calculated.  The Dice similarity between the network output and the CT only 
median contour was 0.65, while the Dice similarity between the network output and the 
PET/CT median contour was 0.69. However, when the post-processing was applied, the 
Dice for the PET/CT dropped to 0.66, while the CT only Dice similarity rose to 0.70.  This 
suggests the network predictions for the tumor location may be closer to those made by 
physicians only looking at a CT image rather than discerning any information from the CT 
image alone that would indicate areas of high metabolism as indicated on PET image.   
4.3.2.3 IF_Only	Network	
The last network explored was the IF_Only network which endeavors to predict the 
interface type of a patch known to be from an interface. The existing labeled interface 
patch dataset was again used to create the datasets for the IF_Only network by modifying 
the labels.  This time the existing dataset was first limited to only the patches known to 
contain an interface before the not interface class was removed from the labels of the 
remaining patches before training and testing.  The network was trained using SGD with 
a momentum term, categorical cross-entropy for the loss function and was trained five 
times using a different test subject each time. 
The IF_Only network resulted in an accuracy of between 38% and 65% across the 
five test subjects on the randomly selected test patches.  Prediction maps for all the 
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patches within each subject image were created like with the previous networks to 
visualize the network output.  For these prediction maps, only the patches identified in the 
physician defined interface contour, used as the ground truth, were extracted and fed to 
the trained network for predictions. From the prediction maps, there seemed to be greater 
accuracy in prediction of the interface than the test accuracy demonstrated as can be 
seen in Figure 29 and the illustrative slices from all test subjects in Appendix VI. The 
areas of the image not identified by the physicians were labeled as not interface for the 
purpose of illustration and were not part of the network prediction. 
Figure 29:  Illustrative slice comparing the ground truth physician interface labels 
with the IF_Only network output without post-processing.  The top row indicates the 
maps of predicted and true interface types while the bottom row shows the maps 
overlaid on the corresponding image slice. 
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The Dice overlap between the network prediction and the ground truth was 
calculated for each interface to assess the agreement between the network output and 
the physician identified interface locations across the whole image.  CRF post-processing 
was applied to the interface prediction labels to try and improve the Dice overlap.  The 
results can be seen in Table 9.   
The interface that the network had the most difficulty identifying was the 
mediastinum/tumor interface.  This interface was often confused with atelectasis, vessel, 
chest wall, and airways which all share a similar intensity on CT scans, and in the case 
of vessels and air ways, may be found throughout the mediastinum. One interesting 
observation, however, was the network’s ability to pick up on nearby structures, such as 
bone, that were not part of the physician ground truth label, Figure 30.  These incorrect 
labels may in some cases still be informative and show the ground truth may benefit from 
review or consensus and could affect the accuracy of labels such as the mediastinum. In 
the subjects with large regions of atelectasis, the network seemed able to identify the 
interface with higher accuracy. The network also seemed to be able to predict the lung, 
airways, bone, and chest wall interfaces with relatively high accuracy. The average class 
accuracy for the interfaces are: lung/tumor 82%, atelectasis/tumor 74%, 
Subject Pre-CRF Post-CRF Pre-CRF Post-CRF Pre-CRF Post-CRF Pre-CRF Post-CRF Pre-CRF Post-CRF Pre-CRF Post-CRF Pre-CRF Post-CRF
S 1 0.70 0.83 -- -- 0.12 0.22 0.73 0.84 0.46 0.64 0.31 0.42 -- --
F 2 0.64 0.75 0.04 0.04 0.27 0.25 -- -- -- -- -- -- -- --
H103 3 0.85 0.96 -- -- 0.42 0.68 0.56 0.67 -- -- -- -- -- --
M 4 0.65 0.80 0.51 0.79 0.11 0.12 0.54 0.68 0.22 0.44 0.42 0.51 -- --
W 5 0.69 0.84 0.34 0.54 0.18 0.19 -- -- 0.41 0.57 0.38 0.57 -- --
BoneLung AT Med CW Vessel AW
Table 9: Dice similarity coefficient comparison for IF_Only network predictions before 
and after CRF post-processing. 
-- indicates interface was not present for test subject, AT is the atelectasis/tumor 
interface, Med is the mediastinum/tumor interface, CW is the chest wall/tumor 
interface, and AW is the air way/tumor interface. 
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mediastinum/tumor 67%, chest wall/tumor 89%, vessel/tumor 82%, air way/tumor 91%, 
and bone/tumor 95%.  Similarly, the physician contour delineation uncertainty was also 
low for these interfaces as seen in Figure 21, while the atelectasis region had the largest 
contour delineation uncertainty.   
 
Figure 30:  Illustrative slice of comparison of the ground truth and predicted maps (top 
row) with the maps overlaid on the corresponding image. Of interest is the area predicted 
as bone and its proximity to the rib in the corresponding image. 
 
A summary of all the networks investigated as part of specific aim 2 can be seen in 
Table 10.   
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Table 10: Summary of networks investigated and findings. 
Network Name Task Description Results 
Initial CNN 
Identify interface 
type including ‘not 
interface’ class 
Traditional CNN structure 
with 6 weight bearing 
layers and small subject 
set. 
Interface types able to 
be identified with 
moderate accuracy 
Extended CNN 
Identify interface 
type including ‘not 
interface’ class 
Traditional CNN structure 
with 8 weight bearing 
layers and expanded 
subject set. 
Increased accuracy of 
predictions, but false 
positives for ‘not 
interface’ class 
ResNet CNN 
Identify interface 
type including ‘not 
interface’ class 
Modified extended CNN 
with skip connections 
across 2 convolution 
layers and followed by 
varying number of identity 
layers 
Reduced number of 
false positives from 
extended ResNet CNN, 
and achieved moderate 
accuracy 
Encoder Net 
Identify presence 
of interface and 
which type 
Modified extended CNN 
with skip connections 
across 1 convolution layer 
and followed by varying 
number of identity layers.  
Preforms 2 tasks 
simultaneously combined 
loss function and two 
predictions per patch.  
Trade off in accuracy 
regarding if a patch is 
an interface or which 
interface type.  Hinted 
the network may not 
identify tumor location 
BinaryRes_IF Identify presence of interface 
Modified encoder net for 
only interface presence.  
Input became binary labels 
with only one loss function 
and output per patch 
Confirmed suspicion 
that network was not 
identifying tumor 
location before 
identifing interface 
BinaryRes_Tumor Identify presence of tumor 
Same network as 
BinaryRes_IF, input data 
altered to contain labeled 
image patches indicating 
presence of tumor 
Network achieved good 
accuracy for most 
patients.  False 
positives in regions of 
involved lymph nodes, 
muscle, and atelectasis 
IF_Only 
Identify interface 
type without ‘not 
interface’ class 
Modified encoder net for 
only interface presence.  
Input became binary labels 
with only one loss function 
and output per patch 
Network achieved good 
accuracy for most 
interfaces particularly 
with top 2 and 3 results.  
Basis of information 
provided to physician 
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4.4 Uncertainty tool 
The uncertainty tool proposed by this aim seeks to combine the predictive power of 
the IF_Only network with a measure of uncertainty in the interface.  As discussed in 1.4 
Contour Delineation Uncertainty, a margin is added to the GTV to account for uncertainty 
such as inconsistencies in set-up, motion, mechanical uncertainties, and others. The 
contour delineation uncertainty is only one of the uncertainties counted as part of this 
margin which for lung cancer is approximately 5mm.  The proposed uncertainty tool seeks 
to provide the probability that the contour delineation uncertainty exceeds the 5mm 
threshold for the interface at the physician selected point. The confidence the network 
has in its interface type prediction is displayed along with the probabilities for the top three 
predictions to provide the physician with additional information. 
The probability of the contour delineation uncertainty exceeding a threshold was 
calculated utilizing the bilinear distances from the median contour to the individual 
contours from the study by Karki el al.83  For this work, only the data for the contours 
drawn using both the PET and CT images for the primary tumor were considered.  The 
probability of exceeding a threshold was calculated by dividing the total number of points 
exceeding the desired threshold by the total number of points evaluated.  The results of 
various thresholds by interface type can be seen in Table 11. 
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The IF_Only network was able to predict the type of interface with suitable accuracy 
for the best guess.  Looking at the top two predictions for the network, the accuracy 
increased to 55%-92% where 14% is guessing.  If the top three predictions are 
considered, the accuracy improves to 75%-97%.  The output of the IF_Only network 
provides the level of activation from the network for all classes providing a measure of 
certainty for the final class assignment.  The activation level of the top three interface 
predictions provides the physician with a measure of certainty from the network that can 
be used with the associated probability of exceeding the 5mm threshold. 
The proposed usage for this tool would be for the physician to click on a point of 
interest along the interface of the tumor.  The uncertainty tool extracts the image patch 
around the point of interest and runs the IF_Only prediction.  The uncertainty tool returns 
the top three interface predictions with the network’s activation levels and associated 
Interface/				
Threshold(mm) AT CW Hilum	 Lung Med Vessel
1 0.9677 0.6871 0.8297 0.8106 0.7062 0.6851
2 0.6615 0.2033 0.3871 0.2375 0.2519 0.0797
3 0.2856 0.0683 0.1375 0.0735 0.0894 0.0036
4 0.0840 0.0300 0.0431 0.0212 0.0285 0.0000
5 0.0264 0.0085 0.0144 0.0081 0.0131 0.0000
6 0.0091 0.0049 0.0047 0.0044 0.0051 0.0000
7 0.0047 0.0031 0.0009 0.0019 0.0009 0.0000
8 0.0018 0.0011 0.0000 0.0004 0.0000 0.0000
9 0.0007 0.0005 0.0000 0.0001 0.0000 0.0000
10 0.0002 0.0000 0.0000 0.0000 0.0000 0.0000
Table 11: Probability of contour delineation uncertainty exceeding various 
thresholds by interface type. 
The probability of exceeding the 5mm threshold is highlighted for all  
 interface types 
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probability of exceeding the 5mm threshold.  The physician can then use this information 
to adjust their contour accordingly.  A mock visualization can be seen in Figure 31. 
   
4.5 Conclusion and Future Work 
This aim developed a potential tool to provide additional information to physicians 
during contouring.  During the course of network exploration, two networks were 
developed that succeeded at performing tumor location and interface type identification 
for known interface patches.  The earlier network designs produced promising results at 
first glance; however, they seemed to struggle with identifying the location of the 
interfaces without guidance.   The initial task appeared too complex to complete in one 
Figure 31:  Mock contour assistance tool.  The network prediction with certainty and 
probability uncertainty exceeds 5mm is presented for the selected point (exaggerated 
red dot with arrow). 
Interface	
Network	
Certainty
Probability	
Uncertainty	
>	5mm
Mediastinum 0.16 0.013
Lung 0.42 0.008
Atelectasis 0.26 0.026
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pass for the simple CNN network structures investigated in this work.  The final tool gives 
additional information to the physicians, but does not propose a tumor contour as has 
been suggested to reduce contour delineation by other research.87  The information 
provided by the developed tool seeks to  improve the contour accuracy by making 
physicians aware of how much uncertainty to expect allowing them to use their best 
judgement in defining the treatment target. 
The networks in their current form have good accuracy, but not high enough for 
clinical use. Additional techniques could be implemented to refine and increase the 
accuracy of the network predictions to provide more accurate information to physicians.  
One such technique is a cascade network where the results of one network are fed to the 
next in order to increase the accuracy of the second network or to refine the output.123,156 
Christ et al.156 first trained a network to identify the liver then the second network identified 
the liver lesions.  For the interface prediction, this technique could increase the accuracy 
by first training the network to identify if an interface belongs to an easier to identify class 
such as lung/tumor interface and the second network could be trained to distinguish 
between similar tissues such as atelectasis and the mediastinum. 
In future work, the BinaryRes_Tumor network could be modified to include the PET 
data as an additional channel during network training and prediction which may improve 
the accuracy of the tumor identification.  This type of network could be used in an 
alternative manner to reduce tumor uncertainty by first suggesting a tumor contour and 
allowing the physician to refine the contour as necessary. An alternative potential 
extension with cascade networks could be to first train a network to identify the lung, 
including pathology within a candidate region, and then identify the tumor. This could 
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reduce the false positives in muscle tissue outside the lung.   The percentage certainty of 
the network for each voxel could then be used to highlight were the network was uncertain 
in the tumor location and a physician could expect larger uncertainty.  
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5 Conclusion 
 
 
 
The goal of this dissertation was to investigate the feasibility of building MR and multi-
modality predictive models for lung cancer and to investigate the feasibility of using 
machine learning techniques to build an uncertainty model to aid in contour delineation. 
The first aim of this work was to investigate the feasibility of building predictive models 
using single CT and MR modalities and multi-modality models.  Repeatability for the MR 
texture features was first determined and compared with the repeatability of CT features. 
Several texture features were identified as repeatable for MR and CT images suggesting 
MR could be used as a basis for predictive modeling provided standardized imaging 
techniques are used.  Next, a workflow for creating predictive models was developed and 
used to identify predictive models for single modality MR and CT features, as well as  
multi-modality models for local control at the end of treatment, and overall survival at 12, 
18, and 24 months. Two different feature selection techniques were investigated as part 
of the work flow.  After controlling for false discovery rates, multiple significant models 
were identified for overall survival while the local control at the end of treatment models 
were not significant.  A control experiment was conducted on normal tissue to further aid 
in identifying spurious results. The normal tissue models identified the medoid feature 
selection method as a more robust method for the small subject group used in this study 
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as it produced a smaller number of significant models for tumor outcome.  The accuracy 
of the significant MR models was comparable to the significant CT models and MR 
features appeared in the top multi-modality models as well, suggesting that further study 
of MR features in a larger patient cohort is warranted.    
The second aim of this work sought to investigate the feasibility of building an 
uncertainty model to aid in physician contour delineation.  This work built on previous 
work by Karki et al.83 to investigate the link between the tumor interface type and the 
amount of uncertainty.  While the interface type alone was not enough to explain the level 
of uncertainty, there appeared to be a relationship between uncertainty and interface type.  
Several convolution neural networks were tested to predict the interface type and tumor 
location from image patches.  The accuracy of the interface type prediction network 
developed achieved moderate accuracy on the best guess but was significantly improved 
by scoring the top 2 or 3 interface class accuracy. The tumor location network had an 
acceptable accuracy for most patients; however, still struggled with similar looking 
physiology, such as near atelectasis.  Further refinement would be needed for either 
network to be clinically acceptable, but the results show neural networks warrant further 
research in lung cancer. 
Improved patient treatment and outcome is a constant goal in radiation oncology.  
Being able to predict treatment outcome prior to, or early during treatment, and improving 
accuracy of treatment targets are two ways to improve on current practices.  The results 
of this work investigated the potential uses of radiomics in MR imaging for lung cancer as 
well as convolutional neural networks to assist in contour delineation by providing 
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physicians with addition information.  These techniques show promise and should be 
investigated further. 
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Title 
Repeatability of Magnetic Resonance Image Derived Texture Features and Use in Predictive 
Models for Non-Small Cell Lung Cancer Outcome 
 
Authors 5	
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Abstract 
Purpose: To evaluate the repeatability of MRI and CT derived texture features and investigate 
feasibility of use in predictive single and multi-modality models for radiotherapy of non-small cell 
lung cancer. 15	
 
Methods: Fifty-nine texture features were extracted from unfiltered and wavelet filtered images.  
Repeatability of test-retest features from helical 4D CT scans, true fast MRI with steady state 
precession (TRUFISP), volumetric interpolation breath-hold examination (VIBE), and diffusion 
weighted MRI (both the acquired images and processed apparent diffusion coefficient (ADC) 20	
images) was determined by the concordance correlation coefficient (CCC).  A workflow was 
developed to predict overall survival at 12, 18, and 24 months and tumor response at end of 
treatment for tumor features, and normal tissue features as a control. Texture features were 
reduced to repeatable and stable features before clustering. Cluster representative feature 
  129 
 
	 2	
selection was performed by univariate or medoid analysis before model selection. P-values 25	
were corrected for false discovery rate. 
 
Results: Repeatable (CCC ≥ 0.9) features were found for both the tumor and normal tissue: CT: 
54.4% for tumor and 78.5% for normal tissue, TRUFISP: 64.4% for tumor and 67.8% for normal 
tissue, VIBE: 52.6% for tumor and 72.9% for normal tissue, DWI: 10.2% for tumor, ADC: 18.6% 30	
for tumor. Normal tissue control analysis found 7 significant models with 6 of 7 models utilizing 
the univariate representative feature selection technique. Tumor analysis revealed 12 significant 
models for overall survival and 0 for tumor response at end of treatment. The accuracy of 
significant single modality was about the same for MR and CT. Multi-modality tumor models had 
comparable performance to single modality models. 35	
 
Conclusion: MR derived texture features may add value to predictive models and should be 
investigated in a larger patient cohort.  Control analysis demonstrated the medoid 
representative feature selection method may result in more robust models. 
 40	
Keywords 
Radiomics; magnetic resonance imaging; computed tomography; texture features; repeatability; 
predictive modeling; lung cancer 
 
Introduction  45	
 
In recent years, predictive models built on imaging features have been investigated as 
biomarkers for various clinical endpoints and anatomical sites. This research area, termed 
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	 3	
‘radiomics’, seeks to extract a large number of pre-determined features from an image and use 
these features to phenotypically characterize the tissue in question. Imaging features that 50	
quantitatively describe tissue characteristics such as texture and shape are used in various 
models to predict treatment response.  In addition, a sub area of radiomics, delta radiomics, 
seeks to extract information from the changes in the extracted texture features as a result of 
treatment-induced changes.3–5  Both single time point, such as pre-treatment, and delta 
radiomics features have been used to explore correlations between the extracted features and  55	
histology6, gene mutation5, 7, local control8–11, distant metastasis, and overall survival3, 12–15.3, 16–18 
Utilizing the information contained in medical images is attractive for two reasons: it is non-
invasive and gives information of the whole tumor volume unlike a biopsy, and can often be 
extracted from images obtained for routine patient management purposes. Radiomics for lung 
cancer has primarily focused on computed tomography (CT) and positron emission tomography 60	
(PET) images.4, 5, 9, 19–22 Magnetic Resonance (MR) images, on the other hand, have been less 
prominently studied for use in lung cancer, partly due to the high variability in the extracted 
features due to variations in imaging protocol and acquisition signal.23–31 However, the superior 
soft tissue contrast and lack of additional dose to a patient treatment make MR a potentially 
useful imaging modality for lung cancer radiomics. In addition, with the introduction of MR 65	
simulation and use of MR for image guidance, MR images may become more common in the 
radiation treatment workflow which makes the exploration of their potential desirable. 
 
This work aims to first characterize the repeatability of MR texture features of lung cancer 
extracted from a single machine and imaging protocol and compare them to CT texture features 70	
extracted with the same workflow.  Then, for pretreatment CT and MR images, utilize the 
repeatable features to assess the feasibility of predicting local control and overall survival for 
each modality individually and for a set of multi-modality models.  For validation of the selected 
models in lung cancer and to serve as a control, predictive models were also constructed for 
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normal tissue features which were expected not to change in response to radiation treatment or 75	
predict treatment outcome for the same endpoints.   
 
Methods 
 
Patient characteristics  80	
This study utilized images of 15 subjects with non-small cell lung cancer enrolled on an IRB 
approved study. Diffusion weighted and morphological MRI and CT images before and during 
the course of radiotherapy were acquired in order to investigate the potential use of MRI in lung 
cancer treatment planning and response evaluation. All subjects underwent radiation therapy 
with or without concurrent chemotherapy for stage IIB to IV non-small cell lung cancer per 85	
department protocol. See Table 1 for summary of patient characteristics. 
  
  132 
 
	 5	
 
 
Images  90	
Five different imaging types were evaluated in this study: T1-weighted Volumetric Interpolation 
Breath-Hold Examination (VIBE), True fast MRI with steady state precession (TRUFISP), 
diffusion weighted MRI (both the acquired images and processed apparent diffusion coefficient 
(ADC) images), and helical 4D CT scans. The ADC maps were created utilizing 8 b-value DWI 
images (b-values between 0 and 1000 s/mm2). MR images were all acquired on a 1.5 T scanner 95	
(Avanto, Siemens, Munich, Germany), CT images were acquired as 4D images (Brilliance Big 
Bore, Philips, Amsterdam, Netherlands). Table	2 details the different imaging parameters used 
for each modality. 
 
Table	1:	Summary	of	patient	characteristics		
for	texture	feature	repeatability	study.		
	
	
Male	 10
Female	 5
Squamous	cell	carcinoma	 9
Adenocarcinoma	 6
IIB 3
IIIA 6
IIIB 4
IV 2
Yes 12
No 3
Mean	Dose	(Range)
61.6	(59.4-66)	Gy
59.1	(50.0-73.4)	years
Sex
Mean	Age	(Range)
Histology	
Stage
Chemotherapy
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Sets of CT and MR images were acquired on the same day before treatment (“Time 1”), 100	
approximately three weeks into treatment (“Time 2”) and/or at the conclusion of treatment 
(“Time 3”). To evaluate the repeatability of texture features extracted from the various imaging 
modalities, test-retest image sets were acquired utilizing the same protocol with a short break 
(“coffee break”) in between scans without repositioning the patients. Images were acquired 
utilizing 4D acquisition for the CT images, breath hold for the TRUFISP and VIBE images and 105	
respiration triggering for the DWI images.  The short time interval between the two image sets 
allows for evaluation of random changes in a texture feature as it can be assumed that there is 
no true physiological change in the tumor between the two images. The 4D CT images were 
comprised of 33 pairs of inspiration and expiration phase images. While the TRUFISP and VIBE 
images totaled 34 and 32 same session inspiration-expiration breath-hold image pairs 110	
respectively. For the diffusion weighted and corresponding ADC maps, there were 8 imaging 
pairs with slice thickness difference of 4mm or 6mm and 16 ascending or interleaved acquisition 
pattern image pairs for the repeatability analysis referred to as “Thickness” or “Order” 
respectively. Table 3 outlines the test – retest image pairs available for all subjects in the study. 
Table	2:	Summary	of	imaging	parameters	for	each	modality.	
	
	
CT TRUFISP VIBE DWI
Machine	 Phillips	Brilliance	Big	Bore Siemens	Avanto	1.5	T	 Siemens	Avanto	1.5	T	 Siemens	Avanto	1.5	T	
Contrast No No No No
Pixel	Spacing 0.98mm	to	1.37mm 0.74mm 1.57mm 2mm
Slice	Thickness	 3mm	 5mm 1.6mm	or	2mm 4mm	or	6mm
Gap 3mm 6.4mm 0 4.8mm	to	9.6mm	
In-plane	Matrix	Size 512	x	512 512	x	512 208	x	256 144	x	192
Breathing	Regulation Free	Breathing Breath	Hold Breath	Hold Respiration	Triggered
kVp 120	or	140 NA NA NA
Coil NA Body Body Body
Flip	angel	 NA 57	or	66	degrees 12	degrees 90	degrees
TR NA 3.65ms 3.56ms Various	
TE NA 1.82ms	to	1.89ms 1.28ms 74
Number	of	Echos NA 1 1 1
Echo	Train	length	 NA 1 1 1
Number	of	Averages	 NA 1 1 2
b-values
NA NA NA
0,	50,	100,	250,	500,	650,	
800,	and	1000	mm/s2
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Region of Interest  
The primary gross tumor volume was delineated as the region of interest (ROI) by one 
experienced radiation oncologist on one of the images in the image pair using clinical 
segmentation and registration software (MIM Maestro v6.X, Cleveland, OH). The test and retest 
images were rigidly registered together, and the contour was transferred to the corresponding 120	
image and manually adjusted as necessary to ensure the volumes had a no greater than 10% 
difference and visually defined the tumor.  The normal tissue contours used to build a control 
model consisted of a cylindrical volume of 5.75 mL, sampled from an erector spinae or 
infraspinatus muscle outside the radiotherapy fields depending on primary tumor location. In 
addition to the muscle contours, blood contoured inside the descending aorta and air contoured 125	
inside the trachea were also tested.   
 
 
	
Table	3:	Summary	of	test-retest	image	pairs		
available	for	all	subjects	in	the	study.	
	
”Thickness”	refers	to	different		
slice	thicknesses	between	the	test	and	re-test	
images	and	”Order”	refers	to	different	
slice	acquisition	orders.	
Time	1 Time	2 Time	3
CT	 15 9 9
TRUFISP 15 10 9
VIBE 16 9 7
DWI_Thickness 4 2 2
DWI_Order 4 6 6
ADC_Thickness 4 2 2
ADC_Order 4 6 6
  135 
  
	 8	
Texture Features 130	
Fifty-nine texture features were extracted, Table 4, at five different wavelet ratios, 0.5, 0.67, 1, 
1.5, and 2, utilizing the Radiomics Matlab code (2016b, MathWorks, Natick, MA) by Vallières et 
al. which was extended in-house to include additional texture features, quantization by the gray 
level number, and to increase speed of code.16 Prior to feature extraction, all images were 
resampled to the in-plane voxel size, and for the MRI images, any voxels with intensity greater 135	
than +/- 3s from the mean were removed as suggested by Collewet et al. for greater feature 
stability.24   The gray level values were used as the bins for quantization resulting in a bin width 
of 1HU. 
 
The extracted texture features were from five different texture feature categories: the intensity 140	
histogram, the gray level occurrence matrix (GLCM) with features calculated as described by 
Haralick et al.32  and extended by Conners et al.33, the neighborhood gray tone difference matrix 
(NGTDM) with features calculated as described by Amadasun and King34, the gray level run 
length matrix (GLRLM) with feature described by Galloway35, and the gray level size zone 
difference matrix (GLSZM) with feature calculated as described by Thibault et al.36  The different 145	
Table	4:	List	of	all	59	texture	features	extracted	from	images.	
	
Texture	catagories	are:	Grey	Level	Co-Ocurrence	Matrix	(GLCM),	the	Neighborhood	Gray	Tone	Difference	
Matirx	(NGTDM),	Gray	Level	Run	Length	Maritx	(GLRLM)	and	Gray	level	Size	Zone	Matrix	(GLSZM)	
	
Histogram GLCM NGTDM GLRLM GLSZM
Variance Energy Coarseness Short	Run	Emphasis	(SRE) Small	Zone	Emphasis	(SZE)
Skewness Contrast Contrast	(ContrastN) Long	Rum	Emphasis	(LRE) Large	Zone	Emphasis	(LZE)
Kurtosis Entropy Busyness Gray	Level	Non-Uniformity	(GLN) Gray	Level	Non-Uniformity	(GLNS)
Standard	Deviation	(SD) Homogeneity Complexity Run	Length	Non-Uniformity	(RLN) Zone	Size	Non-Uniformity	(ZSN)
Mean Correlation Strength Run	Percentage	(RP) Zone	Percentage	(ZP)
Minimum Sum	Average Low	Gray	Level	Run	Emphasis	(LGRE) Low	Gray	Level	Zone	Emphasis	(LGZE)
Maximum Variance	(VarianceG) High	Gray	Level	Run	Emphasis	(HGRE) High	Gray	Level	Zone	Emphasis	(HGZE)
Median Dissimilarity Short	Run	Low	Gray	Level		Emphasis	(SRLGE) Small	Zone	Low	Gray	Level	Emphasis	(SZLGE)
Quartile1 Mean	Pair	Sum	(MeanPS) Short	Run	High	Gray	Level		Emphasis	(SRHGE) Small	Zone	High	Gray	Level	Emphasis	(SZHGE)
Quartile2 Variance	Pair	Sum	(VariancePS) Long	Run	Low	Gray	Level		Emphasis	(LRLGE) Large	Zone	Low	Gray	Level	Emphasis	(LZLGE)
Entropy	Pair	Sum	(EntropyPS) Long	Run	High	Gray	Level		Emphasis	(LRHGE) Large	Zone	High	Gray	Level	Emphasis	(LZHGE)
Variance	Pair	Difference	(VariancePS) Gray	Level	Variance	(GLV) Gray	Level	Variance	(GLVS)
Entropy	Pair	Difference	(EntropyPD) Run	Length	variance	(RLV) Zone	Size	Variance	(ZSV)
Information	Correlation	Measure	1	(InfoCorr1)
Information	Correlation	Measure	2	(InfoCorr2)
Auto-Correlation	(AutoCorr)
Cluster	Prominence	(ClusterProm)
ClusterShade
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texture categories capture first order texture features through the intensity histogram as well as 
second order features which encode information about the spatial distribution of the voxels 
through the other categories. The higher order features were derived from the GLCM, which 
measures the co-occurrence of different voxel intensities in a defined distance and direction 
away, the GLRLM, which measures characteristics of the distribution of connected isointense 150	
voxels in a given direction, the GLSZM, which extends the GLRLM feature to connected 
isointense voxels in all direction, and the NGTDM, which characterizes the difference between a 
voxel and its neighbors.  The GLCM and GLRLM feature were averaged across all directions to 
make features rotationally robust.  For all image sets except the DWI/ADC images, 3D texture 
features were calculated.  For several patients, the large tumor volumes were not completely 155	
covered by the DWI protocol. Therefore, multiple overlapping acquisitions were used to cover 
the entire tumor volume as recommended in the imaging protocol.  In this situation, because of 
slice to slice intensity variations, a surrogate 3D texture feature value was calculated for the 
DWI/ADC images by using a volumetrically weighted average of the texture features calculated 
from non-overlapping 2D slices.  160	
 
Repeatability Analysis 
An analysis of the repeatability of texture features extracted from each image type was 
performed with R (3.3.1) in R Studio (1.0.143, RStudios Inc., Boston, MA).  First, repeatability of 
texture features was assessed for all image types at all 3 time points by using the concordance 165	
correlation coefficient (CCC) as described by Lin et. al. utilizing all available time points for each 
image type.37 The CCC measures the correlation between two paired measurements by 
calculating the deviance from perfect one-to-one correlation.  
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Outcomes Modeling 170	
Texture features were evaluated for predictive power in logistic regression models for local 
control and overall survival.  Prior to model selection, the features were first reduced to 
repeatable and stable features before clustering.  After clustering, a representative feature from 
each cluster was selected as a candidate for modeling.  The “best” models were selected based 
on accuracy and fit according to each clinical endpoint. The workflow process can be seen in 175	
Figure 1 and is described in greater detail below.  
	
Figure	1:	Workflow	for	model	selection.		
Read	Raw	Texture	 Feature	Data
Remove	1	Subject	from	Raw	Data
Limit	to	Stable	and	Repeatable	
Test	Data,	Format	Data,	and	
Perform	 Z-Score	Normalization
Append	Results	
of	Each	Fold	to	
Separate	Data	Set	
Perform	 Test	Re-test	Analysis	to	
Determine	 CCC	and	Repeatable	
Features
Limit	Data	to	Only	Representative	
Features	and	Add	Response	Data:	
Modeling	Data
Perform	 Clustering,	 Determine	
Optimum	Number	 of	Clusters,	
and	Representative	Features	
Perform	 Logistic	Regressions	for	
Each	Endpoint	 and	Image	Type
Determine	 CCC	Stability	Across	K	
Leave-One-Out	Folds	and	Save	
Stable	Features	List
Select	‘Best’	 Models	Based	on	
Accuracy	and	AIC/BIC
Repeatability
Clustering
Modeling
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Feature Reduction 
Repeatability was again computed as part of the model selection workflow using a leave-one-
out cross validation of only the pretreatment images in order to select stable features and 
increase robustness of the models. During model selection, a feature was deemed repeatable if 180	
the CCC value exceeded a cut off of 0.9 as recommended by McBride.38 If the 0.9 cutoff failed 
to produce more than 5 repeatable texture features, the cutoff was lowered in 0.05 steps until at 
least 5 features were found with 0.7 being the minimum allowed cutoff to compensate for having 
less than the 25 recommended samples. The stability of the CCC calculation was determined by 
the coefficient of variation (COV) across all folds.  Texture features with a COV less than 5% 185	
were considered stable repeatable features and included in the feature reduction and model 
selection process.  
 
Representative Feature Selection 
A z-score normalization was then applied to the subset of repeatable and stable features before 190	
undergoing hierarchical clustering based on the absolute value of the Spearman distance using 
the Cluster Consensus Plus package (1.38.0, open source, Bioconductor.org) in R with an 85% 
subject resample and 1000 iterations.39  The optimum number of clusters was determined by 
identifying the highest median cluster consensus from the range of cluster numbers k=[5,7].  
The upper bound was selected in order to have twice as many pretreatment subjects images as 195	
texture features in the model as is generally recommended in regression,  and the lower bound 
selected to be the minimum number of clusters where the relative change in the area under the 
cumulative density function curve, which is the ‘Delta Area’ plot returned as part of the 
consensus cluster plus package output, appeared to become stable.39 
 200	
A representative feature was selected from each of the k clusters of the optimum number 
previously established by one of two methods: medoid or univariate prognostic power.  With the 
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medoid selection process, the Spearman correlation among cluster members was calculated 
and the feature with the highest average correlation was selected.20, 40  For the univariate 
prognostic power selection, a log likelihood ratio test was performed comparing the model with 205	
each individual feature to the model containing only the intercept, and the feature with the most 
significant log likelihood p-value was selected as the representative feature.3   
 
Model Selection 
Following feature reduction and representative feature selection, an exhaustive search of all 210	
possible models was performed for the CT, VIBE and TRUFISP pre-treatment images only.  
The sample size of the remaining image types and time points was too small for consideration. 
The logistf package41 in R was used to regress the selected variables to four different endpoints: 
Overall survival at 12 (OS_12), 18 (OS_18) and 24 (OS_24) months and tumor response at end 
of treatment (PT_endTx). For the OS_12, OS_18 and PT_endTx there were 14 available 215	
subjects. One subject was lost to follow up after 20 months and was not included in the OS_24 
dataset resulting in a total of 13 subjects’ data being available for modeling at this time point. 
The maximum likelihood equation was penalized using the Firth method42 to reduce small 
sample bias, and the “best” models were selected based on a combination of high leave-one-
out cross validation accuracy, low Akaike information criterion (AIC), and low Bayesian 220	
information criterion (BIC).  One model for each outcome, image type, and representative 
feature selection method was selected and compared resulting in a total of 48 models.  The 
selection methods and image processing methods were compared on the basis of corrected 
significance, and accuracy to determine the “best” 4 models for each image type. For 
significance testing, the log likelihood ratio test was used to compare the selected model to the 225	
model containing only the intercept.  The log likelihood ratio test p-values were corrected using 
the Benjamini-Hochberg-Yekutieli (BHY) procedure43   to control for multiple dependent 
comparisons with an acceptable false discovery rate of 0.05.  
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The single modality and muscle studies utilized all available pretreatment images, while the 230	
multi-modality study utilized the subset of 9 patients with all three pre-treatment images.  The 
multi-modality data set was created by concatenating all the repeatable and stable features from 
each of the three modalities into one data set then proceeding with clustering, representative 
feature determination, and model selection.  For comparison, the single modality clustering, 
representative feature determination and model selection process was repeated for the same 235	
subset of 9 patients. In the case of the single modality utilizing the full image set and muscle 
studies, only the best model was selected, while for the multi-modality and comparison single 
modality image study, the top 3 models were compared for trends due to the sample size. 
 
Results  240	
 
Repeatability 
Three different tissue types were investigated for the normal tissue control, blood within the 
descending aorta, air within the trachea and muscle.  The blood and air were not used as 
repeatability was difficult to establish using the CCC calculation as small difference between test 245	
and re-test value caused a large drop in CCC value with the narrow range of values in the 
population.  Analysis for the normal tissue control modeling was completed on texture features 
derived from the muscle contours and revealed a number of repeatable and stable features. For 
the wavelet with the highest number of repeatable features, each of the modalities achieved the 
following results:  CT: 55.9% of features were considered highly repeatable (CCC ≥ 0.95) and 250	
an additional 18.6% were considered repeatable (CCC ≥ 0.9), TRUFISP:  59.3% highly 
repeatable features and an addition 8.5% repeatable features, VIBE: 47.5% highly repeatable 
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features and an additional 25.4% repeatable features.  The DWI and ADC images were not 
tested for the normal tissue. 
 255	
The CCC score for the top 25 repeatable primary tumor features from all time points for each 
image type can been seen in Table 5. The b-value of 650 s/mm2 for the diffusion weighted 
images was selected because it had the most repeatable features for the images without 
perfusion contamination for both the DWI_Order and DWI_Thickness image sets.  For the 
wavelet with the highest number of repeatable features, each of the modalities achieved the 260	
following results:  CT: 39% of features were considered highly repeatable (CCC ≥ 0.95) and an 
additional 24.4% were considered repeatable (CCC ≥ 0.9), TRUFISP:  16.9% highly repeatable 
features and an addition 47.5% repeatable features, VIBE: 3.4% highly repeatable features and 
an additional 49.2% repeatable features, DWI_Order: 10.2% repeatable features, ADC_Order: 
18.6% repeatable features, DWI_ Thickness and ADC_Thickness: 0% repeatable features. 265	
There were several features that were repeatable across multiple modalities as can be seen in 
Table 5. In addition, texture features were found to be repeatable across the majority of the 
different wavelet filtered images in 97.5% for CT images, 76.1% for TRUFISP images, 84.8% for 
the VIBE images, 28.6% of the DWI_Order image, and 100% in the ADC_Order image.  The 
percentage of repeatable texture features from each category (histogram, GLCM,…) was 270	
approximately the same within each imaging modality. For the CT image all texture categories 
had a percentage of repeatable features between 60% and 80%, for TRUFISP the majority of 
texture feature categories were between 83%-100% with the exception of histogram features 
where only 40% were repeatable at any wavelet ratio, and for VIBE all texture categories were 
between 46% and 62% repeatable. For the DWI_Order, the GLRLM and GLSZM were both at 275	
8% and all other categories at 0% and for the ADC_Order, the GLCM, GLRLM and GLSZM 
were between 15% and 23% while the NGTDM had the most at 40% and the histogram feature 
the least at 0%. There were no repeatable features for the DWI_Thickness or ADC_Thickness. 
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Model Selection 280	
Preliminary analysis of feature clusters revealed that individual texture features from different 
wavelets were in the same clusters regardless of image type.   Therefore, only the texture 
feature values from the wavelet ratio 1, the unfiltered image, denoted “image_1” or “feature_1”, 
and texture feature values averaged across all wavelet ratios, denoted “image_avj” or 
“feature_avj”, were considered.  During feature reduction, the minimum repeatability cutoffs 285	
used for any leave one out fold for the primary tumors were: 0.9 for CT_avj and CT_1, 0.85 for 
VIBE_avj, VIBE_1, and TRUFISP_avj, and 0.8 for TRUFISP_1.  The minimum threshold for 
repeatability in any leave one out fold for the muscle was 0.9 for all image types.   
 
Regarding the normal tissue contours, for the VIBE_avj , VIBE_1 and CT_avj there were 32 290	
features available for clustering, TRUFISP_avj had 35, TRUFISP_1 had 29, and CT_1 had 25.  
The optimum number of clusters as determined by the highest median cluster consensus was 7 
for CT_1 and VIBE_avj, 6 for the CT_avj and TRUFISP_avj, and 5 for the VIBE_1, TRUFISP_1 
images. For CT, no models were found to be significant predictors of tumor outcome. For 
TRUFISP 6 of 16 models and 14/16 models for VIBE were found to be significant predictors of 295	
tumor outcome. The primary tumor had a similar number of repeatable and stable features for 
clustering and optimum cluster number as the normal tissue.  The number of repeatable and 
stable features remaining for clustering for the VIBE_avj was 41, VIBE_1 was 34, TRUFISP_avj 
was 25, TRUFISP_1 was 30, CT_avj was 32, and CT_1 was 35.  The optimum number of 
clusters as determined by the highest median cluster consensus was 7 for the VIBE_avj, 300	
TRUFISP_avj, and TRUFISP_1, 6 for the CT_avj and CT_1, and 5 for the VIBE_avj images. 
 
For the CT images, each filtering and feature selection method produced the same significant 
model.  The selected single modality model found to be significant by the BHY procedure was 
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for OS_12, with an accuracy of 0.93 ± 0.13The only significant models based on the TRUFISP 305	
images were derived from the unfiltered image with medoid feature selection.  The significant 
models from the BHY procedure were: OS_12 with accuracy 0.93 ± 0.13, and OS_18 with 
accuracy 0.87 ± 0.18.  OS_24 and PT_endTx were not determined to be significant.  The VIBE 
significant models were derived from all four combinations of filtering and representative feature 
selection processes with the univariate selection method producing more significant models 310	
than the medoid method PT_endTx was not predicted significantly by any of the tumor models. 
The highest accuracy achieved for the OS_12 was 0.93± 0.13, the OS_18 was 0.93 ± 0.13, the 
OS_24 was 0.86 ± 0.22. The	accuracy	of	the	significant	models	for	the	muscle	and	primary	
tumor	can	be	seen	in	Figure	4. 
 315	
Figure 3 depicts the frequency of texture features occurring within the significant models.  It can 
be seen that while the muscle texture features did produce significant models very few 
overlapped with texture features selected in the best primary tumor models. 
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 320	
	
Figure	4:	Accuracy	of	significant	models	for	primary	tumor	and	muscle	by	modality	and	
image	filtering/representative	feature	selection	technique.	
	
Figure	3:	Comparison	of	texture	features	utilized	within	significant	models		
derived	from	both	the	primary	tumor	and	muscle	tissue	by	modality	and	endpoint.		
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Following the analysis of the normal tissue and single modalities models, a multi-modality model 
selection and reduced subject single modality, referred to as reduced_SM, model selection was 
performed.  Multi-modal and reduced_SM model selection was performed for the PT_endTx, 
OS_12 and OS_24 only as the responses for the reduced patient set for OS_24 and OS_18 end 
points were identical.  In addition, the number of clusters was set to 5 due to the number of 325	
patient remaining.  None of the models were significant under the BHY procedure for any of the 
reduced_SM or multi-modality models. 
 
The top 3 multi-modality models had features from all three modalities represented. The 
TRUFISP derived features appeared in 26 of the 36 models more often than the VIBE (11/36) 330	
and CT (12/36) features.  The average accuracy of the top 3 models was comparable or more 
accurate than the reduced_SM models.  For the OS_12 and OS_24, the multi-modality average 
accuracy by wavelet filtering and representative feature selection ranged from 67% to 85% 
	
Figure	5:	Highest	model	accuracy	by	endpoint	and	modality	for	the	primary	tumor.	
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while the corresponding single modalities ranged in accuracy from 72% to 81%.  For the 
PT_endTx, the multi-modality accuracy had a range of 71%-88% and the corresponding single 335	
modalities ranged from 54%-88%.  Compared to CT only the OS_12 and OS_24 predictive 
ranges were 78%-81% and the PT_endTx was 67%-88% suggesting the multi-modal models 
may add some small accuracy benefits.  A comparison of the highest accuracy for top 3 models 
for all modalities can be seen in Figure 5. 
Discussion  340	
 
Our work evaluated the repeatability of MR derived texture features and their usefulness in 
predictive models as compared to and in combination with CT derived features and models. We 
were able to identify repeatable texture features and predictive models for the primary tumor in 
both the VIBE and TRUFISP image sequences that were significant under the BHY procedure 345	
and had promising accuracy.  In addition, we demonstrated the feasibility of constructing multi-
modality based predictive models that were comparable to the single modality predictive models 
for the primary tumor.  However, since the multi-modality models did not outperform the single 
modality models, this particular combination of multi-modality imaging does not appear 
warranted for the purpose of outcome prediction using above described radiomics approach.  350	
 
Finally, we evaluated the ability of radiomics in out-of-field un-irradiated normal tissue to predict 
tumor outcome. Because this tissue is minimally affected by radiation and tumor response, we 
expected to find no significant relationship between texture features in any modality and 
outcome.  The results of the normal tissue portion of this work emphasizes the need for caution 355	
as a number of MR based models were found to be significant predictors of outcome, but also 
demonstrates how such a technique can be used to assist in model development. For example, 
the use of univariate feature selection from a cluster gave a higher number of spurious results 
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compared to medoid based feature selection. From these results, one can select the medoid-
based method as potentially being more robust, presuming the muscle region has no true ability 360	
to predict patient response to therapy. Furthermore, the features from the significant models 
derived from primary tumor and muscle had no overlap.  
 
By using only one scanner and imaging protocol with manual contours from one physician, we 
were able to reduce many potentially confounding factors that affect texture feature 365	
repeatability.  The features we found to be repeatable for the CT images are comparable to 
findings by Larue et. al.12for their 4D CT images. The repeatability of MR features has not been 
as highly investigated in the literature.   One recent study published by Gourtsoyianni et. al.31 on 
MR texture feature repeatability showed very low repeatability of higher order texture features 
(GLRLM, NGTDM, LGSZM) and more repeatable features in the global (histogram) features 370	
and GLCM.  Some of the features our work found to be repeatable were in agreement with the 
study by Gourtsoyianni et al.; however, it should be noted that the Gourtsoyianni et al. study 
focused on T2-weighted turbo spin echo image technique for rectal cancer whereas this work 
utilized VIBE and TRUFISP image techniques and focused on non-small cell lung cancer. 
 375	
This study was the first, to our knowledge, to investigate the predictive power of un-irradiated, 
out-of-field normal tissue for clinical endpoints.  The discovery of significant predictive models 
on MRI derived from muscle tissue throws some doubt on the connection between the 
radiomics texture features extracted from the tumor and underlying biological processes as it 
suggests the correlation may be spurious. The lack of significant muscle-based models for the 380	
CT images and the reduced number of significant muscle-based models for the VIBE and 
TRUFISP image derived features, on the other hand, suggests that not all the results may be 
spurious and that refinement and further exploration of the general approach described here in 
a larger sample size is needed. It is of interest that the texture features present in the best 
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models were different for the primary tumor and muscle tissue.  In addition, the method of 385	
representative feature selection seemed to have a large impact on the significance.  Of the 7 
significant normal tissue models, 6 were formulated utilizing the univariate representative 
feature selection process.  Several authors3, 6, 12 have used univariate based feature selection 
methods to maximize the chance of predictive power, however, this may also increase the risk 
of finding spurious results.  The medoid method, on the other hand, may select more robust 390	
features by selecting the most similar feature within a cluster, therefore the authors suggest the 
use of the medoid representative feature selection method with the workflow presented in this 
work.   
 
Whereas CT and VIBE based primary tumor models did not seem to favor either the unfiltered 395	
or filtered images as the models have about equal accuracy and significance with the texture 
features averaged across wavelet ratios or unfiltered, TRUFISP tumor models prefer the 
unfiltered features. Overall, the VIBE images resulted in more repeatable and stable features 
than the TRUFISP with a minimum threshold and number of features closer to those derived 
from CT images.  In addition, the texture features selected can be related to tumor in-400	
homogeneity such as dissimilarity and contrast, from the NGTDM, that have been identified as 
correlating with outcome.45 In addition, when considering the significant normal tissue models as 
spurious, the pre-treatment images seemed to be a better predictor of overall survival at earlier 
time points as the significant medoid models were for the OS_12. 
 405	
Evaluating the primary tumor clusters across the different methods and image modalities, there 
appeared to be several general themes that could be identified.  All of the imaging modalities 
had a single cluster of features related to tumor homogeneity and another containing 
coarseness. Another theme present in all but two images were derived from the histogram 
features. Variance and energy related clusters appeared in CT and TRUFISP images.  The final 410	
  149 
 
	 22	
cluster theme consisted of image specific features that were unique clusters to each image type. 
These cluster themes suggest the repeatable and stable features seem to capture some similar 
underlying features of the tumor phenotypes regardless of modality such as homogeneity as 
well as identify where MR images may capture different subtleties suggesting that MR features 
may add additional value to predictive models over just using CT features alone. These results 415	
were further explored in a limited fashion through the multi-modality portion of this work.  
 
For the multi-modality study, our results showed that the accuracy of the top 3 multi-modality 
features were comparable to the top 3 reduced_SM derived models since there were no 
significant models for either reduced_SM or multimodality models with 9 subjects. Multi-modality 420	
models may have a small increased accuracy.  The TRUFISP image derived features were 
present in 72% of the top multi-modality models. With comparable performance and 
predominately TRUFISP based features, the results seem to suggest that the MR models could 
stand alone for predictive power.  However, with the small sample size further testing will be 
required.  Future work should also include information from the routinely acquired pre-treatment 425	
PET scans which have been shown to have some added benefit to CT3, 46 and MR.16   
 
Our work did not seek to evaluate robustness of texture features acquired on different imaging 
machines and locations which would be necessary to establish imaging texture features as 
biomarkers.  One of the main challenges facing radiomics as a whole is establishing a 430	
standardized protocol for image acquisition and texture feature extraction.44  There is a great 
variability of techniques currently used in radiomics and, so far, there has not been a firm 
conclusion on recommended procedure or best practices as far as image processing. As a 
result, the goal of this study was to assess feasibility and potential value for MR texture features 
while comparing them to CT models derived with the same texture feature extraction procedure.  435	
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The main limitation of our study is the small sample size. Due to the challenging nature and 
burden on patients of collection of multi-modality imaging at multiple time points along with 
repeatability studies, only a small pilot cohort was available.  However, techniques to minimize 
bias due to the small sample size were employed throughout.  The Firth small sample bias 440	
penalization to the maximum likelihood values was used during models selection when 
preforming the log likelihood ratio test against a model containing only the intercept.41  This 
procedure adds a small penalty to the maximum likelihood inversely proportional to the sample 
size.  When analyzing the CCC, all time points were considered together to provide a larger 
picture of the range of the texture features present in the subject population which seemed 445	
justified by the overall lack of a significant difference in the texture features when comparing the 
various time points of the populations under the Wilcoxon Rank test.  In addition, clinical factors 
were not included as model selection variables to allow maximum exploration of the texture 
features. Studies have shown that adding radiomics features to models with clinical factors have 
increased the predictive ability of models3 and future work should explore this possibility with 450	
MR features in a larger dataset. 
 
Conclusion  
In this study, we measured repeatability of MR and CT texture features and then used these to 
build models for estimating outcome after radiation therapy for non-small cell lung cancer.  The 455	
results show that MR images may hold valuable information in addition to the features from CT 
images and should be investigated further in a larger patient cohort.  
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GLCM GLRLM
HIST NGTDM
GLSZM
Table	5:	Table	of	top	25	repeatable	texture	features	for	all	image	types.	
	
Highly	Repeatable	
Repeatable
Potentially	Repeatable
Not	Repeatable
Wavelet	Ratio 0.67 1 0.67 1 0.67 1 0.67 1 0.67 1 0.67 1 0.67 1
EntropyPS 0.951 0.945 0.946 0.934 0.924 0.922 0.855 0.866 0.926 0.927 0.729 0.728
InfoCorr1 0.960 0.954 0.932 0.940 0.816 0.808 0.827 0.867 0.772 0.773 0.834 0.827
Coarseness 0.966 0.966 0.968 0.967 0.957 0.941 0.846 0.802 0.731 0.722
Entropy 0.955 0.946 0.932 0.929 0.879 0.898 0.931 0.931 0.794 0.796
EntropyPD 0.956 0.956 0.934 0.928 0.714 0.735 0.869 0.879 0.765 0.744
Median 0.959 0.960 0.914 0.916 0.852 0.852 0.806 0.806 0.713 0.713
Quartile3 0.930 0.929 0.922 0.921 0.869 0.869 0.809 0.809 0.738 0.738
VariancePS 0.952 0.950 0.962 0.961 0.847 0.847 0.781 0.781 0.740 0.740
AutoCorr 0.941 0.941 0.840 0.840 0.741 0.738 0.785 0.785
Complexity 0.954 0.946 0.956 0.955 0.912 0.914 0.819 0.820
Dissimilarity 0.962 0.959 0.926 0.921 0.837 0.837 0.801 0.801
Energy 0.962 0.958 0.918 0.921 0.864 0.876 0.917 0.921
GLN 0.956 0.938 0.934 0.935 0.889 0.890 0.921 0.925
GLNS 0.951 0.943 0.937 0.936 0.902 0.905 0.921 0.925
Homogeneity 0.943 0.947 0.923 0.918 0.870 0.864 0.776 0.772
LGRE 0.970 0.969 0.913 0.931 0.904 0.895 0.900 0.902
LGZE 0.970 0.969 0.920 0.936 0.902 0.874 0.926 0.927
Mean 0.959 0.959 0.911 0.912 0.847 0.846 0.800 0.802
SD 0.947 0.946 0.956 0.953 0.758 0.755 0.782 0.782
Skewness 0.929 0.932 0.870 0.869 0.789 0.794 0.769 0.769
SRHGE 0.942 0.942 0.834 0.834 0.740 0.737 0.787 0.787
SRLGE 0.970 0.969 0.913 0.931 0.906 0.899 0.912 0.914
SZHGE 0.948 0.950 0.834 0.834 0.733 0.726 0.789 0.789
SZLGE 0.970 0.969 0.920 0.936 0.905 0.884 0.904 0.901
Variance 0.951 0.949 0.962 0.961 0.773 0.769 0.764 0.764
Busyness 0.909 0.949 0.768 0.782 0.905 0.914
ClusterProm 0.951 0.947 0.834 0.834 0.823 0.824
ClusterShade 0.952 0.948 0.919 0.919 0.835 0.834
HGRE 0.941 0.942 0.745 0.741 0.787 0.787
HGZE 0.944 0.945 0.747 0.742 0.788 0.788
LRHGE 0.939 0.939 0.755 0.759 0.785 0.785
Maximum 0.850 0.850 0.807 0.807 0.750 0.750
SumAverage 0.933 0.932 0.837 0.840 0.741 0.741
SZE 0.941 0.948 0.941 0.937 0.930 0.921
VarianceG 0.963 0.961 0.828 0.834 0.881 0.882
ZSN 0.945 0.952 0.941 0.938 0.931 0.924
Contrast 0.954 0.952 0.809 0.809
ContrastN 0.955 0.960 0.939 0.926
Correlation 0.887 0.890 0.765 0.765
Kurtosis 0.852 0.839 0.729 0.729
LRLGE 0.970 0.969 0.893 0.877
LZHGE 0.684 0.771 0.780 0.781
MeanPS 0.715 0.714 0.801 0.801
Quartile1 0.959 0.961 0.789 0.789
RLV 0.912 0.895 0.626 0.688
VariancePD 0.950 0.951 0.826 0.826
GLV 0.771 0.732
GLVS 0.801 0.796
LRE 0.912 0.917
LZE 0.932 0.953
LZLGE 0.743 0.795
Minimum 0.692 0.692
RLN 0.914 0.917
RP 0.913 0.917
SRE 0.914 0.917
Strength 0.827 0.817
ZP 0.920 0.920
ZSV 0.844 0.632
ADC_Order DWI_Thickness	
(b-value	650)
ADC_ThicknessCT TRUFISP VIBE	(T1-
weighted)
DWI_Order	(b-
value	650)
Highly	Repeatable:	CCC	≥	0.95		 	 	 Repeatable:		0.90	≤	CCC	<	0.95		
Potentially	Repeatable:	0.85	≤	CCC	<	0.90	 																Not	Repeatable:	CCC	<	0.	
Texture	feature	abbreviations	are	listed	in	table	4.		Texture	features	are	arranged	in	decreasing	
order	of	frequency	across	all	modalities.		Gray	Level	Co-Occurrence	Matrix	(GLCM),	Gray	Level	
Run	Length	Matrix	(GLRLM),	Gray	Level	Size	Zone	Matrix	(GLSZM)	and	Neighborhood	Gray	Tone	
Difference	Matrix	(NGTDM).	
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Appendix II 
 
 
 
Formula for the fifty-nine texture features used in specific aim 1. 
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Histogram Texture Features 
 
Texture features are calculated from the intensity values in a region of interest. 
 
Feature  Formula  Description 
Mean 𝜇 = 	 1𝑁 𝑝<Z<ab  
 
𝑝<is element 𝑖 in the region of 
interest and N is the total 
number of elements in the 
region of interest 
Standard 
Deviation 𝜎 = 	 1𝑁 𝑝< − 𝜇 $Z<ab  
𝑝<is element 𝑖 in the region of 
interest, N is the total number 
of elements in the region of 
interest and µ is the mean 
Variance 𝑉 = 	 1𝑁 − 1 𝑝< − 𝜇Z<ab  
𝑝<is element 𝑖 in the region of 
interest, N is the total number 
of elements in the region of 
interest and µ is the mean 
Skewness 𝑠 = 	 1𝑁 𝑝< − 𝜇 *Z<ab𝜎*  
𝑝<is element 𝑖 in the region of 
interest, N is the total number 
of elements in the region of 
interest, µ is the mean and s 
is the standard deviation. 
Kurtosis 𝑘 = 	 1𝑁 𝑝< − 𝜇 gZ<ab𝜎g  
𝑝<is element 𝑖 in the region of 
interest, N is the total number 
of elements in the region of 
interest, µ is the mean and s 
is the standard deviation. 
Minimum Smallest 𝑝< in region of interest 𝑝<is element 𝑖 in the region of interest 
Median 
Middle 𝑝< in ordered list of all elements if 
odd or average of two middle values if 
even 
𝑝<is element 𝑖 in the region of 
interest 
Maximum Largest 𝑝<in region of interest 𝑝<is element 𝑖 in the region of interest 
Quartile 1 
The 𝑝< separating the lowest 25% of values 
from the upper 75% in ordered list of all 
elements 
𝑝<is element 𝑖 in the region of 
interest 
Quartile 3 
The 𝑝< separating the lowest 75% of values 
from the upper 25% in ordered list of all 
elements 
𝑝<is element 𝑖 in the region of 
interest 
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Gray Level Co-occurrence Matrix Texture Features 
 
Texture features are calculated from the gray level co-occurrence matrix 
 
Feature 	 Formula  Description 
Energy 𝑓b = 𝑝 𝑖, 𝑗 $Zjkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, 𝑁n is the number 
of gray levels 
Contrast 𝑓$ = 𝑛$ 𝑝 𝑖, 𝑗Zjkab
Zj
<ab
Zjp?
qar  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, 𝑁n is the number 
of gray levels. Sum over 𝑖, 𝑗 for all 𝑖, 𝑗 where 𝑖 −𝑗 = 𝑛 only 
Entropy 𝑓* = − 𝑝 𝑖, 𝑗 log	(𝑝 𝑖, 𝑗 )vkabw<ab  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, 𝑁n is the number 
of gray levels 
Homogeneity 𝑓g = 𝑝(𝑖, 𝑗)1 + 𝑖 − 𝑗 $Zjkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, 𝑁n is the number 
of gray levels 
Correlation 𝑓x = 𝑖𝑗 𝑝 𝑖, 𝑗 − 𝜇y𝜇zZjkabZj<ab 𝜎y𝜎z  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, 𝜇y, 𝜇z, 𝜎y, and 𝜎z are the mean µ and 
standard deviation 𝜎 of 
the marginal distributions 
(sum along the columns 
and rows respectively) 
Sum	Average 𝑓{ = 12 𝑖𝑝 𝑖, 𝑗Zjkab + 𝑗𝑝 𝑖, 𝑗
Zj
<ab  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, and 𝑁n is the 
number of gray levels  
Variance 𝑓| = 𝑖 − 𝜇y $𝑝 𝑖, 𝑗Zjkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, 𝑁n is the number 
of gray levels, and 𝜇y is 
the mean of the row 
marginal distributions 
(sum along the columns) 
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Dissimilarity 𝑓} = 𝑖 − 𝑗 𝑝 𝑖, 𝑗Zjkab
Zj
<ab  
(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, and 𝑁n is the 
number of gray levels 
Mean	Pair	Sum 𝑓~ = 𝑥𝑆(𝑥)$Zjya$  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, 𝑁n is the number 
of gray levels and 𝑆 𝑥 = 𝑝(𝑖, 𝑗)<4kay  
Variance	Pair	
Sum 𝑓br = 𝑥 −	𝑓~ $𝑆(𝑥)$Zjya$  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, 𝑁n is the number 
of gray levels, and 𝑆 𝑥 = 𝑝(𝑖, 𝑗)<4kay  
Entropy	Pair	Sum 𝑓bb = − 𝑆(𝑥)log	(S x )$Zjya$ 	 
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, 𝑁n is the number 
of gray levels, and 𝑆 𝑥 = 𝑝(𝑖, 𝑗)<4kay  
Variance	Pair	
Difference 𝑓b$ = 𝑥 − 𝑥𝐷(𝑥) $𝐷(𝑥)Zj2byar  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, and 𝑁n is the 
number of gray levels 
and 𝐷 𝑥 =𝑝(𝑖, 𝑗)<2k ay  
Entropy	Pair	
Difference 𝑓b* = − 𝐷 𝑥 log	(𝐷 𝑥 )Zj2byar  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, and 𝑁n is the 
number of gray levels 
and 𝐷 𝑥 =𝑝(𝑖, 𝑗)<2k ay  
Information	
Correlation	
Measure	1 
𝑓bg = 𝑓* + 𝑝 𝑖, 𝑗 𝑙𝑜𝑔 𝑝y,<𝑝z,kZjkabZj<ab− 𝑝y,<log	 𝑝y,<Zj<ab  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM, and 𝑁n is the 
number of gray levels, 𝑝y 
and 𝑝zare the distribution 
of sums along the 
column and rows 
respectively 
Information	
Correlation	
Measure	2 
𝑓bx = 1 − 𝑒2$ 2    4j@B?jB?  𝑝y and 𝑝zare the distribution of sums along the column and 
rows respectively 
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Auto-Correlation 𝑓b{ = (𝑖𝑗)Zjkab 𝑝 𝑖, 𝑗
Zj
<ab  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM 
Cluster	Shade 𝑓b| = 𝑖 + 𝑗 − 𝜇y − 𝜇z * 𝑖, 𝑗Zjkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM and 𝜇y, 𝜇z is the 
mean marginal 
distributions (sum along 
the columns and rows 
respectively) 
Cluster	
Prominence 𝑓b| = 𝑖 + 𝑗 − 𝜇y − 𝜇z g𝑝 𝑖, 𝑗Zjkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row 𝑖 and 
column 𝑗 element of the 
GLCM and 𝜇y, 𝜇z is the 
mean marginal 
distributions (sum along 
the columns and rows 
respectively) 
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Gray Level Run Length Matrix Texture Features 
 
Texture features are calculated from the gray level run length matrix 
 
Feature  Formula  Description 
Short	Run	
Emphasis 𝑆𝑅𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑗$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Long	Rum	
Emphasis 𝐿𝑅𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑗$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Gray	Level	Non-
Uniformity 𝐺𝐿𝑁 = 1𝑁 𝑝(𝑖, 𝑗)Zkab
$Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Run	Length	Non-
Uniformity 𝑅𝐿𝑁 = 1𝑁 𝑝(𝑖, 𝑗)Zj<ab
$Z
kab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Run	Percentage 𝑅𝑃 = 𝑁𝑝 𝑖, 𝑗 𝑗 
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, and 𝑁 is the total number of 
elements. 
Low	Gray	Level	
Run	Emphasis 𝐿𝐺𝑅𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑖$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
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High	Gray	Level	
Run	Emphasis 𝐻𝐺𝑅𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑖$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Short	Run	Low	
Gray	Level	
Emphasis 
𝑆𝑅𝐿𝐺𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑖$𝑗$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Short	Run	High	
Gray	Level	
Emphasis 
𝑆𝑅𝐻𝐺𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑖$𝑗$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Long	Run	Low	
Gray	Level	
Emphasis 
𝐿𝑅𝐿𝐺𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑗$𝑖$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Long	Run	High	
Gray	Level	
Emphasis 
𝐿𝑅𝐻𝐺𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑖$Zkab
Zj
<ab 𝑗$ 
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Gray	Level	
Variance 𝐺𝐿𝑉 = 1𝑁 𝑖𝑝 𝑖, 𝑗 − 𝜇nZkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 𝑁 
is the total number of 
elements, and 
 𝜇n = bZ 𝑖𝑝(𝑖, 𝑗)ZkabZj<ab  
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Run	Length	
Variance 𝑅𝐿𝑉 = 1𝑁 𝑗𝑝 𝑖, 𝑗 − 𝜇Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (run length) 𝑗 
element of the GLRLM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 𝑁 
is the total number of 
elements, and 
 𝜇 = bZ 𝑗𝑝(𝑖, 𝑗)ZkabZj<ab  
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Gray Level Size Zone Matrix Texture Features 
 
Texture features are calculated from the gray level size zone matrix 
 
Feature  Formula  Description 
Small	Zone	
Emphasis 𝑆𝑍𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑗$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Large	Zone	
Emphasis 𝐿𝑍𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑗$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Gray	Level	Non-
Uniformity 𝐺𝐿𝑁𝑆 = 1𝑁 𝑝(𝑖, 𝑗)Zkab
$Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Zone	Size	Non-
Uniformity 𝑍𝑆𝑁 = 1𝑁 𝑝(𝑖, 𝑗)Zj<ab
$Z
kab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Zone	Percentage 𝑍𝑃 = 𝑁𝑝 𝑖, 𝑗 𝑗 
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, and 𝑁 is the total number of 
elements. 
Low	Gray	Level	
Zone	Emphasis 𝐿𝐺𝑍𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑖$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
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High	Gray	Level	
Zone	Emphasis 𝐻𝐺𝑍𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑖$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Small	Zone	Low	
Gray	Level	
Emphasis 
𝑆𝑍𝐿𝐺𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑖$𝑗$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Small	Zone	High	
Gray	Level	
Emphasis 
𝑆𝑍𝐻𝐺𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑖$𝑗$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Large	Zone	Low	
Gray	Level	
Emphasis 
𝐿𝑍𝐿𝐺𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑗$𝑖$Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Large	Zone	High	
Gray	Level	
Emphasis 
𝐿𝑍𝐻𝐺𝐸 = 1𝑁 𝑝(𝑖, 𝑗)𝑖$Zkab
Zj
<ab 𝑗$ 
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 
and 𝑁 is the total number of 
elements. 
Gray	Level	
Variance 𝐺𝐿𝑉𝑆 = 1𝑁 𝑖𝑝 𝑖, 𝑗 − 𝜇nZkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 𝑁 
is the total number of 
elements, and 
 𝜇n = bZ 𝑖𝑝(𝑖, 𝑗)ZkabZj<ab  
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Zone	Size	
Variance 𝑍𝑆𝑉 = 1𝑁 𝑗𝑝 𝑖, 𝑗 − 𝜇Zkab
Zj
<ab  
𝑝(𝑖, 𝑗) is the row (gray level) 𝑖 and column (zone size) 𝑗 
element of the GLSZM, 𝑁n is 
the number of gray levels, 𝑁 
is the maximum run length, 𝑁 
is the total number of 
elements, and 
 𝜇 = bZ 𝑗𝑝(𝑖, 𝑗)ZkabZj<ab  
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Neighborhood Gray Tone Difference Matrix Texture Features 
 
Texture features are calculated from the neighborhood gray tone difference matrix. 
 
Feature  Formula  Description 
Coarseness 𝑓b = 1𝑁<𝑁 − 2𝑑 $ 𝑠(𝑖)<ar  
𝑠(𝑖) is the 𝑖th element of the 
NGTDM, 𝐺 is the maximum 
gray level, 𝑁< is the number 
of elements of with gray tone 𝑖 in the image, 𝑁 is the total 
number of elements in the 
image, and 𝑑 is the size of the 
neighborhood used to 
calculate the NGTDM 
Contrast 
𝑓$ = 1𝑁n 𝑁n − 1 𝑝<𝑝k 𝑖kar<ar− 𝑗 $ 1𝑁$ 𝑠(𝑖)<ar  
𝑠(𝑖) is the 𝑖th element of the 
NGTDM, 𝐺 is the maximum 
gray level, 𝑝<, 𝑝k = Z(@)Z2$ , 𝑁<(k) is the number of 
elements of with gray tone 𝑖(𝑗) in the image, 𝑁 is the 
total number of elements in 
the image, 𝑑 is the size of the 
neighborhood used to 
calculate the NGTDM, and 𝑁nis the number of distinct 
gray levels. 
Busyness 𝑓* = 𝑝<𝑠(𝑖)<ar 𝑖𝑝< − 𝑗𝑝kkar<ar  
𝑠(𝑖) is the 𝑖th element of the 
NGTDM, 𝐺 is the maximum 
gray level, 𝑝<, 𝑝k = Z(@)Z2$ , 𝑁<(k) is the number of 
elements of with gray tone 𝑖(𝑗) in the image, 𝑁 is the 
total number of elements in 
the image, and 𝑑 is the size of 
the neighborhood used to 
calculate the NGTDM; 	𝑝< ≠0, 𝑝k ≠ 0 
Complexity 𝑓g = 𝑖 − 𝑗𝑁$ 𝑝< + 𝑝k 𝑝<𝑠 𝑖 + 𝑝k𝑠(𝑗)kar<ar  
𝑠(𝑖) is the 𝑖th element of the 
NGTDM, 𝐺 is the maximum 
gray level, 𝑝<, 𝑝k = Z(@)Z2$ , 𝑁<(k) is the number of 
elements of with gray tone 𝑖(𝑗) in the image, 𝑁 is the 
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total number of elements in 
the image, and 𝑑 is the size of 
the neighborhood used to 
calculate the NGTDM; 𝑝< ≠0, 𝑝k ≠ 0 
Strength 𝑓x = 𝑝< + 𝑝k 𝑖 − 𝑗 $kar<ar 𝑠(𝑖)<ar  
𝑠(𝑖) is the 𝑖th element of the 
NGTDM, 𝐺 is the maximum 
gray level, 𝑝<, 𝑝k = Z(@)Z2$ , 𝑁<(k) is the number of 
elements of with gray tone 𝑖(𝑗) in the image, 𝑁 is the 
total number of elements in 
the image, and 𝑑 is the size of 
the neighborhood used to 
calculate the NGTDM; 𝑝< ≠0, 𝑝k ≠ 0 
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Appendix III 
 
 
 
Violin plots of the CT only interface uncertainty by individual subject.  
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Figure 1: Violin plots of the CT only uncertainty by interface type of subject A where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum interface. 
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Figure 2: Violin plots of the CT only uncertainty by interface type of subject B where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum interface. 
●●●
●●●●●●●
●●●
●
●●
●●●●●●●
●●●●●
●●●●●●●●
●●
●
●●●●●
●
●
●●
●●●●●●
0
5
10
15
AT Hilum Lung Med
Interface Type
St
an
da
rd
 D
ev
iat
ion
 (m
m
)
Interface
AT
Hilum
Lung
Med
Subject B  CT Uncertainty by Interface Type
  174 
 
Figure 3: Violin plots of the CT only uncertainty by interface type of subject F where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum interface. 
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Figure 4: Violin plots of the CT only uncertainty by interface type of subject G where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum interface. 
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Figure 5: Violin plots of the CT only uncertainty by interface type of subject I where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum interface. 
●●●
●
●●●●●●
●●●●●●●●●●●●
●
●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●
●
●
●●
●●●●●●●●●
●●●●●●
●●●●●●●●●
●
●
●
●
●
●
●
●
●
●
●
●
●
●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
0.0
2.5
5.0
7.5
AT CW Hilum Lung Med
Interface Type
St
an
da
rd
 D
ev
iat
ion
 (m
m
)
Interface
AT
CW
Hilum
Lung
Med
Subject I  CT Uncertainty by Interface Type
  177 
 
Figure 6: Violin plots of the CT only uncertainty by interface type of subject J where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum interface. 
●●●
●●●●
●●●●●●●
●
●●●
●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
●
●●
●●
●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●●
0
2
4
6
AT Hilum Lung Med
Interface Type
St
an
da
rd
 D
ev
iat
ion
 (m
m
)
Interface
AT
Hilum
Lung
Med
Subject J  CT Uncertainty by Interface Type
  178 
 
Figure 7: Violin plots of the CT only uncertainty by interface type of subject M where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum interface. 
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Figure 8: Violin plots of the CT only uncertainty by interface type of subject N where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum interface. 
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Figure 9: Violin plots of the CT only uncertainty by interface type of subject O where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum interface. 
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Appendix IV 
 
 
 
Violin plots of the PET/CT only interface uncertainty by individual subject.  
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Figure 1: Violin plots of the PET/CT uncertainty by interface type of subject A where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum. 
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Figure 2: Violin plots of the PET/CT uncertainty by interface type of subject B where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum. 
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Figure 3: Violin plots of the PET/CT uncertainty by interface type of subject F where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum.  
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Figure 4: Violin plots of the PET/CT uncertainty by interface type of subject G where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum. 
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Figure 5: Violin plots of the PET/CT uncertainty by interface type of subject I where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum. 
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Figure 6: Violin plots of the PET/CT uncertainty by interface type of subject J where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum. 
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Figure 7: Violin plots of the PET/CT uncertainty by interface type of subject M where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum. 
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Figure 8: Violin plots of the PET/CT uncertainty by interface type of subject N where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum. 
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Figure 9: Violin plots of the PET/CT uncertainty by interface type of subject O where the 
width of the plot represents the probability density function (PDF) of values with the 
indicated standard deviation.  Along the center line is a box plot showing the first 
quartile, median, and third quartile along with the extreme minimum and maximum 
values within 1.5 times the inner quartile range. Values more extreme are indicated by 
dots along the whiskers. AT indicates atelectasis interface, CW indicates the chest wall 
interface, and Med indicates the mediastinum. 
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Appendix V 
 
 
 
Examples of prediction map crated from the BinaryRes_Tumor network output.  
Illustrative slice from all test subjects spread evenly throughout the tumor contour.
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Figure 1: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 2: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 3: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 4: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 5: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 6: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 7: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 8: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 9: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 10: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 11: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 12: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 13: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 14: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
  206 
 
Figure 15: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 16: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice.  
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Figure 17: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 18: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 19: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 20: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 21: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 22: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 23: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 24: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 25: Comparison of the ground truth tumor location map with the predicted location map 
from the BinaryRes_Tumor network following CRF post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Appendix VI 
 
 
 
Examples of prediction map crated from the IF_Only network output.  Illustrative 
slice from all test subjects spread evenly throughout the interface contours.
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Figure 1: Comparison of the ground truth interface labels map with the predicated labels 
map from the IF_Only network no post processing. The top row represents the map of 
true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
  219 
	
Figure 2: Comparison of the ground truth interface labels map with the predicated labels 
map from the IF_Only network no post processing. The top row represents the map of 
true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 3: Comparison of the ground truth interface labels map with the predicated labels 
map from the IF_Only network no post processing. The top row represents the map of 
true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 5: Comparison of the ground truth interface labels map with the predicated labels 
map from the IF_Only network no post processing. The top row represents the map of 
true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 4: Comparison of the ground truth interface labels map with the predicated labels 
map from the IF_Only network no post processing. The top row represents the map of 
true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 6: Comparison of the ground truth interface labels map with the predicated labels 
map from the IF_Only network no post processing. The top row represents the map of 
true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 7: Comparison of the ground truth interface labels map with the predicated labels 
map from the IF_Only network no post processing. The top row represents the map of 
true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 8: Comparison of the ground truth interface labels map with the predicated labels 
map from the IF_Only network no post processing. The top row represents the map of 
true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 9: Comparison of the ground truth interface labels map with the predicated labels 
map from the IF_Only network no post processing. The top row represents the map of 
true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 10: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 11: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 12: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 13: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 14: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 15: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 16: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
  234 
	
Figure 17: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 18: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 19: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 20: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 21: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 22: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 23: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 24: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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Figure 25: Comparison of the ground truth interface labels map with the predicated 
labels map from the IF_Only network no post processing. The top row represents the 
map of true and predicted labels while the bottom row shows the maps overlaid on the 
corresponding image slice. 
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